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Abstract
Retinal lipofuscin (RLF) is an intra-lysosomal accumulating waste product thought to 
be composed of oxidatively modified lipids and proteins. The substrates are proposed 
to be derived from old or damaged organelles and phagocytosed photoreceptor outer 
segments (POS). The material that is not degradable by retinal pigment epithelium 
(RPE) lysosomes accumulates within the cell and has the capacity to photogenerate 
reactive oxygen species. Consequently, the accumulation of RLF within RPE cells has 
been linked to cell dysfunction and the onset of age-related macular degeneration 
(AMD) and other retinal degenerative diseases. This study sought to gain important 
insights into RLF composition and formation, to analyse the efficacy of optical filters 
in reducing photoexcitation of RLF and develop a nanomedicine with the potential to 
prevent RLF accumulating and/or degrade RLF accrued within RPE cells.
Ex vivo RLF granules were isolated and analysed by mass spectrometry to determine 
their protein content, and Western blotting to probe for oxidatively modified 
components. RLF was found to contain a number of molecules adducted to lipid 
peroxidation products and minimal protein. In vitro models of RLF formation were 
designed and their physio-chemical characteristics analysed using: 
spectrophotometry/fluorometry, SDS-PAGE, Western blotting, HPLC and singlet 
oxygen production measurements. The in vitro models shared a number of 
characteristics with ex vivo RLF including: the presence of species adducted to lipid 
peroxidation products, a protein smear on an SDS-PAGE gel and the ability to 
photogenerate singlet oxygen. The capability of yellow-tinted optical filters to reduce 
the blue-light hazard of RLF towards RPE cells was analysed using cell viability 
assays and fluorescence microscopy. Results showed yellow-tinted filters provided 
significant protection to RLF-loaded RPE cells when irradiated with blue-light 
compared to a UV blocking filter or no filter. The suitability of a potential 
nanomedicine for use in abolishing RLF from RPE cells was assessed using: 
fluorescence and transmission electron microscopy, cell viability assays and flow 
cytometry. The study succeeded in identifying a carrier molecule that was localised to 
the lysosomes of RPE cells and an active component capable of degrading POS. 
When conjugated, the nanomedicine displayed the ability to degrade accumulated 
RLF.
The findings presented within this study have enhanced our understanding of RLF 
composition and the key substrates involved in its formation. This has lead to 
proposals of how lipofuscin is associated with the onset of AMD. Studies conducted 
using UV and blue-light blocking optical filters may assist in the future design of 
intraocular lenses and aid ophthalmologists in advising cataract patients of the most 
appropriate lens for surgery. Preliminary work has been undertaken to develop a 
nanomedicine which has been demonstrated to eliminate RLF from the RPE in vitro. 
providing the basis for further development of a therapeutic strategy.
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1. The Retinal Pigment Epithelium
1.1 Structure
The retinal pigment epithelium (RPE) is a monolayer of post-mitotic cells found in the 
neural retina below the photoreceptor layer and overlying the Bruchs’ membrane 
(Figure 1.1). The cells are cuboidal when viewed by cross-section, hexagonal when 
viewed from above and have a characteristic orange/red colour arising from the high 
density of pigment present. There is geographic variation in the size and shape of RPE 
cells throughout the retina, with cells located in the macula being columnar and 
roughly 10-14 pm in diameter, then growing broader and flatter towards the periphery 
with diameters around 60 pm (Marmor, 1998). Despite these variations in size, the 
number of photoreceptor outer segments (POS) opposing each RPE cell remains at 
approximately 45 throughout the retina, emphasising also the variation in POS density 
between the macula and periphery (Newsome, 1983).
RPE cells are polarised into two physiologically and biochemically separate regions, 
the apical and basal portions. The apical portion faces the overlying photoreceptor 
layer and has numerous extending microvilli. The microvilli can be distinguished into 
two separate types. The most numerous are those that are approximately 5-7 pm in 
length and function to increase surface area and thus enhance transepithelial transport. 
The other group of microvilli are often referred to as photoreceptor sheaths; these 
have two variants, one that interacts with rods, the other cones. The basal portion of 
the cell has a membrane that opposes the choroid. This membrane has many deep 
infoldings that increase the surface area of the membrane to maximise the absorption 
of nutrients and disposal of waste.
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Figure 1.1. Low magnification haematoxylin and eosin image of a human eye showing the 
positioning of the RPE between the photoreceptor layer (Ph) and choroid (A). The higher 
magnification image details the microvilli that extend from the RPEs’ apical side into the outer 
segment layer (OS) and the high density o f blood vessels, the choriocapillaries (cc), present below the 
basal side of the RPE (B). (Source: (Marmorstein, 2001)
Each RPE cell is differentiated internally, with a varied distribution of organelles 
throughout the cell (Marmorstein, 2001). The apical section of the cell cytoplasm 
contains many microtubules and microfilaments and is where the greatest 
concentration of melanin granules accumulate. The nucleus together with the many 
mitochondria are located in the mid-section of the cell (Marmorstein, 2001). 
Lipofuscin granules progressively accumulate in the basal to mid-section of the cell 
(Feeney-Bums et al., 1980).
The apical and basal membranes of the RPE are also differentiated with respect to the 
ion channels present in both (Bok, 1993). For instance there are ion pumps such as the 
Na+ -K+ -ATPase located on the apical membranes that are not present on the basal 
membrane (Defoe et al., 1994). This assists transepithelial transport of molecules and 
metabolites to and from the blood and photoreceptors.
1.2 Function
1.2.1 Transepithelial transport
The health of neuronal cells is regulated by accessory cells such as the RPE. The RPE 
plays a central role in regulating the microenvironment of the photoreceptors with
3
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critical roles including phagocytosis of POS, vitamin A transport and metabolism, but, 
most pertinent to this section is its ability to transport ions, fluids and metabolites. 
Transport is generated by proteins present within two distinct membrane domains, the 
apical and basal membranes. The functions of the RPE are illustrated in Figure 1.2.
The movement of water from the photoreceptors to the choroid is blocked via the 
paracellular route because the RPE has tight junctions. Its movement through the 
transcellular route is thought to be assisted by the presence of aquaporin-1 that has 
been detected in the RPE (Stamer et a l, 2003).
Transepithelial transport is important in the removal of lactic acid that is largely 
generated by the photoreceptors from the cells. Removal requires efficient regulation 
of intracellular pH and lactic acid is removed from the subretinal space by the 
Lactate-H+ co-transporter MCT1 and excreted from the basal membrane to the 
choroid by the MCT3 co-transporter (Philp et al., 1998).
Essentially, the RPE transports electrolytes and water from the subretinal space to the 
choroid and it supplies the photoreceptors and neurons with glucose and other 
nutrients including docosahexaenoic acid (DHA). To achieve the transport of glucose 
the RPE contains a number of glucose transporters in the apical and basal membranes 
with both GLUT1 and GLUT3 transporters being highly expressed in the RPE (Ban 
and Rizzolo, 2000).
Another important function of the RPE is the transport of retinol to ensure that retinal 
is supplied to the photoreceptors. Most retinal is cycled between the photoreceptors 
and the RPE, however, the vitamin A (all-zram-retinol) taken up from the blood 
stream does add a small quantity to this process. Uptake occurs in a receptor mediated 
process with recognition by a serum retinol-binding protein/transthyretin complex 
(Pfeffer et al., 1986; Ottonello et al., 1987).DHA uptake into the RPE is a third type 
of transport into the cells. DHA is a major component of the membranes of neurons 
and photoreceptors as well as photoreceptor disks and cannot be synthesised by 
neuronal tissue, therefore, a regular supply is of great importance (Bazan et al., 1990; 
Wang et al., 1992)
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5
Matthew Davies Chapter 1
1.2.2 Blood Retinal Barrier
The RPE acts as a selective barrier and regulator to the microenvironment of 
the over-lying photoreceptor and neural layers. This action is facilitated by the 
existence of tight junctions between adjacent cells meaning that movement of fluids 
and molecules via the transcellular route is lOx less restricted than through the 
paracellular pathway (Miller and Steinberg, 1977).
In this way the RPE is able to regulate the passage of substances from the choroid to 
the retina and vice versa. Passage through the cell is aided by selective transporter 
proteins present in the polarised apical and basal membranes of the cell (see 
transepithelial transport section). The selectivity of these transport proteins allows the 
transfer of metabolites and nutrients, whilst preventing the passage of potentially 
harmful substances. In doing so the RPE maintains the optimal composition of 
intraocular fluids and sustains RPE/photoreceptor function.
1.2.3 Regeneration of visual pigment
The RPE plays a critical role in maintaining the visual process by acting to replenish 
the supply of 11 -cis-retinal to the photoreceptors that is lost during photoactivation 
(Figure 1.3). The visual process begins in photoreceptors when a photon of light 
reacts with the photosensitive molecule, rhodopsin, causing the photoisomerisation of 
1 1-cA-retinal to a[\-trans-roXm&X (ATR).
ATR is released from its binding to opsin after the decay of the light activated 
metarhodopsin and quickly conjugates with phosphatidylethanolamine to form N- 
retinylidine phosphatidylethanolamine. The conjugate is transported from the 
intradiscal area into the photoreceptor cytoplasm with the assistance of a retina 
specific ATP-binding cassette transporter (ABCR), known as ABCA4. Hydrolysis of 
the conjugate leaves free ATR in the cytoplasm. This is a chemically unstable 
molecule that has the potential to react with other biological material, hence it is 
quickly reduced to all-rra/w-retinol (vitamin A), a reaction catalysed by all-retinol 
dehydrogenase (Palczewski et a l , 1994).
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The resultant all-fnms-retinol must then be transferred to the RPE so that regeneration 
of the visual pigment and thus the visual process can continue. The exact method for 
shuttling vitamin A to the RPE from the photoreceptors is unknown, however, it is 
believed to be assisted by a transport protein named interphotoreceptor retinoid 
binding protein (IRBP) (Gonzalez-Femandez et al., 2007). The function of IRBP is a 
matter of dispute, as the all-trans-retinol is able to diffuse across cellular membranes 
with relative ease for a hydrophobic alcohol, so IRBP is possibly not there to aid 
kinetics. It is postulated that perhaps IRBP adds directionality to the movement of 
vitamin A, or is there to prevent its degradation (Dingle and Lucy, 1965; Rando, 
2001).
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Figure 1. 3. Schematic of the reactions of the visual cycle involved in the interconversion of 
vitamin A and l l - c «  retinal (Thompson and Gal, 2003).
Once inside the RPE, vitamin A is bound to a cellular retinol binding protein and 
undergoes esterification to form retinyl esters, a process catalysed by the action of 
lecithin.retinol acyl-transferase (Batten et a l , 2004). Initially, it was thought that this 
process was assisted by the chaperone RPE65 and that the retinol esters were 
isomerised by an unknown enzyme termed isomerohydrolase (Moiseyev et al., 2003).
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However, recent work has indicated that RPE65 is responsible for the isomerisation of 
all-trans-retinyl ester to 11 -czs-retinol (Jin et a l, 2005; Moiseyev et al., 2005; Jin et 
al., 2007).
Finally, 11 -cfs-retinol is oxidised to the aldehyde, a reaction step requiring 11-cis- 
retinol dehydrogenase before being transported to photoreceptor cells for re­
attachment to opsin, thus, completing the retinoid cycle.
1.2.4 Phagocytosis of photoreceptor outer segments
A primary function of the RPE cell layer in maintaining the visual process is the 
phagocytosis of spent photoreceptor tips. Photoreceptor cells contain numerous 
photosensitive components that are exposed to high intensities of light on a diurnal 
basis. This can lead to the production of reactive oxygen species within the cell and 
consequently the accumulation of modified lipid and protein moieties that need to be 
removed to sustain visual function.
To regenerate the photoreceptor layer, spent tips of POS are shed to the RPE where 
the damaged molecules are degraded, whilst important elements such as visual cycle 
pigments and DHA are recycled (Bibb and Young, 1974; Bazan et al., 1992). The 
importance of this role of the RPE is illustrated in Royal College of Surgeon (RCS) 
rats that display degeneration of the photoreceptor layer because their RPE cell layer 
is unable to ingest old POS (Dowling and Sidman, 1962).
It has been proposed that the presence of POS is enough to instigate phagocytosis into 
the RPE (Boulton and Marshall, 1986). However, other evidence suggests an 
involvement of a number of receptors, ligands and messenger molecules, plus the 
onset of light and circadian rhythms have been implicated in initiating and regulating 
phagocytosis (Basinger et al., 1976; LaVail, 1980; Fisher et al., 1983; LaVail, 1983: 
Nandrot et al., 2004).
It is thought that oxidised phospholipids within POS can act as ligands for CD-3 6- 
mediated phagocytosis of POS and that the protein, MFG-E8, acts as a ligand for 
avP5-integrin, the sole intergrin receptor at the RPE -  photoreceptor interface that is
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responsible for promoting RPE phagocytic signalling (Sun et al., 2006; Nandrot et al.,
2007).
avp5-integrin activates focal adhesion kinase which in turn phosphorylates Mer 
tyrosine kinase (MerTK) that initiates a second messenger cascade that leads to 
internalisation of POS (Finnemann et al., 1997; Finnemann, 2001; Finnemann et al., 
2003; Strauss, 2005). Cells lacking MerTK have the ability to bind POS but not to 
ingest them, indeed, it is mutations leading to MerTK being absent from the RPE of 
RCS rats that result in their photoreceptor degeneration. (Feng et al., 2002a; Feng et 
al., 2002b).
Once ingested into the RPE cell the POS are degraded via a sequential pathway 
(Figure 1.4). The process of POS degradation begins when shed photoreceptor discs 
are phagocytosed into the RPE where microfilaments and microtubules are activated 
that endocytose the POS. The spent tips are then wrapped in a membrane forming a 
phagosome, which next merges with a lysosome to form a secondary lysosome. RPE 
lysosomes contain many hydrolytic enzymes thought to be specific to the degradation 
of POS, of particular importance are the Cathepsin family of enzymes (Rakoczy et a l, 
1997; Rakoczy et al., 1999). The POS are enzymatically degraded into smaller 
constituents until they can diffuse out into the cytoplasm. Here they are either 
recycled back to the photoreceptor layer, stored in the RPE for future use or excreted 
to the blood stream. However, the process of degradation appears to be inherently 
flawed as not all substrates are degraded leading to the slow accumulation of 2  
cellular waste product known as lipofuscin. This process is further described in 
section 1.3.1. Within a human life-time the volume of lipofuscin accrued in RPE cells 
can account for up to 20% of the cytoplasmic area. (Feeney-Bums et al., 1984).
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Figure 1.4. Schematic of the phagocytosis of POS and digestion within RPE. (Adapted from 
Kennedy etal 1995).
1.3 Retinal lipofuscin
1.3.1 Retinal Lipofuscin formation
Lipofuscins are cellular waste products that accumulate in the lysosomal machinery of 
many post-mitotic cells as a function of age (Terman and Brunk, 2006). The term 
lipofuscin is derived from the Greek word for fat, lipo, and the Latin for dark,fuscus. 
However, lipofuscins are often referred to as ‘age-pigment’ or ‘wear and tear’ 
pigment, emphasising their occurrence in aging cells and the fact they are derived 
from spent or damaged organelles. Lipofuscins that form in cells such as neurons and 
heart myocytes are primarily derived from the autophagy of organelles present in 
those cells. However, lipofuscin that progressively accumulates in RPE cells is 
unusual as its components are also derived from material phagocytosed into the cell 
from the overlying photoreceptor outer segments (Wihlmark et a l,  1996b). The 
accumulation of the fluorescent material is highlighted in Figure 1.5 which shows an 
increase in fluorescence levels in the RPE at the three age stages.
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Figure 1.5. Fluorescence micrographs of retinas illustrating lipofuscin accumulation in RPE cells 
with age. Fluorescence of the RPE layer, attributable to lipofuscin accrual progressively increases from 
low levels at 9 years (bottom) to higher levels at 43 years (middle) and very high levels by 93 years of 
age (top). Reproduced with the kind permission of Mike Boulton.
Evidence to substantiate that RPE lipofuscin is significantly derived from POS was 
initially found by Feeney-Bums and co-workers (Feeney -Bums and Eldred, 1983). 
They discovered that the RPE contains inclusion bodies that have ultrastructural 
features of both lipofuscin and phagosomes derived from POS. This suggests there is 
a pathway that starts with POS, continues through the phagosome and can result in the 
formation of lipofuscin. Further evidence was compiled by Boulton et al (1989) who 
showed that prolonged feeding of POS to RPE cells in vitro resulted in the 
accumulation of inclusion bodies with lipofuscin-like properties (Boulton et al., 
1989). In vivo work has shown that RCS rats who fail to phagocytose POS have 
substantially diminished levels of RPE lipofuscin, as do rats with hereditary 
photoreceptor degeneration who accumulate lipofuscin at much slower rates than age 
matched controls (Katz et a l , 1986). Equally, the topographical nature of lipofuscin 
distribution throughout the retina indicates that POS phagocytosis plays an important 
role in its formation with areas of greatest lipofuscin accumulation mirroring those 
with the greatest POS density (Feeney-Bums et al., 1984; Delori et al., 2001).
As described in section 1.2.4, a primary function of the RPE is the phagocytosis of 
POS, with each RPE cell opposing on average greater than 45 POS and over 10% of 
each being phagocytosed daily (Young, 1967; Newsome, 1983). This invariably 
places a huge demand on the degradative systems of the RPE cell; however, the 
lysosomes are equipped with over 40 hydrolytic enzymes to deal with this demand 
(Boulton et al., 1994; Kennedy et al., 1994). A probable cause of the inefficiency of 
the acidic vacuolar apparatus in breaking down phagocytosed POS tips is that the 
constituents are modified in a manner that renders them non-degradable once they
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reach the RPE. The environment of the POS and RPE is conducive to the formation of 
reactive oxygen intermediates (ROI) due to the high oxygen tensions and the diumal 
influx of light that is a source of high energy. The influence of oxidative stress on 
lipofuscin formation in the RPE is demonstrated in studies by Wihlmark et al (1996) 
(Wihlmark et al., 1996a,b). They showed a rapid increase in lipofuscin-like inclusion 
bodies in cells fed POS in an oxygen rich environment compared to those maintained 
in normabaric conditions. This is an effect that can be reduced by the presence of 
antioxidants (Sundelin and Nilsson, 2001).
ROI, such as singlet oxygen and hydroxyl radicals, can interact with the numerous 
polyunsaturated fatty acids (PUFA) that are present within the lipid bi-layers of POS 
membranes (Bazan et a l,  1990) (Figure 1.6). Initially, free radicals act by removing a 
hydrogen atom from a carbon atom of a PUFA creating a carbon-centred radical that 
may undergo conformational rearrangement. This facilitates the reaction with 
diatomic oxygen to form a lipid peroxyl radical, which due to their close proximity, 
can interact with an adjacent PUFA instigating a chain-reaction.
M o le c u la r 
R e a r r a n g e m  e n t
Li pi d  H y d r o p e r o x i d e
Figure 1.6. The oxidation of PUFAs 
The end products of the lipid peroxidation chain reaction are a series of reactive 
secondary aldehydes that are able to diffuse from their site of origin and react with 
other molecules. The aldehydes are reactive due to an electron deficient carbon atom 
that will readily react with nucleophilic amines, thereby forming adducts. Of great 
importance to the formation of retinal lipofuscin are the aldehydes 4-hydroxynonenal
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and 4-hydroxyhexenal, derived from arachidonic and docosohexanoeic acid 
respectively (Dei et al., 2002; Schutt et al., 2003a). Both of these fatty acids are 
present in POS in extremely high quantities (Bazan et al., 1990). It appears that the 
products of lipid peroxidation could have at least a dual role in lipofuscinogenesis. 
Firstly, they adduct to biomolecules rendering them non-degradable, secondly, they 
have been shown to induce the mis-sorting and inhibition of lysosomal enzymes 
(Schutt et al., 2003a; Kaemmerer et a l, 2007). Numerous other oxidative 
modifications have been shown to be present within the lipofuscin granules including 
nitrotyrosine, isolevuglandin-2 and carboxyethylpyrrole, underlining the importance 
of oxidative stress and adduction of biomolecules in lipofuscinogenesis (Ng e/ al.,
2008).
1.3.1.1 Vitamin A derivatives in the formation o f retinal lipofuscin
Together with products of lipid peroxidation, retinoid derivatives are also involved in 
the formation of retinal lipofuscin. The significance of these components was initially 
highlighted by the insightful work of Katz et al who noted diminished levels of 
fluorescent material in the RPE of rats fed diets lacking precursors of 11 -cis-retinal 
(Katz et al., 1985; Katz et al., 1987). This work has been substantiated using Rpe65 
knockout mice, in which 11-cis and all-trans-retinal (ATR) are absent and where 
lipofuscin fluorescence is markedly reduced (Katz and Redmond, 2001).
To date, the retinoid derivatives from the visual cycle that have been identified 
include A2E, iso-A2E (plus other minor isomers) and all-trans-retinal dimer 
phosphatidylethanolamine (see figure 1.7) (Parish et al., 1998; Ben-Shabat et al., 
2002b; Fishkin et al., 2004). A2E formation is light dependent, with mice reared in 
dark maintained conditions accumulating very little A2E compared to age matched 
controls reared in cyclic light/dark conditions (Mata et al., 2000). A2E formation 
begins in the photoreceptors and the sequence of reactions that are needed to result in 
its accumulation are described below and illustrated in Figure 1.8.
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Figure 1.7 RPE lipofuscin fluorophores form as a by-product of the retinoid visual cycle. In a 
normal functioning visual cycle any all-trans-retinol that is not reduced can react with 
phosphatidylethanolamine (2:1), ultimately leading to the accumulation of lipofuscin fluorophores; 
A2E, iso-A2E, other minor isomers o f A2E, all-trans-retinal dimer-PE and possibly other as yet 
unidentified fluorophores. llcRDH = 11-cis retinol dehydrogenase, atRDH = all-trans retinol 
dehydrogenase, LRAT = Lecithin Retinol acyl transferase (Sparrow and Boulton, 2005).
The initial stage is a non-enzymatic and random condensation reaction between a 
single ATR molecule and phosphatidylethanolamine (PE), resulting in N-retinylidine- 
PE (NRPE). If NR-PE undergoes a further condensation reaction with a second ATR 
molecule, dihydro-N-retinylidene N-retinyl phosphatidylethanolamine (A2PE-H2) is 
formed. This is a particularly unstable species that promptly autooxidises to form A2- 
PE the immediate precursor to A2E.
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Figure 1.8. Biosynthesis of A2E and iso-A2E. In outer segments after photobleach, PE and ATR are 
transiently available for conjugation via a condensation reaction to form NRPE. After tautomerisation 
the resulting secondary amine may condense with another molecule of ATR. Subsequent (3,3) 
sigmatropic rearrangement of the bis-retinoid product results in the formation of A2PE-H2, an 
irreversible step. Oxidation of A2PE-H2 to A2PE occurs within the RPE phagosomes. Finally, A2E is 
formed on acid hydrolysis of the phosphate ester by phospholipase D and release o f phosphatidic acid 
(Parish et al., 1998; Fishkin et al., 2003)
To yield A2E, A2PE must undergo enzymatic hydrolysis, a reaction that 
predominantly takes place within the RPE (Ben-Shabat et al., 2002b). However, it 
also seems likely that phosphodiesterase activity within the POS creates some A2E 
even before POS have been phagocytosed by the RPE (Fishkin et al., 2004). In the 
RPE A2E can undergo photoisomerisation forming iso-A2E. Biologically, A2E and 
iso-A2E are found in a roughly 4:1 ratio. Iso-A2E differs from the wholly all-trans 
configuration of A2E by the presence of a cis olefin between carbons 13 and 14 on 
one of its side arms. The carbon-carbon double bonds present within the side-arms of 
the A2E molecule lend themselves to the formation of numerous structural isomers. 
Some of these isomers have been identified and deemed to be minor constituents of 
retinal lipofuscin. The structure of A2E and its isomers are thought to be biologically
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unique and this renders them unrecognisable to lysosomal enzymes, therefore, they 
are not degraded. In support of this is the finding that rats maintained in a light/dark 
cyclic environment accumulate A2E in their RPE which isn’t diminished or removed 
if these rats are then moved to a dark environment. Control rats maintained solely in 
dark accumulated very little A2E (Mata et al., 2000). Another predominant 
fluorophore that has been identified from retinal lipofuscin is ATR-dimer-PE, which 
forms in the outer segments. The molecule is a dimer of two ATR molecules 
conjugated via a condensation reaction to the aldehyde groups of PE (Fishkin et al., 
2004; Fishkin et al., 2005).
1.3.2 Composition of retinal lipofuscin
As stated in section 1.3.1, retinal lipofuscin is derived primarily from the spent tips of 
POS and old or damaged cellular organelles, and, as such its composition reflects 
these origins. Much of our knowledge of the composition, spectral qualities and 
photoreactivity of retinal lipofuscin comes from chloroform: methanol extraction of 
the granules with subsequent analysis focusing primarily on the chloroform soluble 
fraction (Bazan et al., 1990; Rozanowska et al., 1998). However, the chloroform 
soluble fraction may represent only a small proportion of the lipofuscin granule, and 
certainly one that diminishes with age relative to the insoluble fraction (Rozanowska 
et al., 2002).
Early histochemical data of retinal lipofuscin granules revealed them to be 
predominantly lipidic in nature (Kennedy et al., 1995). Bazan et al (1990) conducted 
a comprehensive review of the lipid component and noted that there was a 
considerable increase in lipid content with age per eye (Bazan et al., 1990). The study 
also stated that the predominant fatty acids present in retinal lipofuscin granules were 
palmitic, arachidonic and oleic acids, largely dissimilar to the major fatty acids the 
study identified in POS and neural retina.
It is proposed that retinal lipofuscin is composed principally of products of lipid 
peroxidation that have adducted to other biomolecules and have formed largely 
modified structures that are no longer recognised by the degradative machinery of the
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cells. Lipid peroxidation products have demonstrable ability to inhibit the action of 
lysosomal enzymes and are often not recognised by them and thus not degraded 
(Burcham and Kuhan, 1997; Zamora and Hidalgo, 2001). Indeed, studies of lipofuscin 
components have shown the presence of biomolecules such as proteins adducted to 
aldehydes derived from lipids that are present in abundance in POS (Tanito et al, 
2005). These include; proteins modified by malondialdehyde, 4-hydroxynonenal and 
4-hydroxyhexenal plus advanced glycation end products (Schutt et al., 2003a). One of 
these studies was an annex to a further study that attempted to identify the protein 
components of retinal lipofuscin (Schutt et al, 2003b). This study, together with a 
more recent proteomic analysis of retinal lipofuscin, stated that granules were 
composed of proteins derived either from the POS or from cellular organelles 
(Warburton et a l, 2005). However, each of these studies was marred by apparent 
contamination of the sample used for analysis with debris that co-localises with 
lipofuscin during the isolation procedure. Therefore, caution must be used when 
drawing any conclusions from these results. Both studies noted that proteins present 
had undergone a considerable increase in mass indicating that the proteins had 
undergone oxidative damage, cross-linking, or adduction to other molecules.
Lipidic derived components may be the primary source of retinal lipofuscin granules, 
but other components present do indeed confer some unique properties upon the 
granules. These unique properties include the golden-yellow fluorescence 
characteristic to retinal lipofuscin. This distinct feature cannot be attributed to lipid 
derived aldehydes adducted to amines as these fluoresce in the blue-green region of 
the spectrum. The most likely cause of this fluorescence is the vitamin A derivatives 
that are present. Eldred and Katz isolated at least 10 fluorophores from the chloroform 
soluble fraction of RPE cells (Eldred and Katz, 1988). Of these, 3 fluorophores: A2E. 
iso-A2E and ATR-dimer-PE have been clearly identified and defined as components 
of retinal lipofuscin.
To date, some interesting and insightful studies have been conducted with regard to 
elucidating the components of retinal lipofuscin and thus our knowledge of retinal 
lipofuscin is continually expanding, however, there is still much to leam and clarify.
A number of oxidatively modified molecules have been identified as components of 
retinal lipofuscin, but it is the authors’ opinion that this list is far from exhaustive and
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further research would lead to the identification of other oxidatively modified 
molecules derived from different adduction pathways.
1.3.3 The absorbance and fluorescence characteristics of retinal lipofuscin
Retinal lipofuscin is one of the dominant fluorescent species present within the 
fundus. It has a characteristic golden-yellow fluorescence when excited with UV light 
and is strongly fluorescent when excited with light of all visible wavelengths 
(Docchio et a l , 1991; Marmorstein et al., 2002). Indeed, the fluorescence of retinal 
lipofuscin can be used as a non-invasive method to measure its levels throughout the 
retina (Delori et al., 1995a; Delori et al., 1995b; Spaide, 2003).
When excited with 364 nm wavelength light, retinal lipofuscin exhibits a broad 
fluorescent emission. There are a number of factors that influence the emission profile 
of retinal lipofuscin including; age of donor, wavelength of excitation light and 
whether granules are measured singularly or en mass (Boulton et al., 1990; 
Haralampus-Grynaviski et al., 2001; Haralampus-Grynaviski et al., 2003).
Boulton et al (1990) noted that there were four main regions of spectral interest when 
comparing emission spectra of lipofuscin granules from different age groups. These 
included; a principal peak at 600-610 nm, a blue-green shoulder present in retinal 
lipofuscin from younger donors that diminishes to nothing with older samples, a 
yellow-green shoulder at 550 nm and a red shoulder at approximately 680 nm that 
increases with age of donor (Boulton et al., 1990). Also, with increasing age of donor 
there is a relative increase in the emission and excitation peaks of isolated retinal 
lipofuscin when compared to that isolated from younger donors (Boulton et al., 1990; 
Docchio et al., 1991). Altering the excitation wavelength from 532 to 400 nm when 
irradiating retinal lipofuscin in bulk leads to a broadening of the emission spectrum 
(Haralampus-Grynaviski et al., 2003). This most probably occurs due to the 
photoexcitation of additional fluorophores that emit in this region with the lower 
wavelength, higher energy light. The changes seen with higher energy excitation light, 
however, have no effect on the red-edge of the spectrum, possibly because there is 
one dominant fluorophore that emits in this region. Comparing the emission spectrum
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of individual retinal lipofuscin granules highlighted a large degree of variability 
between granules (Haralampus-Grynaviski et al., 2001; Haralampus-Grynaviski et al., 
2003). The wavelength at which emission maxima were found was spread over a 101 
nm range, emphasising the heterogeneity of retinal lipofuscin granules.
1.3.4 Phototoxicity of RPE lipofuscin
The autofluorescent characteristics of retinal lipofuscin when excited with short 
wavelength light indicate that it contains photo-oxidative compound(s) that have the 
capacity to stimulate oxygen in close proximity (Wihlmark et al., 1997). The 
opportunity for photosensitisation of oxygen molecules are at much increased rates in 
the retina due to the favourable conditions for free radical formation consisting of: 
high oxygen tensions and intense light exposure.
Boulton et al (1993) first demonstrated that lipofuscin was photoreactive and that it 
had the capacity to generate super oxide anions in a light intensity and wavelength 
dependant manner. Later, the light-induced production of singlet oxygen and hydroxyl 
radicals by retinal lipofuscin were reported (Gaillard et al., 1995; Rozanowska et al., 
1995). These studies showed that the production of reactive species by lipofuscin 
showed a wavelength dependence, with singlet oxygen production being lOx greater 
when irradiated with 420 nm light than 520 nm (Rozanowska et al., 1998).
Some of the free radical species generated by lipofuscin have lifetimes that are 
sufficiently long so as to allow their movement away from their area of origin. They 
can thus cause damage to biomolecules in other areas of the cell including 
modification of important cellular components, such as: lipids, proteins and DNA 
(Boulton et al., 2001). Indeed, levels of products of lipid peroxidation in RPE cells 
that have been loaded with lipofuscin and irradiated with short wavelength light have 
been shown to increase (Davies et al., 2001). These products, including 
malondialdehyde (MDA) and 4-hydroxynonenal (HNE), have been noted as being 
toxic to RPE cells (Choudhary et al., 2005). Other consequences of irradiating RPE 
cells containing lipofuscin with short wavelength light have been noted as: protein 
oxidation, loss of lysosomal integrity, cytoplasmic vacuolation and membrane
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blebbing (Davies et a l,  2001). The consequence of these actions eventually being cell 
death. Additionally, irradiation of lipofuscin has been shown to inhibit lysosomal and 
anti-oxidant enzyme activity in RPE cells (Wassell et a l,  1999; Shamsi et a l, 2001). 
This is an effect that can be reduced by the presence of anti-oxidants, implicating that 
oxidative stress is a cause of these changes.
With an increase in age of the donor from whom lipofuscin is isolated there is a 
corresponding increase in the photoreactivity of lipofuscin (Rozanowska et a l, 2004). 
Retinal lipofuscin can be separated into chloroform soluble and insoluble fractions 
using Folchs’ extraction (chloroform: methanol 2:1 v/v) (Rozanowska et a l, 2004). It 
was noted that neither the chloroform soluble or insoluble fraction displayed increased 
photoreactivity with age (Rozanowska et al, 2004). However, there was a significant 
increase in the chloroform insoluble fraction with age that could possibly account for 
increased photoreactivity.
Studies involving lipofuscin have shown it to be a photoreactive molecule that has the 
capacity to photogenerate ROI and increase oxidative stress within the cell. 
Consequences of this include: DNA lesions, lipid peroxidation and lysosomal 
dysfunction that could eventually lead to cell atrophy. Lipofuscin is likely to be a 
contributor to diseases of the retina including age-related macular degeneration 
(AMD), however, this is a multi-faceted disease and other factors such as genetics and 
environmental stressors are also likely to play a role.
1.3.4.1 Is A2E responsible for livofuscin phototoxicity?
One of the lipofuscin components that has been suggested as being responsible for its 
photoreactivity is A2E (Sparrow et al., 2003b). Initial interest arose as it was noted 
the molecule absorbs light in the blue region and emits in the yellow-region. Later, in 
vitro studies using RPE cells loaded with A2E and irradiated with short wavelength 
light demonstrated that A2E was capable of causing cell death (Schutt et al., 2000).
Studies into the photoreactivity of A2E concluded that when photoactivated, A2E 
could produce singlet oxygen, however, the yields were very low (Cantrell et al., 
2001; Lamb et al., 2001; Kanofsky et al., 2003; Gaillard et al., 2004; Lamb and
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Simon, 2004). When the photoconsumption of oxygen by ATR, one of the precursors 
of A2E, was compared with that of A2E, ATR was found to consume 20.6 times more 
oxygen than A2E (Pawlak et al., 2003).The same study showed that A2E was capable 
of peroxidising cholesterol with 5-a ChOOH and 7-a/p ChOOH products being 
formed (Pawlak et a l, 2003). 5-a ChOOH is a product formed specifically by 
interaction with singlet oxygen, whilst the 7-a/p ChOOH product is indicative of free 
radical formation, but may also derive from the breakdown of 5-a ChOOH. All three 
of the cholesterol hydroperoxides were formed in low yields, whereas ATR 
peroxidised cholesterol via the type II singlet oxygen specific pathway in much higher 
yields (Pawlak et al., 2003). A2E is able to quench singlet oxygen at rates comparable 
to endogenous singlet oxygen quenchers such as a-tocopherol and ascorbic acid 
(Roberts et al., 2002; Gaillard et a l, 2004). This action is thought to be due to A2E's 
long conjugated structure which resembles that of dietary carotenoids. However, it 
was also noted that the use of singlet oxygen scavengers reduced the photocytotoxic 
effect of A2E (Sparrow et al., 2002). Ben-Shabat et al (2002), noted that during 
illumination with blue light a species of higher molecular mass than A2E was detected 
using fast atom bombardment mass spectrometry, with the mass of the species 
increasing in increments of 16 (Ben-Shabat et a l, 2002a). Singlet oxygen is known to 
add across double bonds giving epoxides. Irradiation of A2E in D2 O, in which singlet 
oxygen has a longer half-life than H2 O, showed that A2E undergoes photooxidation 
producing epoxide rings (Sparrow et al., 2003c; Gaillard et al., 2004).
The epoxides formed could result from singlet oxygen self-generated by A2E. 
however, as stated previously this is an inefficient process and it is more probable that 
A2E epoxides are generated by other chromophores present within lipofuscin. It is 
possible the A2E epoxides are responsible for blue-light induced damage caused to 
A2E-laden RPE cells that includes; DNA base lesions, modification of proteins, 
increase in vascular endothelial growth factor and complement activation (Sparrow et 
al., 2003a; Gaillard et al., 2004; Zhou et a l, 2005; Zhou et al., 2006).
Together with the light induced effects, A2E loaded into RPE cells has been shown to 
affect other cellular functions. Bergmann et al (2004) found that A2E laden cells 
displayed reduced capacity for the phagocytosis of POS. Finnemann et al (2002) who 
conducted a similar study over a shorter time period noted that phagocytosis was not
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disrupted by A2E loading, but that degradation of phagocytosed particles was. The 
disruption of lysosomal processes by A2E correlates with the earlier work of Schutt et 
al (2001), who described the effect as not being a result of direct inhibition of 
lysosomal enzymes by A2E. Therefore, a secondary mechanism involving a shift in 
lysosomal pH was assessed. One action of A2E that could cause a change in 
lysosomal pH has been suggested to be inhibition of the lysosomal proton pump 
(Bergmann et a l, 2004). A2Es structure means it can act as a detergent towards 
lysosomal membranes. The lysosomal proton-translocating ATPase represents an 
integral protein complex whose conformational structure and hence its activity may be 
influenced by its microenvironment in the membrane. It is possible that once A2E is 
integrated within the membrane it could interact directly with the proton pump 
thereby inhibiting its activity.
Substantial evidence has been collected in studies researching the effects of A2E on 
RPE cells. It has been noted that A2E is phototoxic to RPE cells, most probably 
through the formation of epoxides, and has the capacity to up-regulate vascular 
endothelial growth factor (VEGF) and complement factor (Zhou et al., 2005; Zhou et 
al., 2006). However, A2E is likely to be only a minor component of the retinal 
lipofuscin granule. A2E is extracted into the chloroform soluble fraction of lipofuscin, 
a fraction that accounts for at most 35% of lipofuscin granules. It is highly likely that 
other components of the chloroform soluble and larger insoluble fraction of this 
complex aggregate play important roles in the effects of lipofuscin upon RPE cell 
function as well.
1.3.5 The association of retinal lipofuscin with retinal disorders
Despite extensive research into the physical and bio-reactive properties of retinal 
lipofuscin, its relationship with retinal disorders is based largely on circumstantial 
evidence. There are a number of factors that have led to the association of retinal 
lipofuscin with retinal diseases, in particular AMD. These include the greatest density 
of lipofuscin accumulation being in the perimacular region, mirroring the densest 
population of rod outer segments (Feeney-Bums et a l, 1984; Marshall, 1987). This is 
of interest as lipofuscin accumulation increases with age in this area, a region that
22
Matthew Davies Chapter 1
concomitantly has a preferential loss of rods with age and the onset of AMD (Curcio 
et al., 1996). Areas with high levels of fundus autofluorescence have been deemed 
more at risk for AMD, whilst high levels of lipofuscin appear to precede cell death in 
geographic atrophy (Holz et al., 2001; Lois et al., 2002). Other incidental evidence 
includes studies that have shown A2E induces elevated levels of VEGF and 
complement factor, implicated in the onset of AMD, and pigment granules being 
observed in drusen, a prerequisite for AMD (Hageman et al., 2001; Zhou et al., 2005; 
Zhou et al., 2006). Some of the strongest evidence supporting the role of retinal 
lipofuscin in being involved in inducing the onset of AMD has come from recent 
work identifying the presence of carboxyethylpyrrole (CEP)-adducted molecules in 
lipofuscin granules (Ng et al., 2008). CEP-adducted molecules have been recorded at 
elevated levels in patients suffering from AMD and been shown to provoke choroidal 
neovascularisation (CNV) in a chick model system (Ebrahem et al., 2006).
Lipofuscin accumulates at an increased rate in the RPE of sufferers of the juvenile 
onset macular degenerative diseases Best’s and Stargardts’. The patterns of 
accumulation coincide with areas of greatest cell loss, however, to date no causative 
association has been found between lipofuscin accumulation and the onset of these 
diseases (Allikmets, 1997; Wabbels et al., 2006; Bakall et al., 2007; Gerth et al.,
2007).
Considering the evidence presented so far it is tempting to speculate lipofuscin that 
accumulates as a result o f oxidative stress within the retina can cause further damage 
to this tissue via a number of the mechanisms discussed above. However, as yet no 
complete link between lipofuscin and the onset of retinal dystrophies has been 
illustrated and so the question remains as to whether lipofuscins’ accumulation in the 
RPE is the cause or the result of retinal dysfunction.
1.3.5.1 Ase-related Macular degeneration
AMD is the leading cause of irreversible vision loss in developed nations, affecting 
more than 50 million people world wide. AMD is an affliction of the aged, primarily 
affecting those over the age of 55, with its prevalence increasing with age. As this 
demographic is the fastest growing in first world countries, the number of those
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affected is predicted to increase dramatically unless an effective cure or preventative 
measure is introduced.
AMD is characterised by a deterioration of the macular region of the retina; showing 
RPE dysfunction and photoreceptor cell degeneration. Consequently, patients 
experience reduced central vision with an impaired ability to drive, read or recognise 
faces (Figure 1.9). AMD is a multifactorial disease with risk factors including: genetic 
predisposition, environmental stimuli (e.g. smoking and light exposure), dietary 
intake, sex and race.
Figure 1.9 The two pictures above represent the same image as would be seen through a normal 
eye (left) and the image as seen by a patient suffering from AMD (right). Source: National Eye 
Institute.
AMD is a progressive disease that can be broadly separated into wet and dry forms. 
Dry AMD has 3 further sub-classes; early, intermediate and advanced. Early dry 
AMD is characterised by the presence of small to medium sized drusen that result in 
no vision loss, but this can progress to intermediate dry AMD where medium sized 
drusen coalesce to form larger soft drusen, possibly resulting in a slight blurring of 
vision. Late stage or advanced dry AMD is often referred to as geographic atrophy 
(GA) (Figure 1.10). GA is present when there is a relatively large area of well 
demarcated hypopigmented RPE. Cells surrounding these areas often have increased 
pigmentation, possibly arising from the phagocytosis of melanin and lipofuscin 
released from other cells. GA progresses slowly as photoreceptors gradually shorten 
and broaden. The initial stage of vision loss is believed to be atrophy of RPE cells, 
followed by degeneration of photoreceptors and choriocapillaries. The cause of RPE 
cell death is as yet unknown, but has been associated with excessive lipofuscin 
accumulation within the cells (Holz et al., 2001; Schmitz-Valckenberg et a l, 2006).
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Dry AMD is the most prominent form of the disease, which in some cases progresses 
to the wet form. Currently, the pathogenesis of dry AMD is poorly understood and as 
such there is no treatment available to combat its progression.
Yellow deposits 
indicate drusen 
deposits
Figure 1.10. The fundoscopic image shows an eye with advanced dry form AMD. The many 
yellow deposits are the drusen that have accumulated.
Wet AMD is also known as exudative or neovascular AMD. The term neovascular is 
used as this form of AMD is characterised by the growth of new blood vessels arising 
from breaks in Bruchs’ membrane that continue into the sub-retinal space. The blood 
vessels are quickly and poorly formed so are susceptible to damage and leakage 
resulting in haemorrhaging within the retina (Figure 1.11). Under normal conditions 
the balance between vascular inhibitory factors such as pigment epithelial-derived 
factor (PEDF) and VEGF remain balanced. However, in eyes suffering from choroidal 
neovascularisation (CNV) there is a tilt in the PEDF: VEGF ratio, in favour of VEGF. 
VEGF is a potent stimulator of new blood vessel formation and advances the changes 
seen during CNV, however, the exact causes for the elevation in VEGF levels are 
unclear. Hypoxia and ischemia have both been associated with the changes whilst 
significant increases in VEGF levels have been noted to be stimulated by the presence 
of ROI (Kannan et a l , 2006). Most recently, photoexcited components of lipofuscin 
granules have been shown to induce up-regulation of VEGF in RPE cells, a factor that 
could be very important in inducing AMD (Zhou et al., 2005).
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Figure 1.11. The fundoscopic image shows an eye with choroidal neovascularisation. The grey area 
demonstrates where weak blood vessels have haemorrhaged into the retina.
Haemorrhages of weak blood vessels can cause vision loss via RPE detachment, 
retinal scarring and photoreceptor death. RPE detachment caused in this way can 
happen quickly, thus, unlike the slowly progressing dry form, wet AMD can be fast 
acting.
It should be noted that haemorrhages are not the exclusive cause of RPE detachment. 
Accumulation of lipids within Bruchs’ membrane is thought to be another causative 
element as this inhibits the movement of fluids from the RPE/photoreceptor complex 
to the choroid through the mesh-like structure of the membrane (Starita et al., 1995). 
The accumulation of fluid in the sub-RPE space increases pressure on the adhesive 
forces between RPE and Bruchs’ that may result in detachment of one from the other.
Wet AMD accounts for fewer cases than the dry form (between 10-20%), however, it 
is estimated to cause around 80% of the severe vision loss attributable to AMD. 
Patients with wet AMD in one eye have a 4-12% chance of developing it in the fellow 
eye. Recent advances in treatment of AMD have all focused on the wet form of the 
disease by attempting to prevent further neovascularisation or stabilising the weak 
blood vessels that have already formed. The primary current treatments available for 
AMD are discussed below.
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1.3.5.1.1 Treatment of AMD
Photodynamic therapy (PDT) in the treatment of wet AMD involves an intravenous 
injection of a photosensitiser, for example benzoporphyrin, trade name Visudyne, 
which is activated upon reaching the retina using a non-thermal laser set at 
wavelength 689 nm. Excitation of the photosensitiser halts progression of 
neovascularisation by generating ROI that damage the endothelial cells of unwanted 
proliferating blood vessels. Unlike conventional photocoagulation therapy, the laser 
used in photodynamic therapy does not induce cell damage when used on its own, and 
so theoretically, tissue surrounding the weak blood vessels should not be damaged 
during surgery. Drawbacks of PDT include that it may serve only to stabilise existing 
weak vessels and does not prevent the formation of new vessels that could potentially 
haemorrhage and that it has the potential to damage functional vessles. Indeed, some 
studies have suggested that the laser used in PDT treatment may even induce the 
production of VEGF (Schmidt-Erfurth et al., 2003). This has led to trials of 
combination therapy using both PDT and the VEGF agonists described below (Kim et 
a l, 2006).
Macugen is the trade name for the anti-VEGF aptamer named pegaptanib. Aptamers 
are macromolecules composed of chemically synthesised single-stranded nucleic 
acids. Pegaptanib has a high binding affinity for the VEGF 165 iso-form and once 
bound, pegaptanib prevents the VEGF molecule binding to its receptor. Thereby, 
further angiogenesis is prevented which halts a key stage in the wet form of AMD 
(Fraunfelder, 2005; Ng et al., 2006). Initial in vitro studies were useful in 
demonstrating that the aptamer was effective in inhibiting the action of VEGF and led 
to clinical trials of pegaptanib (Jellinek et al., 1994). 3 years after FDA approval of 
pegaptanib for clinical use its ocular and systemic safety and its effectiveness in 
slowing the progression of wet AMD have been confirmed (Quiram et a l, 2007). 
However, some authors have stated that the success of Macugen was limited and have 
recorded re-growth of vessels in some patients (Pieramici and Rabena, 2008).
Another anti-angiogenic treatment available to sufferers of wet AMD is ranibizumab, 
trade name Lucentis. Lucentis is a fragment of a monoclonal antibody that has a high 
affinity towards VEGF binding. Lucentis is derived from the full length monoclonal
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antibody used in fighting colorectal cancer, bevacizumab (Avastin), a drug that has 
itself been shown to be effective in treating wet AMD when used in an ‘off-label’ 
manner (Levy et al., 2008; Melamud et al., 2008). Both Lucentis and Avastin have a 
mechanism of action similar to Macugen and thus work to prevent further growth of 
leaky blood vessels, which eliminates the potential for haemorrhaging.
The anti-VEGF treatments have been shown to be effective in the treatment of wet 
AMD, but due to their administration via intravitreal injection, local side-effects have 
been noted including: inflammatory reactions, infections, elevated intraocular 
pressure and in some patients (1.6%) RPE tears that led to severe vision loss (Kiss et 
al., 2007). To date all treatments available for AMD focus on the wet form of the 
disease and are only applicable to patients that have progressed to quite a late stage. 
The development of a therapeutic agent that could act in a preventative way for 
people who have been identified at risk for the disease would be a significant 
progression in the battle against AMD. Equally a treatment that addresses the issues 
faced by patients that present the dry form of the disease could possibly increase their 
quality of vision and consequently life.
Much of the work contained in this thesis is concerned with the dry form of AMD and 
therefore it seems pertinent to feature the proposed means of preventing this form 
also. Currently, the method of treating dry AMD that has generated the most interest 
is the use of nutritional supplements.
The role of nutritional supplementation in the prevention and treatment of dry AMD is 
a contentious subject with antioxidants being the most widely hypothesised 
supplement to have a beneficial effect. The influence of anti-oxidants upon the RPE is 
theorised to work by reducing the impact of normal metabolic functions which 
generate ROI on a daily basis (Beatty et al., 2000). Indeed, in vitro work using animal 
models showed that supplementation of lutein, zeaxanthin. lycopene or a-tocopherol 
to RPE cells maintained under normobaric conditions or loaded with POS resulted in 
significantly lower lipofuscin-like levels than controls without anti-oxidant 
supplementation (Sundelin and Nilsson, 2001).
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As discussed previously, the eye is an ideal environment for the generation of reactive 
oxygen species and as such the retina is equipped with numerous anti-oxidant 
systems, including: enzymatic anti-oxidants such as: superoxide dismutase and 
glutathione peroxidase, as well as non-enzymatic anti-oxidant nutrients like; vitamin 
E and certain carotenoids. However, with age the efficiency with which these 
protective mechanisms act is thought to deteriorate (Winkler et a l , 1999). Thus, 
hypothetically replenishing the supply of anti-oxidants could help maintain the health 
of the tissue.
Numerous trials have been conducted into the effects of anti-oxidant supplementation 
in AMD progression (Cangemi, 2007; Jones, 2007; SanGiovanni et a l , 2007). Of 
particular interest is the Age-related eye disease study (AREDS). The AREDS 
investigated the effect of a high dose of vitamins E and C, beta-carotene and zinc 
supplements on AMD progression and noted that a group supplemented with anti­
oxidants who were deemed high risk for drusen accumulation showed significantly 
less progression to later stage AMD. However, vitamin E supplementation appeared 
to have no impact on the development of drusen. Other anti-oxidants that have 
generated interest are lutein and zeaxanthin (Seddon, 2007). The protective action of 
these carotenoids could be two-fold. Lutein and zeaxanthin filter blue-light reducing 
the excitation of photoreactive chromophores, plus they are capable of quenching 
singlet oxygen and possibly other reactive oxygen species (Edge et a l , 1997; Cantrell 
et a l, 2003). Indeed, it has been reported that a high intake of vegetables rich in lutein 
can lower the risk of exudative AMD by 40% (Seddon et a l , 1994).
However, not all studies have reported a beneficial impact of anti-oxidant 
supplementation in preventing the onset or progression of AMD (West et a l, 1994; 
Evans and Henshaw, 2008; Zhao and Sweet, 2008). This leaves the extensive 
literature upon the subject inconclusive and contradictory (Tan et al., 2008). 
Therefore, further research into therapeutic strategies aimed at alleviating the 
progression of dry AMD is needed.
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1.3.5.1.2 Risk Factors for AMD
AMD is a complex disease whose onset can be induced by a combination of factors. 
As previously noted, the greatest risk factor for developing AMD is age; people over 
the age of 90 years have approximately ten times the risk of developing the disease as 
those aged 50 years (Evans, 2001). As discussed in section 1.3.5 lipofuscin has been 
associated with AMD for a number reasons including; inducing up-regulation of 
VEGF, activation of complement factors and generation of free radicals leading to cell 
atrophy, each highlighted in preceding AMD. To prevent repetition this section 
features other factors besides lipofuscin that have also been deemed risks for the onset 
of AMD.
Clinical studies have also shown that whites and women are more susceptible to 
developing AMD (Evans, 2001; Leske et al., 2006). However, it is well established 
that women live longer than men and, as incidence of AMD increases with age, the 
distinction as to whether there is a genetic predisposition in women that makes them 
more susceptible to the disease than men, or, simply that they live longer and are, 
therefore, at greater risk has not yet been adequately addressed (Evans, 2001).
A number of environmental stimuli have been associated with AMD, including: high 
dietary fat intake, smoking, sunlight exposure and a low level of anti-oxidant intake. 
High levels of fat in the diet my have a bimodal influence in determining the onset of 
AMD. Raised levels of cholesterol may increase the likelihood of developing 
atherosclerotic plaques, another systemic factor associated with onset of AMD 
(Fraser-Bell et al., 2008). Alternatively, excess fat in circulation could lead to fatty 
deposits in Bruchs’ membrane that would disrupt the flow of fluids between the 
choroid and RPE, with consequences described in section 1.3.5.1 earlier. However, no 
consistent relationship between AMD and dietary fat intake has been found. Equally, 
conflicting reports with regard to cholesterols’ contribution to AMD are to be found in 
the literature (Cruickshanks et al., 1997; Klein et al., 1997; Rudolf et al, 2004; 
McGwin et al., 2005). Indeed, an increased level of fish in the diet may proffer an 
advantageous effect against the onset of AMD, so rather than levels, the type of fat 
present in the diet may be of importance.
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Smoking is a risk that may have two possible mechanisms by which it affects the 
onset of AMD; a direct impact upon choroidal circulation or, it may decrease levels of 
plasma anti-oxidants. The influence of smoking in the aetiology of AMD is evident by 
the dose-responsive relationship between smoking and developing AMD (Christen et 
al., 1996). Heavy smokers (greater than 20 cigarettes per day) are at greater risk than 
lighter smokers (less than 20 cigarettes per day) with an odds ratio of 2.4 versus 1.26. 
Like high dietary fat, if the association between smoking and AMD is true, this is of 
particular importance as it is a risk factor that can be removed.
The effect of light exposure on the incidence of AMD has been addressed by a 
number of studies, however, difficulty in accurately assessing exposure levels and 
identifying the key periods of exposure has ensured that few correlations were made 
with regard to AMD prevalence (Hyman et al., 1983; Rosenthal et al., 1991). 
However, a positive correlation between blue-light exposure and the incidence of 
AMD was reported by Taylor et al (1990), whilst Cruickshanks et al (1993) noted that 
the use of sun hats and sunglasses reduced the impact of sunlight exposure as a 
causative factor in the onset of AMD (Taylor et al., 1990; Cruickshanks et al., 1993).
Increased prevalence of AMD in smokers, together with the apparent association 
between light exposure and the disease, suggests that oxidative stress may play a role 
in its onset. Further support for oxidative stress being instrumental in retinal 
degeneration is that Superoxide dismutase 1 (SOD1) knockout and SOD2 knockdown 
results in an AMD-like phenotype in rodents (Justilien et al., 2007; Hashizume et al.,
2008) As discussed previously, it has been proposed that the presence of anti-oxidants 
in the retina could protect against AMD by reducing the impact of free radicals in 
damaging the RPE, a key initial stage of the disease (Beatty et al., 2000). Indeed, in 
vitro studies have shown that supplementation of anti-oxidants such as a-tocopherol 
reduce the effect of oxidative stressors on the RPE, whist in vivo studies have shown 
that a-tocopherol is found in lower levels in AMD sufferers than age-matched 
controls (West et a l,  1994; Lu et al., 2006). Thus, it is highly likely that oxidative 
stress is involved in the onset of AMD, however, continued research is needed into 
methods of reducing its impact.
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The familial associations and race bias indicate that genetic predispositions may play 
a significant role in determining whether or not someone will be afflicted by AMD. 
Early studies attempted to link AMD with other known genetic disorders that 
manifested as macular degeneration including; ABCA4 and ELOVL4 (Tuo et al., 
2004; Traboulsi, 2005). However, recent research has focused upon particular genes 
whose variants appear to pre-dispose the carrier to AMD.
Of particular interest are variants of genes located on chromosomes lq32 and 10q26. 
The region of 10q26 has highlighted two genes whose variants could potentially pose 
a high risk for developing AMD. It has been noted that a single nucleotide 
polymorphism (SNP) in the promoter region of HtrA serine peptidase 1 (HTRA1) is 
significantly more prevalent in the eyes of AMD patients than in non-sufferers 
(Dewan et al., 2006; Yang et al., 2006; Chen et al., 2008). The other gene; age-related 
maculopathy susceptibility 2 (ARMS), also located on chromosome loci 10q26 has 
been affiliated with the onset of AMD (Francis et a l, 2008; Fritsche et al., 2008). 
Contradictory studies have shown that both HTRA1 and ARMS2 may play a role in 
determining the risk of developing AMD (Rivera et al., 2005; Francis et al., 2008). 
However, convincing experiments conducted by Kenda et al claim that variants in 
ARMS2, that encode for an unknown protein, are the actual risk factors involved with 
10q26 (Haines et al., 2007; Kanda et a l, 2007).
Hageman et al., 2001 studied the eyes of patients suffering from AMD and compared 
them to age matched controls, finding that AMD sufferers had proteins involved in 
inflammation and the immune response present around drusen. These proteins 
included members of the complement system, later to be deemed important when a 
variant of the gene Y402H on chromosome lq32, encoding for complement factor H, 
a protein involved in regulating the complement system, was identified by four 
separate groups to be involved in increased risk of developing AMD (Edwards et al., 
2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005). The link between 
complement factors and AMD was strengthened when variants in the gene encoding 
for complement factor B, a protein involved in the activation of the complement 
system, was identified in AMD patients (Gold et al., 2006; Hageman et al., 2006).
Matthew Davies Chapter 1
Factors proposed to be responsible for initiating the inflammation response have 
included infection and oxidative stress. Recent work by Hollyfield et al proposed a 
link between CEP adducts (an oxidation product of DHA that has been identified in 
lipofuscin and drusen), and the development of lesions within the RPE that mimic 
those seen in geographic atrophy (Crabb et a l, 2002; Hollyfield et al., 2008). Thus, 
providing a further association of retinal lipofuscin with AMD.
1.3.5.2 Starsarts disease
Stargardts’ disease is an autosomal recessive disease that is characterised by rapid 
accumulation of the lipofuscin fluorophore, A2E, within the RPE. Stargardts’ disease 
is the most common early onset disease of inherited macular degeneration. It 
primarily affects juveniles, with disease symptoms usually manifesting by 20 years of 
age, however, some people may not be aware they have a problem until 30 or 40 years 
into their life-time.
Sufferers of the disease have been noted to accrue up to 7 times the quantity of 
lipofuscin as age-matched controls (Bimbach et al., 1994). Despite no causal link 
between lipofuscin accumulation and Stargardts being established, it is believed that 
the enhanced accumulation of A2E plays a role in the development of macular 
degeneration, causing a reduction in central visual acuity (Sun and Nathans, 2001).
The gene associated with development of Stargardts is ABCA4, a gene that encodes 
for a photoreceptor specific ATP-binding protein. In vitro work with purified ABCA4 
and in vivo work using ABCA4 knock-out mice has indicated that ABCR transports 
ATR from the photoreceptor disc lumen into the cytosol where it is exposed to all- 
trans retinol dehydrogenase for its reduction to all-trans retinol (Sun et a l, 1999; Ahn 
et al., 2000; Mata et al., 2000). It is believed that reduced levels of all-trans-retinol 
transport across the membrane results in increased ATR levels in the photoreceptor 
discs and an increased probability of A2E forming. The increased levels of A2E being 
phagocytosed into the RPE are likely to increase its susceptibility to photo-oxidative 
stress and possibly result in atrophy within these cells. To date, no treatment is 
available for sufferers; however, identification of the gene responsible and its function
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will assist future endeavours in combating the disease. Equally, if a mechanistic link 
is formed between lipofuscin accumulation and the onset of Stargardts, a therapeutic 
agent that could either prevent its accretion or degrade the lipofuscin already there 
would possibly be beneficial to Stargardt disease sufferers.
1.3.5.3 Bests disease
Bests’ Disease is a rare, bilateral dominantly inherited condition that results in slowly 
progressive macular dystrophy. Onset of symptoms usually occurs in early childhood, 
but sometimes this is delayed until teenage years. Like Stargardts’, Bests’ is 
characterised by a rapid accumulation of lipofuscin within and beneath RPE cells 
(Petrukhin et al., 1998). Accumulation of lipofuscin within the RPE has been 
associated with degeneration of RPE and subsequently, the overlying photoreceptor 
layer, both of which are key stages in Bests’ disease that lead to central vision loss 
(Allikmets et al., 1999; Wautier and Schmidt, 2004).
Variants in the gene termed VMD2 that is located on chromosome 11 q l3 have been 
identified as being responsible for predisposing carriers to Bests’ disease (Petrukhin et 
al., 1998). Bestrophin is the product of this gene and is a protein that localises in the 
basolateral membrane of RPE cells and is thought to be a chloride and/or calcium 
channel that has also been linked to regulation of intraocular pressure (Marmorstein et 
al., 2000; Yu et a l , 2000; Bakall et al., 2008).
Bests’ disease shares a number of features that are clinically similar to AMD; 
however, studies into the VMD2 gene, which is responsible for Bests’ disease, found 
that its occurrence in AMD sufferers was not significantly different from that of age- 
matched controls (Allikmets et al., 1999). Similar to Stargardts’ disease, no treatment 
has yet been established for sufferers of Bests’ disease. Again, identification of the 
gene responsible and the possible function of the gene product should aid 
development of therapeutic strategies against the disease. Equally, if a functional link 
between lipofuscin accumulation and the onset of the disease can be verified and 
lipofuscin is found to be a causative element in the disease, strategies to prevent 
lipofuscin accumulation or enhance its degradation may be advantageous to those 
afflicted by Bests’ disease.
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1.3.6 Diseases related to lipofuscin accumulation in other post-mitotic cells
The focus of this project is based primarily on the affect of lipofuscin accumulation in 
the RPE cells of the eye and mechanisms of preventing its formation or degradation 
once there. However, it would seem naive to simply ignore lipofuscins that develop in 
other cells, particularly as the pathways of formation have many similarities (Brunk 
and Terman, 2002). Some conditions that correlate with excessive lipofuscin 
accumulation in other tissues are described below.
1.3.6.1 Cardiac hypertrophy
Cardiac hypertrophy is a thickening of the heart muscles that occurs in response to 
increased stress on the heart. It is related to a weakening of individual muscle fibres, 
meaning the fibres then need to work harder to pump blood and become thickened 
over time. Biopsy o f hypertrophied papillary muscle of human heart reveals that the 
larger sized cells are packed with mitochondria, lysosomes and heavy aggregates of 
lipofuscin granules (Dalen et al., 1987; Dolara et al., 1996)
1.3.6.2 Cirrhosis o f  the liver
Cirrhosis of the liver develops due to chronic damage resulting in scar tissue slowly 
replacing normal functioning liver tissue, progressively diminishing blood flow 
through the liver. As normal tissue is lost the functional efficiency of the liver is 
lowered, therefore, nutrients, hormones, drugs and poisons are not processed 
effectively.
Induction of liver cirrhosis in Male F-344 rats resulted in enlarged cells that contained 
high levels of lipofuscin, while large deposits of lipofuscin accumulating in liver have 
been suggested as a diagnostic indicator of underlying liver diseases (Szende et al., 
1988; Hubscher and Harrison, 1989).
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1.4 Hypothesis
Chapter 1
In light of the literature reviewed above it appears that lipofuscin which forms 
within the RPE may have a deleterious effect upon the ageing retina and may be 
involved in the onset of age-related retinal diseases. To gain a greater 
understanding of retinal lipofuscin the genesis and composition of the granules 
were investigated. Equally, we propose that reducing the potential for 
photoexcitation of retinal lipofuscin would have a beneficial impact upon RPE 
cell function. It is proposed that the use of blue-light blocking filters would have 
a beneficial impact upon RPE cells laden with lipofuscin when irradiated with 
blue-light compared to conventional UV-blocking filters. Equally, reducing the 
levels of lipofuscin that form or accumulate in the RPE may have a beneficial 
impact upon the deterioration of these cells. It is hypothesised that 
supplementing RPE cells with a novel nanomedicine would assist in the 
degradation of retinal lipofuscin substrates and of granules accrued within the 
cells.
1.5 Aims
The aims of this project are broad in nature; however, all are linked by the common 
theme of retinal lipofuscin. The projects interests are based around lipofuscin 
formation, degradation, composition and in reducing its phototoxicity to RPE cells. 
Specifically the project aspires to:
1) Undertake a systematic analysis of the proteomic composition of purified 
retinal lipofuscin to improve on those that have been undertaken previously, 
but were potentially contaminated with extra-granular debris.
2) Design and create in vitro models of retinal lipofuscin formation using what 
are believed to be its primary substrates and compare the physical 
characteristics of the model with those of ex vivo human retinal lipofuscin.
3) Develop a methodology to reliably measure the ability of IOLs to reduce the 
phototoxicity of lipofuscin to RPE cells. Using the novel method to compare 
the action of yellow-tinted lenses and UV-blocking lenses.
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4) Quantitatively measure the phototoxic effect of increasing retinal lipofuscin 
concentration within RPE cells. Also, record the impact of light intensity on 
the impact of the phototoxicity of retinal lipofuscin loaded into RPE cells.
5) Analyse a potential nanomedicine consisting of a carrier molecule that can be 
localised to RPE cell lysosomes and an active component that has the capacity to 
degrade lipofuscin substrates and/ or lipofuscin accrued in RPE cells. Later, 
conjugate the two components and determine their ability to remove or degrade 
retinal lipofuscin in RPE cells.
Matthew Davies Chapter 2
Chapter 2
General Materials and Methods
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This chapter contains details of techniques that are used in more than one chapter in 
the thesis to prevent repetition. Techniques described within the General Materials 
and Methods will be referenced in the experimental design of chapters in which they 
are used, together with any variation of the technique.
2.1 Isolation of RPE cells and retinal lipofuscin
Donors eyes were received from Bristol Eye Bank with the cornea removed for 
transplantation and permission given for research use. Donors were anonymised 
before receipt. Donor information included: age, sex and cause of death. Dissection 
began with the separation of the anterior segment of the eye by circumferential 
incision immediately posterior to the ora serrata. The vitreous was gently detached 
and the neuroretina removed from the underlying RPE by dissection of the optic disk. 
The remaining eye cup was washed with 1 ml of phosphate buffered saline (PBS). 
RPE cells were detached by gently washing the RPE/choroid complex with a fine 
camel hair brush and 1 ml of fresh PBS. The process was repeated once and the cell 
suspension transferred to a cryovial (Nalgene, Rochester, NY, USA) using a sterile 
pastette (Copan Innovations, Murrieta, CA, USA) before being stored at -80°C until 
needed for further use.
Lipofuscin granules were isolated from the RPE cell extracts as described by Boulton 
and Marshall (Boulton and Marshall, 1985). When needed RPE cell suspensions were 
thawed, removed from the cryovials and pooled. Each cryovial was washed with PBS 
to ensure all RPE cells were collected.
The suspensions were homogenised through a 25 G needle (BD Microlance, Oxford, 
UK) attached to a plastic 10 ml syringe into 15 ml centrifuge tubes (Sterilin, Staffs. 
UK), before being centrifuged at 100 g (Boeco U-32R, Hamburg, Germany) for 7 
mins at 4°C to remove cellular debris. The resultant supernatant was kept on ice 
whilst the pellet was further homogenised through a 25 G needle attached to a plastic 
10 ml syringe and the centrifugation repeated at 100 g, 1 mins and 4°C. The 
supernatant was centrifuged at 7000 g  (Sorvall Ultra-Pro 80) for 10 mins at 4°C to
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create a pellet of pigment. The pigment was resuspended in 0.25 M sucrose and 
homogenised with a 25 G needle attached to a plastic 10 ml syringe, before being 
layered on a discontinuous sucrose density gradient (1.0, 1.2, 1.4, 1.5, 1.6, 1.8 and 2.0 
M). The gradient was centrifuged at 103000 g for 1 hr at 4°C. Lipofuscin 
accumulating at the 1.2 and 1.4 M interphase was isolated using a sterile Pasteur 
pipette. The granules were diluted in PBS and washed twice at 7000 g, 10 mins and 
4°C. The resulting pellet was re-suspended in 0.25 M sucrose and further 
homogenised through a 25 G needle attached to a plastic 10 ml syringe. The 
suspension was layered onto a modified discontinuous density sucrose gradient (1.0,
1.2, 1.4 and 1.5 M sucrose) and the centrifugation and washing steps repeated.
The final pellet was resuspended in the minimum volume of PBS and yield 
determined by counting on a haemocytometer (Biirker, Sigma, UK). Lipofuscin 
granules were stored in cryovials at -80°C until needed.
2.2. Cell culture
The ARPE -19 cell line was used as a model of the RPE in cell culture experiments 
carried out in this thesis. The cell line was obtained from the American Type Culture 
Collection (ATCC), and is an immortalised cell line which originates from cells 
cultured from a 19 year old donor. ARPE-19 cells have been shown to have many 
structural and functional characteristics of human RPE cells (Dunn et al., 1996).
2.2.1 Cell Culture Media and Conditions
ARPE-19 cells were maintained in a 37 °C humidified atmosphere containing 5% 
CO2 / 95% air and cultures were grown in 75cm2 flasks (Triple Red, UK). The cell 
culture medium used was Ham’s F10 nutrient medium which was obtained from 
Gibco-BRL, UK, and is the medium specifically recommended to allow optimum 
growth conditions by the ATCC data sheet. In addition, all cell growth media 
contained antibiotics (100 pg/ml streptomycin, 100 pg/ml kanamycin and 60 pg/ml 
penicillin, all of which were purchased from Sigma, UK) and 2% v/v fungizone 
(Gibco-BRL, UK). The culture media was further supplemented with 10% fetal calf
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serum (FCS) (Bio-West, UK) until the cell monolayer had reached confluence. Once 
confluent, cells were maintained in culture medium that was supplemented with 2% 
FCS (basal medium) until needed for experimental procedures. Cells were used 
between passage 23 and 26.
2.2.2 Maintenance of Cell Cultures
Routine cell culture involved splitting the cells approximately every 7 days. This was 
achieved by removal of the cell culture medium by aspiration and washing the 
monolayer with sterile PBS. Cells were dissociated from the flask using a 0.25% 
trypsin/0.02% EDTA solution for approximately 2 min. Detached cells were pelleted 
by centrifugation at 700 g  for 5 min, 4°C. The supernatant was discarded while the 
pellet was re-suspended in pre-warmed Hams F-10 culture medium supplemented 
with 10% FCS. At this point, the cells were spilt in a 1:3 ratio and seeded in further 
75cm2 flasks and stored at 37°C with 5% CO2 / 95% air in a humidified incubator. 
Cells needed for experimental procedures were split into the wells of 24-well plates. 
For microscopy work a glass slide was placed within the 24 well plate upon which the 
cells were grown. Cells were maintained in culture medium containing 10% FCS 
until confluent. At the point of confluence, medium was changed to that 
supplemented with 2% FCS and the cells maintained in this basal medium for a 
further 7 days. These cell cultures were then used for subsequent experiments.
2.2.3 Liquid nitrogen storage of cell cultures
After trypsinisation as described above, the detached cells were pelleted by 
centrifugation at 700 g  for 5 min, 4°C. The supernatant was discarded and the pellet 
was resuspended in 10% v/v dimethylsulphoxide (DMSO) (Sigma, UK) prepared in 
FCS (Bio-West, UK). Cells were gradually frozen to -80°C using an isopropanol 
cryostorage box (Nalgene, UK) to prevent the formation of ice crystals in cells. Once 
frozen, cells were stored in a liquid nitrogen refrigeration chamber for later use.
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2.3 Extraction of bovine retina
Retinas of bovine eyes were extracted by removing the anterior portion of the eye by 
circumferential incision, gently discarding the vitreous then detaching the retina by 
cutting at the optic nerve.
2.3.1 Isolation of photoreceptor outer segments form bovine retina
Photoreceptor outer segments (POS) were isolated from bovine retinas using a 
method adapted from that originally described by Papermaster (Papermaster, 1982). 
Initially, 25 retinas were added to 15 ml of homogenisation medium (Table 2.1) and a 
Teflon hand-held (Fisher Scientific, UK) homogeniser passed through the 
homogenisation media three times. The homogenate was decanted into a cold 
centrifuge tube then back into the homogenisation tube and the homogenisation 
repeated. The homogenate was centrifuged at 1500 g  for 4 min at 4°C (Boeco U- 
32R).
Table 2.1. Homogenisation media for isolation of POS
Fresh retina (34% w/w)
42% Sucrose 191g
1 M NaCl 13ml
0.1 M MgCl2 0.4ml
1.0 M Tris-acetate 1.0ml
Add H20  to: 230g
The resultant supernatant was decanted into ice-cold centrifuge tubes and the pellet 
re-homogenised with a further 15 ml of homogenisation medium. The centrifugation 
step was repeated as before with the supernatant kept in ice-cold centrifuge tubes and 
the pellet discarded. The volume of the supernatant was determined before being 
transferred to an ice-cold 500 ml conical flask. Two volumes (relative to supernatant)
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of 0.01 M Tris-acetate buffer (pH 7.4) were added slowly to the conical flask whilst 
stirring. The POS were then pelleted at 1500 g  for 4 min at 4°C (Boeco U-32R).
The pellet was re-suspended in 1.10 g/ml sucrose solution and passed through an 18 
G needle rapidly ejecting the homogenised solution against the wall of the plastic 
tube and re-homogenising as above. Sucrose gradients were prepared using ice- 
chilled 1.15 g/ml, 1.13 g/ml and 1.11 g/ml solutions. The crude POS suspended in 
1.10 g/ml sucrose was then gradually and gently layered onto the gradient. The 
gradients were then spun at 50000 g  for 30 min at 4°C (Sorvall Ultra-Pro 80). POS 
were located between the 1.11/1.13 g/ml and 1.13/1.15 g/ml interfaces. The POS 
were removed using a sterile Pasteur pipette and recovered as a pellet after dilution in 
0.01 M Tris-acetate and sedimentation by centrifugation at 45000 g  for 20 min 
(Sorvall Ultra-Pro 80). The POS pellet was re-suspended in the minimum volume of 
PBS and the yield determined by counting on a haemocytometer (Biirker, Germany). 
POS in PBS were then stored at -80°C until needed for future experiments.
2.4. Measurement of mitochondrial activity as an indicator of cell 
viability using the MTT assay
Immediately subsequent to the experimental procedure where measurement of cell 
viability was required the MTT assay was undertaken (Schutt et al., 2000). The MTT 
assay was used to provide a reliable technique for measuring levels of cell viability in 
test and control cultures. The MTT assay uses the ability of a mitochondrial 
dehydrogenase enzyme from viable cells to cleave the tetrazolium rings of the pale 
yellow MTT and form dark blue formazan crystals that are largely impermeable to 
cell membranes, thus resulting in its accumulation within healthy cells. The intensity 
of the product colour is directly proportional to the reductive capacity of cells which 
can be used to measure the number of living cells in the culture. To undertake the 
MTT assay, medium was aspirated from the wells containing cells and 250 pi of PBS 
containing dissolved MTT (1 mg/ml. Sigma, UK) was gently added into each well. 
The cells were incubated with MTT solution for 3 hours at 37 °C, after which the 
MTT was aspirated, and 250 pi of acidified iso-propanol (containing 0.04 M HC1. 
Acros Organics, UK) was added to solubilise the reduced blue formazan crystals.
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Aliquots were transferred to a 96-well plate (Triple Red, UK) and absorbance 
measured at 590 nm, with a reference measured at 690 ran using a 96-well plate 
reader (Multiskan Ascent, Labsystems, UK). Results were analysed using the 
following equation: Viability as a percentage of control = (absorbance of sample 
cells/absorbance of control cells) x 100.
2.5 Flow cytometry
Flow cytometry is a technique based upon the principles of light scattering, light 
excitation and emission of fluorochrome molecules to generate information about the 
physical and chemical characteristics of a population of cells, recording the features 
of one cell at a time.
To generate the multiparameter data about cells in a population the sample is hydro- 
dynamically focused in sheath fluid before intercepting an optimally focused light 
source, usually a laser beam. As each cell passes through the light source it scatters 
the light in some way and fluorochromes present within the cells are elevated to 
higher energy states. The scatter of light and resultant photons of light, generated by 
energy loss from excited fluorochromes, are detected by the flow cytometer and used 
to produce data on the cell population. Flow cytometers also contain a number of 
detectors that measure the forward scatter and side scatter of light caused by the cell. 
The forward scatter produced by a cell relates to the volume of the cell, whereas the 
side-scatter gives information on the complexity of the cell with respect to parameters 
such as granularity.
The procedure for using flow cytometry in this study is as follows; cells were cultured 
as described in Section 2.2.1. and 2.2.2. Experimentation was carried out as described 
in the relevant chapter section.
After experimentation, when cells were ready for analysis, they were washed three 
times by the gentle addition of PBS. After the third PBS wash cells were detached 
from the wells by exposure to a 0.25% (w/v) trypsin solution (Sigma, UK) containing 
0.02% EDTA (w/V) made up in PBS and incubated for 2 min (37°C, 95% air, 5%
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CO2). Trypsin was inactivated by the addition 1 ml of Hams-FlO medium containing 
10% FCS. Cell suspensions were removed from their wells and centrifuged at 700 g, 
4°C for 5 min (U-32R, Boeco, UK) to create a pellet. The medium was gently 
aspirated from the centrifuge tube and replaced with 1 ml of PBS. The pellet of cells 
was then washed twice in PBS by centrifugation at 700 g, 4°C for 5 min. After the 
final wash cells were re-suspended in 300 pi of PBS and transferred to a FACs tube 
(Falcon, UK). FACs tubes containing cell suspensions were taken on ice to the flow 
cytometer (FACSCaliber, BD Life Sciences, UK) for analysis. The fluorescence 
levels of ARPE-19 cells were measured using flow cytometery by exciting the cells 
with a 15 mW 488 nm air cooled argon-ion laser. The emission of the samples was 
detected using high performance, high dynamic range photomultipliers with a 530 nm 
(FITC) filter. The forward and side scatter generated by the cells was recorded as a 
measure of cell size and complexity, respectively.
2.5.1 Flow Cytometry Data Analysis
Data collected from the FACSCaliber was analysed using WinMDI 2.8 Software 
(Perdue University, USA). The programme was used to calculate the geometric mean 
fluorescence of cells in experimental populations, to create histograms of cellular 
fluorescence and dot-plots of the size and granularity of cells within populations. 
Results generated using the WinMDI 2.8 Software were presented using Excel 
(Microsoft, USA).
2.6 Transmission Electron Microscopy
Transmission electron microscopy (TEM) works in a similar manner to conventional 
light microscopes, however, TEM does not have the same theoretical limitations as 
light microscopy and can be used to view specimens in higher resolution. TEM uses a 
focused stream of electrons that are accelerated towards an ultra-thin sample using a 
positive electrical potential. The sample affects the flow of the electrons and these 
changes are detected and used to form an image of the sample.
45
Matthew Davies Chapter 2
The procedure for using TEM in this study is as follows; cells in 24-well plates were 
washed three times by the gentle addition of PBS. After the third PBS wash cells were 
detached from the wells by exposure to a 0.25% (w/v) trypsin solution (Sigma, UK) 
containing 0.02% EDTA (w/V) made up in PBS and incubated for 2 mins (37°C, 95% 
air, 5% CO2). Trypsin was inactivated by the addition 1 ml of Hams-FlO medium 
containing 10% FCS. Cell suspensions were removed from their wells and centrifuged 
at 700 g ; 4°C for 5 min (U-32R, Boeco, UK) to create a pellet. The medium was 
gently aspirated from the centrifuge tube and replaced with 1 ml of PBS. The pellet of 
cells was then washed twice in PBS by centrifugation at 700 g, 4°C for 5 min. After 
the final wash PBS was gently removed and replaced with 1 ml of a mixture of 
glutaraldehyde (the working solution of 2.5% glutaraldehyde was created by diluting 
the stock 25% solution in PBS) and osmium tetroxide (1% w/v generated by disolving 
0.1 g of osmium tetroxide crystals 10 ml of lx PBS over-night with stirring in a foil 
wrapped beaker) buffered with imidazole (0.05 M). Cells were fixed in this mixture 
for 1 hour at 4°C. After this time the pellet had turned black. The pellet was 
centrifuged at 1500 g  for 2 min at room temperature, and then washed once in PBS 
containing 0.05 M imidazole.
The fixed pellet was then embedded in agar 5% (w/v, dissolved in ddFEO by heating 
and allowed to cool) to protect the pellet. The pellet was scraped from the side of the 
eppendorf tube to ensure the whole pellet was embedded in agar. The agar embedded 
pellets were then washed 4 times in de-ionised water, for 10 min each time, to remove 
any residual fixative.
Pellets were then stained with uranyl acetate (UA) (0.5% created by diluting a 2% 
stock solution in ddFEO) for 60 min at 4°C. After staining with UA, pellets were 
dehydrated with a graded series of ethanol solutions: 30%, 50%, 70%, 80%, 90% for 
10 mins each, then 3 x 10 min exposures to 100% ethanol. Pellets were further 
dehydrated with 2 incubations with propylene oxide for 10 min each.
Following dehydration, the pellet of cells was infiltrated in a solution of 50% 
propylene oxide (Sigma, UK) 50% araldite mix (composed of 5 g araldite CY212: 5 g 
dodecenylsuccinic acid (DDSA): 0.15 g benzyldimethylamine (BDMA) overnight at
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room temperature. Samples were clearly labelled then embedded in araldite mix at 
60°C for 48 hours.
Once embedded ultra-thin sections (about 60 nm, light gold in colour) were cut using 
an ultracut microtome (Reichert-Jung E, Austria) and sections were mounted onto 
pioloform coated copper grids. Mounted sections were then counterstained using UA 
(2%) for 10 min and washed three times in de-ionised water. This was followed by 
further counterstaining using lead citrate (produced by dissolving 2.66 g lead nitrate 
in 30 ml H2O which is mixed with 2.52 g of sodium citrate dissolved in a further 30 
ml of ddfUO. The two solutions were mixed for 30 mins with stirring in a foil covered 
beaker. After mixing, 16 ml of 1 N sodium hydroxide was added with a further 24 ml 
of ddfUO. The lead citrate was prepared on the day of use) for 5 min and two more 
washes in de-ionised water.
Sections were examined using a TEM (Philips EM 208, Philips, UK) operated at 80 
kV accelerating voltage with an appropriate magnification. EM images were recorded 
on film plates (Kodak film 4489, Kodak, UK) and developed in a Kodak D19 
developer (Kodak, UK).
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Chapter 3
An Analysis of Retinal Lipofuscin 
Composition
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3.1 Introduction
Retinal lipofuscin is a cellular waste product that accumulates with increasing age in 
the retinal pigment epithelial (RPE) cells of the eye (Feeney-Bums et al., 1984). It has 
a characteristic golden-yellow colour and is autofluorescent when excited with short 
wavelength light (Boulton et al., 2004).
Retinal lipofuscin is thought to be primarily derived from the phagocytosis of spent 
tips of photoreceptor outer segments (POS) that have not been completely degraded 
(Boulton et al., 1989; Wihlmark et al., 1996b). However, the incomplete degradation 
of exhausted or old organelles during autophagy is also likely to contribute to its 
accretion (Brunk et al., 1992; Terman et al., 2006).
Conditions within the retina provide an ideal environment for the generation of 
reactive oxygen intermediates (ROI), with high oxygen concentrations and diurnal 
exposure to high energy light. Therefore, it is likely that many of the precursors for 
lipofuscin are derived from lipids that have undergone oxidative modification and/ or 
adduction to other biomolecules and are no longer recognised as substrates by 
lysosomal enzymes in the RPE (Kopitz et al, 2004b; Tanito et al., 2005; Tanito et al., 
2006; Kaemmerer et al., 2007). Indeed, the contribution of oxidative stress in the 
process of lipofuscinogenesis is highlighted by its reduced rate in the presence of anti­
oxidants (Robison et al., 1980; Sundelin and Nilsson, 2001). Vitamin A derivatives 
involved in the visual cycle also play an important role in the formation of retinal 
lipofuscin, with some reports estimating that up to 90% of lipofuscin constituents 
could originate from retinoid conjugates (Katz et al:, 1985; Katz and Gao, 1995: 
Wassell and Boulton, 1997; Sparrow et al., 2003b). The contribution of retinoid 
derivatives in lipofuscin formation is exemplified using RPE65 knockout mice. These 
mice do not generate 11 -cA-retinal and do not accumulate significant amounts of 
lipofuscin (Katz and Redmond, 2001). The presence of retinoids in large quantities is 
unique to retinal lipofuscin, which together with the environment in which it resides, 
makes retinal lipofuscin granules distinctive amongst lipofuscins found in the body.
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Despite extensive research interest resulting in numerous publications in recent 
decades, the exact mechanisms of retinal lipofuscin formation and its composition are 
still poorly understood (Katz, 1985,1989; Yin et al., 1995; Katz et al., 1996; Yin, 
1996; Schutt et al., 2002a; Warburton et al., 2005). What is known of retinal 
lipofuscin granules suggests that there is heterogeneity between and within granules 
and that the constituent biomolecules have undergone considerable modification 
(Haralampus-Grynaviski et al., 2001; Simon et al., 2002; Schutt et al., 2003a; Holz et 
al., 2004).
Much of the interest surrounding retinal lipofuscin is due to its ability to 
photogenerate ROI when excited with blue-light (Boulton et al., 1993; Nilsson et al., 
2003). Blue-light is of a wavelength that has the capacity to penetrate the cornea and 
lens, reaching the retina and, thus, stimulate lipofuscin in RPE cells (van den Berg 
and Spekreijse, 1997). ROI have the capacity to seriously disrupt cellular function and 
cause RPE cell death, indeed, numerous studies using RPE cells in vitro have shown a 
loss in cell viability after light exposure in cells loaded with lipofuscin (Wassell et al., 
1999; Schutt et al., 2000; Davies et al., 2001). This is important as RPE atrophy is a 
key feature in the pathogenesis of AMD.
In early studies Eldred and Katz identified at least 10 fluorophores in the RPE (Eldred 
and Katz, 1988). Further research then ensued into these fluorophores and to date 
A2E, iso-A2E and all-/Ams-retinal dimer phosphatidylethanolamine have been 
identified as constituents of retinal lipofuscin (Eldred and Lasky, 1993; Parish et al., 
1998; Fishkin et al., 2005). Of these the most widely studied is A2E. A2E has been 
shown to induce DNA lesions and apoptosis in RPE cells when illuminated with blue- 
light, most probably through the formation of A2E-epoxides, whilst other oxidation 
products of A2E have been associated with complement activation, a process 
implicated in the aetiology of AMD (Ben-Shabat et al., 2002a; Sparrow et al., 2003c; 
Zhou et al., 2006).
Thus, retinal lipofuscin and its constituent parts have been associated with AMD. 
together with other diseases affecting the macular including Bests' disease and 
Stargardts’ disease (Dorey et a l, 1989; Lopez et al., 1990; Solbach et al., 1997;
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Bakall et al., 2007). However, to date no molecular mechanisms have been 
determined to form a causative link.
The aim of this study was to enhance the knowledge of lipofuscin components and 
improve our understanding of the proteomic nature of retinal lipofuscin granules. 
Isolation of retinal lipofuscin using a sucrose density gradient results in an enriched 
fraction of lipofuscin granules that invariably contains extra-granular debris of similar 
density. Previous studies looking into the protein content and oxidative modifications 
present within retinal lipofuscin included an extensive quantity o f the extra-granular 
debris in their analysis, but failed to state whether their findings were present in the 
granules, the debris or both (Schutt et al., 2002a; Schutt et al., 2003a; Warburton et 
al., 2005). Equally, many in vitro studies using ex vivo retinal lipofuscin include the 
extra-granular debris in their preparations loaded into cells. Thus, it is important to 
identify whether the bioactivity associated with lipofuscin from these studies comes 
from the granules themselves or the co-localised debris.
Accordingly, we set out to achieve a purified sample of lipofuscin granules that was 
free from contaminating debris and could be characterised with respect to its 
proteomics, oxidative modifications and bioactivity. The purified sample was then 
compared to the ‘crude’ sample of lipofuscin granules with respect to the above 
characteristics. It was believed the complex problem of identifying the proteomic 
components of retinal lipofuscin would be best suited to a multi-disciplinary approach 
so as to prevent a repetition of the mistakes made in previous attempts by other 
groups. As such a collaboration with the Crabb laboratory based in the Cole Eye 
Institute, Cleveland was established as members of this group have considerable 
expertise in dealing with proteomic analysis of related material having published a 
well received article on the proteomic content of drusen (Crabb et al., 2002). During 
this study I was fortunate enough to visit the Crabb laboratory and assist in a number 
of experiments related to this project.
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3.2 Materials and Methods
3.2.1 RPE Lipofuscin Isolation and Purification
RPE cell and lipofuscin isolation took place in the School of Optometry and Vision 
Sciences, Cardiff University, Cardiff. The purification of granules took place in Cole 
Eye Institute and Lemer Research Institute, Cleveland Clinic Foundation, Cleveland. 
Isolation of RPE cells and retinal lipofuscin was conducted as described in the 
General Materials and Methods, Section 2.1. Additional to the method described in 
Section 2.1, the final lipofuscin pellet was further purified by centrifugation on a third 
discontinuous density sucrose gradient (1.0, 1.2, 1.4 and 1.5 M sucrose) and the 
centrifugation (103000 g  for 1 hr at 4°C) and washing steps (7000 g, 10 mins and 4°C) 
repeated. The third step was added after viewing TEM images of lipofuscin granules 
that had been isolated using a method that employed just two density gradients which 
showed considerable debris between lipofuscin granules (Figure 3.2).
Lipofuscin isolated using discontinuous sucrose density gradients were termed ‘crude’ 
lipofuscin. Three crude lipofuscin samples were analysed in this study, Preparation 1, 
from 65 donors, (130 eyes) mean age 70 years ± 1 0  years; Preparation 2, from 30 
donors (60 eyes), mean age 65 years ± 8 years; Preparation 3, from 41 donors (82 
eyes), mean age 76 years ±11.
To purify the crude lipofuscin samples aliquots were either (i) washed 6x in 15 mM 
N-ethyl morpholine acetate (NEM) pH 8.3, 2 mM EDTA, 100 mM BHT, 0.2% SDS; 
or (ii) digestion with proteinase K (10 pg/pl, 24 hours/ room temperature) in 15 mM 
NEM pH 8.3, 2 mM EDTA, 100 mM BHT, 0.2% SDS.
Quantification of each of the lipofuscin samples was conducted by counting on a 
haemocytometer and also measuring dry weight using a Sartorius Model SE2 
microbalance (Data Weighing System Inc. IL, USA).
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3.2.2 Light, Transmission and Confocal Fluorescent microscopy
TEM analysis was conducted initially to analyse the purity of lipofuscin granules. 
This was undertaken in Cardiff using the method described in Section 2.6 of the 
General Materials and Methods Chapter. Variations from the method described were: 
no cells were involved so there was no need for detachment from culture plates. 
Instead, lipofuscin granules were centrifuged at 4000 g, 3 min at 4°C in a cooled 
micro-centrifuge (Sorvall Pico, Sorvall, UK) to create a pellet. The pellet was then 
treated as cells were in Section 2.6, with the exception that the lipofuscin pellet was 
not embedded in agar.
Initial fluorescence microscopy analysis of retinal lipofuscin granules was conducted 
within the School of Optometry and Vision Sciences, Cardiff University. The 
procedure was as follows; 25 pi of retinal lipofuscin suspended in PBS was gently 
loaded onto a glass slide (Lamb RA, Sussex, UK) and a glass coverslip (VWR 
International, UK) applied. The sample was immediately viewed using a fluorescence 
microscope (Leica CTR 6000, Leica, Milton Keynes) equipped with a band-pass filter 
to detect FITC and a DFC359 FX camera (Leica, Milton Keynes). Images were 
analysed using Microsoft Picture Manager (Microsoft, USA).
Retinal lipofuscin granules underwent further microscopic analysis to compare the 
inter-granular debris present between crude and purified samples. This took place in 
the Cole Eye Institute and Lemer Research Institute, Cleveland Clinic Foundation. 
Cleveland. For analysis of both crude and purified lipofuscin granules by TEM and 
light microscopy samples were prepared initially in the same way. Granules were 
fixed in 2% glutaraldehyde and 1% paraformaldehyde, post-fixed in 1% osmium 
tetroxide, dehydrated in a graded series of ethanol concentrations before further 
dehydration in propylene oxide. The dehydrated pellets were then embedded in 
epon/araldite and polymerised for 48 hrs at 60°C.
Semi-thin sections of the embedded pellet were cut using a diamond histotech knife, 
ready for light microscopy. Sections were dried and stained with toluidine blue before
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being imaged on a Zeiss Axiophot microscope equipped with a Hamamatsu digital 
camera.
For TEM, thin sections were taken from each of the samples using an RMC, MT-XL 
(Tucson, AZ) ultramicrotome. Sections were stained with uranyl acetate and lead 
citrate before being viewed using a Tecnai 20, 200 kV digital electron microscope 
equipped with a Gatan image filter.
o
Before the fixing process an aliquot was taken for each sample (~10 granules) for 
immuno-TEM. The crude and purified granules were incubated in PBS containing 2.5 
pg of anti-carboxyethylpyrrole (CEP) monoclonal antibody (mAb) and 1% BSA for 1 
hr at room temperature. The pellets were washed thrice in ice cold PBS containing 1% 
BSA and 0.1% Triton X-100 before incubation with horseradish peroxidise- 
conjugated rabbit anti-mouse imunnoglobulin G (IgG) for 1 hr at room temperature. 
Three more washes ensued after which diaminobenzidine (DAB) was added to 0.5 
mg/ml and incubated until a brown colour formed (~ 20 mins). The pellet was washed 
twice then prepared as described above for TEM. Negative controls were included 
that contained no primary anti-body. A Leica laser scanning confocal microscope 
(TCS-SP2, Leica) using a high magnification, oil immersion objective lens was used 
for confocal microscopy. Images were collected sequentially in the green, red and 
differential contrast channels, through the entire sample using a 1 pm step-size.
3.2.3 Morphometric Analysis
Morphometric analysis took place in the Cole Eye Institute and Lemer Research 
Institute, Cleveland Clinic Foundation, Cleveland. Comparisons of the two samples of 
lipofuscin granules were carried with respect to area, roundness, aspect ratio, 
perimeter and mean diameter. To do this, TEM images of both the crude and washed 
samples were analysed using a semi-automated batch-processing routine generated in 
Image-Pro Plus 6.2 (Media Cybernetics)
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3.2.4 HPLC Analysis of Bisretinoids
HPLC analysis of the bisretinoid components of the crude and purified lipofuscin 
granules took place in the Department of Ophthalmology, Columbia University, New 
York. Crude and purified granule samples were extracted using Folchs extraction 
(chloroform:methanol 2:1 v/v), filtered initially through cotton, then through a C l8 
Sep-Pak cartridge (Millipore, Bedford, MA) in methanol containing 0.1% TFA and 
dried under Argon. The extracts were re-dissolved and analysed on an Alliance HPLC 
system (Waters Corp, Milford, MA) equipped with a 2695 Separation module, a 2996 
Photodiode Array Detector (with monitoring at 430 and 510 nm), Empower® 
software, and Atlantis® dC18 column (3pm, 4.6 x 150 mm, Waters, USA) and using 
aqueous acetonitrile/ 0.1% of TFA gradients with a flow rate of 0.8 ml/min as 
described previously (Parish et al., 1998). A2E, iso-A2E and alWrdms-retinal dimer- 
phosphatidylethanolamine were identified and quantified based on UV-visible 
absorbance spectra and elution times that correspond to authentic synthetic 
compounds.
3.2.5 Phototoxicity Assay
The phototoxicity assays were carried out in the School of Optometry and Vision 
Sciences, Cardiff University, Cardiff. ARPE-19 cells were grown to confluence in 24- 
well plates (Orange Scientific, UK) as described in Section 2.2. of the General 
Materials and Methods chapter. After 7 days at confluency cells were exposed to 
equal amounts (measured by granule count, 300 granules/cell) of either crude or 
washed granules for 24 hrs. Control cells were maintained on the same plates but 
contained no lipofuscin. Cells were then maintained in basal medium as described for 
a further 7 days (Schutt et al., 2000). Immediately prior to light exposure basal 
medium was replaced with a custom-made culture medium (SF10PF, Gibco, UK) 
based on Hams F-10 medium, however, the photosensitisers: phenol red, tyrosine, 
riboflavin, tryptophan and folic acid were removed. Cells were then exposed to blue- 
light (400-500 nm 2.8 mW/cm2), generated by a sunlight simulator (SOL 1200, Holne 
UV Technology, Munich, Germany), at 37°C for 48 hours. A dark maintained control 
consisted of cells, with and without lipofuscin, wrapped in black foil and placed atop
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the lamp. The cell viability was then measured using the MTT assay as described in 
the General Materials and Methods, Section 2.4. The MTT assay was used to provide 
a reliable technique for measuring levels of cell viability (Schutt et al., 2000). Each 
experiment was carried out in triplicate and repeated four times.
3.2.6 SDS-PAGE and Western Analysis
SDS-PAGE and Western analysis was conducted in the Cole Eye Institute and Lemer 
Research Institute, Cleveland Clinic Foundation, Cleveland. Prior to Western blot 
analysis the crude and purified lipofuscin preparations under went Folchs extraction. 
The chloroform soluble and insoluble fractions were separated, with the chloroform 
insoluble fraction being sonicated and then boiled in SDS sample buffer containing 
0.1 M DTT. Approximately 20 pg of this material was then applied to a 
polyvinyldene fluoride (PVDF) membrane (Millipore, Bedford, MA) using a slot blot 
apparatus (Bethesda Research Laboratories HS-1878) and probed with either; mouse 
anti-nitrotyrosine mAb (1 pg/ml in 5% low fat milk in PBS, Upstate Biotechnology, 
Lake Placid, NY, USA), mouse anti-CEP mAb (0.2 pg/ml in 5% low fat milk in 
PBS), or rabbit polyclonal (pAb) anti-iso[4]LGE2 (1 pg/ml in 5% low fat milk in 
PBS). All secondary antibodies were HRP conjugated (0.1 pg/ml in 5% low fat milk 
in PBS, Santa Cruz Biotech, USA). ECL Western blotting detection system (GE 
Healthcare, USA) was used as substrate.
3.2.7 Protein Identification by LC MS/MS
Protein identifications were carried out in the Cole Eye Institute and Lemer Research 
Institute, Cleveland Clinic Foundation, Cleveland. Crude and proteinase K treated 
lipofuscin (-170 pg dry weight each) were sonicated then boiled 5 mins in Laemmli 
SDS-PAGE sample buffer and subjected to 10% SDS-PAGE and stained with 
colloidal Coomassie blue (Gel Code Blue, Pierce Chemical Co.). Gel slices were 
excised from the top to the bottom of the lane, in-gel proteins were reduced with DTT 
(10 mM), alkylated with iodoacetamide (55 mM), and digested in situ with trypsin, 
then peptides were extracted for LC MS/MS. LC MS/MS was performed with a
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QT0F2 instrument (Waters) using a Cap LC system (Waters), a 0.3 x 5-mm trapping 
column (C l8 Pepmap 100, LC Packings), a reverse phase separating column (75 pm x 
5 cm Vydac C l8), and a flow rate of 250 nl/min (Crabb et al., 2002). Gradient LC 
separation was achieved with aqueous formic acid/acetonitrile solvents. The QTOF2 
mass spectrometer was operated in standard MS/MS switching mode with the three 
most intense ions in each survey scan subjected to MS/MS analysis.
Alternatively, equal amounts (by dry weight) of crude or SDS washed lipofuscin 
preparations were subjected to overnight tryptic digestion in 30mM NEM acetate pH 
8.6, 0.05% SDS containing 0.3 pg trypsin and soluble components fractionated by 
strong cation exchange (SCX) chromatography using a PolySulfoethyl A column (1.0 
x 150 mm, 5 pm particle size; 200 A pore size), a flow rate of 50 pl/min and a 
gradient of 0-600 mM KC1 in 25% acetonitrile, 10 mM KH2 PO4 , pH 3 with fractions 
collected at 10, 1 min intervals. SCX fractions were analysed by LC MS/MS on a 
QTOF2 mass spectrometer as described above.
Protein identification from QTOF2 MS data utilised MASSLYNX 4.1 software 
(Waters), the Mascot search engine (Matrix Science, version 2.1), and the Swiss- 
Protein sequence database (August 21, 2007, version 54.1). The Swiss Protein 
database search parameters included all human entries (~17K total sequences), 1 
missed tryptic cleavage site allowed, precursor ion mass tolerance = 0.8 Da, fragment 
ion mass tolerance = 0.8 Da, and protein modifications for Met oxidation and Cvs 
carboxyamidomethylation. A minimum Mascot ion score equal to 25 was used for 
accepting all peptide MS/MS spectra. A minimum of 2 unique peptides per protein 
was required for all protein identifications.
3.2.8 Amino Acid Content Analysis
Amino Acid analysis was performed at the Cole Eye Institute and Lemer Research 
Institute, Cleveland Clinic Foundation, Cleveland. Approximately 1 -  2 pg of sample 
(proteins or peptides) were dried before HC1 (6 N, 300 pi) and a crystal of phenol (~ 1 
-  2 mg) was added. Air was removed from the sample by flushing with argon gas. 
The vial was heated at 150 °C for 1 hour, followed by the release of pressure and
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cooling of the sample to room temperature. The sample was then flushed with argon 
and stored at -20 °C until ready to perform phenylthiocarbamyl derivatisation of the 
amino acids. Phenylthiocarbamyl derivatisation makes amino acids UV visible. The 
acid from the hydrolysis was neutralised with the base diisopropylethylamine (DIEA) 
in methanol and dried. Once dried, samples were analysed immediately. For HPLC, 
the samples were dissolved in transfer buffer (29 mM sodium acetate, pH 5.2, 0.025 
% K3EDTA). Typically, 14 pi of transfer buffer solution was added to hydrolysed and 
derivatised lipofuscin granules and 8  pi of this solution was injected for analysis. 
HPLC was performed with an Agilent 1100 HPLC system, Spheri-5 PTC, 5 p, C l8 , 
220 x 2.1 mm column (Perkin Elmer, Wellesley, MA) and with solvent A (50 mM 
sodium acetate buffer, pH ~5.4) and solvent B (70 % acetonitrile, 32 mM sodium 
acetate, pH ~6.1). The gradient (flow rate of 300 pi / min) was from 20 -  6 8  % B for 
20 mins, and then to 100 % B in five mins and dropped to the initial condition of 20 
% B in 2 mins. Standard amino acids (Standard H, Pierce) were used. Standard H 
(300 pmol) was derivatised and separated using the above chromatographic method. 
The average peak area was calculated for each amino acid from multiple samples of 
standard H and an analysis response factor was calculated for each amino acid by 
dividing the average peak area by the pmole of each amino acid. This was used to 
create a calibration file for each amino acid. The amount of the unknown samples was 
obtained by dividing the peak area from each amino acid by the response factor. For 
pure proteins of known composition and molecular weight, the concentration of the 
protein can be calculated. For mixtures of proteins of unknown mass and sequence, 
the total mole percentages of each amino acid were determined.
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3.3 Results
3.3.1 Purification of Lipofuscin Granules
The isolation of retinal lipofuscin granules from RPE cells using a discontinuous 
sucrose density gradient is an established method that has been used in many studies 
involving analysis of retinal lipofuscin (Boulton and Marshall, 1985; Davies et al., 
2001; Schutt et al., 2003b). However, this method consistently yields a population of 
granules surrounded by a considerable amount of extragranular debris of similar 
density.
After isolation, the retinal lipofuscin granules were viewed by fluorescence 
microscopy. The granules isolated after three discontinuous sucrose density gradients 
display the characteristic autofluorescence associated with retinal lipofuscin (Figure
3.1).
Figure 3.1 Fluorescence microscopy of retinal lipofuscin granules isolated after 3 discontinuous 
sucrose density gradients. The granules display the characteristic autofluorescence associated with 
retinal lipofuscin. Scale bar is equivalent to 75 pm.
TEM images of retinal lipofuscin illustrates that the isolation of granules using a 
discontinuous sucrose density gradient produces an enriched fraction of granules that 
are surrounded by debris of similar density (Figure 3.2). Repeating the isolation step 
with a third discontinuous sucrose density step resulted in a sample of granules that 
were less contaminated with debris (Figure 3.3), however, this method of enrichment
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resulted in a loss of granules. It could be speculated that a fourth or fifth sucrose 
gradient would have resulted in a more pure sample, but the amount of lipofuscin 
recovered would possibly have been too small to conduct any further analysis.
Figure 3.2. TEM images of lipofuscin granules isolated after 2 discontinuous sucrose gradient 
steps. Considerable inter-granular debris can be identified in the images. Scale bars represent 1 pm.
To conduct a proteomic analysis of the retinal lipofuscin granules sample when 
surrounded by debris would simply repeat the studies that had previously been 
undertaken. To overcome this problem and achieve a purified sample for structural 
and functional characterisation, two approaches were taken to purify the sample and 
remove the debris from the extragranular matrix. Initially it was found washing crude 
lipofuscin preparations with proteinase K removed debris without affecting granule 
structure (Figure 3.4. G, H, J). Secondly, simply washing the preparations in 0.2% 
SDS without proteinase K resulted in an extra-granular free granule population 
(Figure 3.4. B, D, L).
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Figure 3.3 TEM images of lipofuscin granules isolated after 3 discontinuous sucrose gradient 
steps. There is a reduction in inter-granular debris compared to granules isolated with two 
discontinuous sucrose gradient steps; however, contaminants are still present. Scale bars represent l 
pm.
There was no statistically significant difference identified in either the granule 
diameter (crude, 0.74 + 0.24pm; purified 0.76 + 0.20 pm, p=0.l2) or circularity 
(aspect ratio crude, l .23 + 0.81; purified l.25 + 0.18, p= 0.06) when analysed using 
morphometric TEM images. However, morphometric analysis revealed that crude 
granules had a smoother surface than those that had been washed (crude, l .06 + 0.09, 
purified, l .08 + 0.09, p< 0.0001). However, this difference has been concluded to not 
be significant and most likely the result of virtual comers created by the analysis 
software when separating touching granules in the more tightly packed pure 
lipofuscin sample.
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Figure 3.4. Light, Fluorescent Confocal and Transmission Electron Microscopy of Lipofuscin.
Light microscopy of (A) crude lipofuscin and (B) SDS washed lipofuscin granules stained with 
toluidine blue. Bar scale equals 20 pm in (A) and (B). Magnified view of boxed region is shown in (C) 
crude lipofuscin and (D) SDS washed granules. Confocal microscopy of crude lipofuscin (E, F) and 
proteinase K treated lipofuscin granules (G, H). Differential interference contrast (DIC) images (E, G) 
and corresponding laser-excited autofluorescence are shown (F, H). Bar scale equals 16 pm in (E-H). 
Transmission electron micrographs of (I, K) crude lipofuscin, (J) lipofuscin granules after proteinase K 
treatment, and (L) SDS washed lipofuscin granules. Bar scale equals 1 pm in (I-L). Significant extra- 
granular debris is apparent in crude lipofuscin but is absent in the SDS washed or proteinase K treated 
lipofuscin granules.
62
Matthew Davies Chapter 3
3.3.2 Bisretinoids in RPE lipofuscin
The quantity of the bisretinoids A2E, iso-A2E and all-trans-retinal dimer -  
phosphatidylethanolamine were examined by HPLC in both the crude and purified 
lipofuscin samples. Equal amounts of granules (by granule count) from the crude and 
purified samples underwent extraction with chloroform and methanol and were then 
analysed using reverse-phase HPLC (Figure 3.5).
There was no significant difference in the fluorophore levels in either the crude or 
purified sample when the 15.1% error in counting is considered. These results are 
consistent with the hypothesis that the vitamin A derived moieties are localised within 
the granules.
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Figure 3. 5. Quantitation of Bisretinoid Pigments in RPE Lipofuscin.
Reverse phase-HPLC analysis of chloroform/methanol extracts of equal amounts (-5.5 x 107 granules) 
of (A) crude lipofuscin and (B) SDS washed lipofuscin granules. Chromatograms obtained with 430 
nm monitoring. Top inserts, UV-visible spectra of A2E, isoA2E, and all-maws-retinal dimer 
phosphatidylethanolamine in acetonitrile/water. Lower right inserts, monitoring at 510 nm, the 
detection wavelength favouring all-trans-retinal dimer phosphatidylethanolamine, with chromatogram 
expanded between retention times 15.5-19 min. The total amount of A2E and isoA2E recovered was 
-380 pmol from the crude and -328 pmol from the purified granules; the total amount of all-trans- 
retinal dimer-PE was -201 pmol and -187 pmol, respectively. These values are within experimental 
error of being equal given the 15.1% relative standard deviation of the mean granule count.
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3.3.3 Phototoxicity of RPE lipofuscin
The phototoxicity of crude and purified lipofuscin granules was assessed by loading 
ARPE-19 cells with equal quantities of either crude or SDS-washed granules (by 
granule count) before exposing them to intense blue-light. Control cells included 
those that were maintained in the dark with and without lipofuscin and those not fed 
lipofuscin and exposed to light. There was no significant loss in viability of cells 
maintained as controls. However, cells loaded with either the crude or SDS-washed 
lipofuscin granules displayed an approximately 50% loss in viability (Figure 3.6). 
These results signify that the photoreactive species associated with retinal lipofuscin 
are unlikely to be protein moieties and are intrinsic to the granules and not the extra- 
granular debris.
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Figure 3.6. Phototoxicity of Lipofuscin.
Cultured ARPE-19 cells were assayed for viability by MTT after treatment with equal amounts (300 
granules/cell) of SDS washed lipofuscin or crude lipofuscin, with or without exposure to intense blue 
light for 48 hrs. Viability was calculated with reference to control cells not fed LF and maintained in 
the dark (set to 100%). Debris-free lipofuscin reduced ARPE-19 cell viability by the same amount as 
crude lipofuscin, namely -50%. **p<0.0001, one-way ANOVA.
no lipofuscin washed lipofuscin crude lipofuscin
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3.3.4 Oxidative modifications in RPE Lipofuscin
Western slot blot analysis was used to determine if either the crude or SDS washed 
lipofuscin granules contained constituents modified by either nitrotyrosine, 2-(co- CEP 
or iso[4 ]LGE2 . Nitrotyrosine is a molecule deemed to be an indicator of cell damage 
and the production of nitric oxide. Nitrotyrosine has also been linked to inflammatory 
conditions such as atherosclerotic plaques. CEP and iso[4 ]LGE2 are the downstream 
products of oxidative damage to docosahexaenoyl and arachidonyl containing lipids, 
respectively. Both samples displayed immunoreactivity for nitrotyrosine, CEP and 
iso[4]LGE2 (Figure 3.7.A, B, C).
CEP-immunoreactivity was confirmed with Immuno-TEM analysis of both the crude 
and washed samples (Figure 3.7.D,E). Both samples exhibited immunoreactivity on 
the surface, however, the crude samples also displayed some immuno-reactive 
products in the extra-granular debris. Control experiments lacking primary antibody 
showed no immunoreactivity in either crude or purified preparations (Figure 3.7 F, 
G).
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Figure 3.7. Oxidative Modifications in Lipofuscin.
Slot blot Western analyses of crude and SDS washed lipofuscin (~4 x 107 granules applied per blot) are 
shown for immunoreactivity to (A) CEP adducts, (B) iso[4]LGE2 adducts, and (C) nitrotyrosine. 
Controls include CEP modified and unmodified human serum albumin (HSA), iso[4]LGE2 modified 
and unmodified BSA and nitrotyrosine modified and unmodified BSA with the applied amounts 
indicated. Analyses by TEM of crude (D) and SDS washed (E) lipofuscin for CEP immunoreactivity 
with anti-CEP primary antibody, HRP-conjugated secondary antibody and diaminobenzidine (DAB) 
detection. TEM control analyses with secondary antibody and DAB but no primary antibody are shown 
for crude lipofuscin (F) and SDS washed granules (G). Intense CEP immunoreactivity is apparent on 
the granule surface (panels D, E) and in regions of the extragranular debris (boxed in panel D).
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3.3.5 Identification of proteins present in RPE lipofuscin granules
Three RPE lipofuscin isolation preparations were used in the determination of its 
protein components. The first was divided equally (according to dry mass) into two 
samples. One was deemed to be the crude sample, the other was ‘purified’ by washing 
with proteinase K. The samples were then fractionated by SDS-PAGE (Figure 3.8), 
with slices of the gel incised and the proteins removed by in situ tryptic digestion. 
Proteomic analysis was performed using LC MS/MS. The second RPE lipofuscin 
preparation was treated in the same manner. Analysis on the first crude preparation 
yielded 77 proteins, many of which were derived from outer segments and with higher 
mass than expected, indicating these proteins had undergone modifications and 
possibly cross-linking. The proteinase K treated samples revealed very few protein 
components. In the second preparation 124 proteins were identified from the crude 
aliquot, again signs of modification were seen (Combined results of two protein 
analyses are displayed in the appendix Table A.2). Very little protein content was 
identified in the second proteinase K treated sample. The third sample was divided 
equally (according to dry mass), one aliquot being kept as the crude sample the other 
washed with SDS. Samples were then digested using dilute detergent solution and 
peptides were fractionated by SCX chromatography. The subsequent LC MS/MS 
analysis identified 75 proteins (Table A.3 in appendix) in the crude sample and
minimal protein in the SDS washed sample.
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Figure 3.8. SDS-PAGE and Western analysis of crude lipofuscin. The chloroform insoluble fraction 
of crude lipofuscin (Preparation 2, average, age 65 years) was separated by 10% SDS-PAGE. Lane 1, 
molecular weight standards; lane 2, crude lipofuscin -2.0 pg.
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3.3.6. Amino acid content of RPE lipofuscin
Amino acid analysis of each of the preparations was used to quantify the protein 
content. Replicate amino acid analyses identified that there was a five-fold greater 
protein content in crude samples than in proteinase K or SDS treated samples (Table
3.1).
Crude preparations contained 10-12% of protein (w/w) that can be degraded to amino 
acids. Proteinase K or SDS treated samples were found to contain very little protein 
that could be degraded to amino acids (~2% w/w) and there was no significant 
difference in the amino acid content of these samples. Differences in the amino acid 
composition in donor group preparations did occur, highlighting the heterogeneous 
make-up of lipofuscin populations.
Table 3.1. Summary o f Amino Acid content o f HCl-Hydrolysate from lipofuscin preparations
Preparation Number of Analyses
% Amino 
Acid (w/w)
Average 
% Amino Acid 
(w/w)
Crude-Preparation 1 3 9.2
Crude-Preparation 3 3 12.3 1 U .O
Proteinase K-Preparation 1 3 1.9 0  0
SDS Washed-Preparation 3 3 2 .5
Phenylthiocarbamyl amino acid analysis was performed on the above lipofuscin preparations as 
describe in the methods. Preparation 1, 65 donors, mean age 70 years and preparation 3,41 donors, 
mean age 76 years.
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3.4.Discussion
This study set out to obtain a purified sample of lipofuscin granules that were free 
from extragranular debris. The purified sample was then compared with the crude 
isolate in respect to bisretinoid components, bioreactivity towards RPE cells, 
oxidative modifications present and proteomic components.
The isolation of retinal lipofuscin from RPE cells involves separating the granules 
from other cell constituents using a discontinuous sucrose gradient (Boulton and 
Marshall, 1985). However, retinal lipofuscin granules are not unique within the RPE 
with respect to their density. Using TEM micrographs we have shown that the 
isolation procedure results in an enriched fraction of granules that is surrounded by a 
considerable amount of other material (Figure 3.2). To reduce the amount of extra- 
granular material surrounding the sample we extended the isolation procedure by 
introducing further sucrose density gradients. Consequently, we have demonstrated 
that the amount of extra granular material is reduced with successive purifications 
using discontinuous sucrose density gradients (Figure 3.3); unfortunately, there is also 
a concomitant loss in granules with the increase in purity. To ensure that enough 
retinal lipofuscin remained for further analysis another method of removing the extra- 
granular debris that would leave a pure sample of granules was sought.
A purified sample of granules was achieved by washing the isolates with either SDS 
or proteinase K. Both samples were then compared using microscopy techniques to 
determine the extent of extragranular contamination present. Aliquots of crude 
granules showed extensive contamination (Figure 3.4. A, C, I, K), whereas the 
purified sample showed no contamination (Figure 3.4. B, D, J, L). However, the 
granules in the purified sample appear to lose their outer membrane. Removal of the 
surrounding material would allow for a more accurate characterisation of granular 
proteins than in previous studies that contained high levels of co-isolated debris in 
their samples (Schutt et al., 2003b; Warburton et al., 2005).
TEM images of the granules underwent morphometric analysis that indicated washing 
granules with SDS or proteinase K left them intact. This is supportive of there being
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no significant difference in mean diameter or circularity between the crude and 
purified samples, with the average diameter for both samples agreeing well with those 
previously cited (Haralampus-Grynaviski et al., 2003). However, the granules in the 
crude sample were found to have a significantly smoother surface than the washed 
granules. This could possibly be the result of surface associated molecules being 
removed during the washing process, or of analysis software limitations.
The two samples were analysed for the presence of the bisretinoids; A2E, iso-A2E 
and the all-fnms-retinal dimer phosphatidylethanolamine. These bisretinoids, in 
particular A2E, have undergone intensive scrutiny with respect to the role they play in 
lipofuscin phototoxicity and the adverse effects they have on cell function (Schutt et 
al, 2000; Sparrow and Cai, 2001; Schutt et al., 2002; Zhou et al., 2006). The two 
samples that were analysed in this study were found to have equivalent levels of each 
of the bisretinoids in samples of equal size (according to granule count) (Figure 3.5.). 
This suggests that the bisretinoid components are present within the core of the 
granule and are not surface associated or easily removed. Similarly, the pure and 
crude samples were found to be equally bioreactive when loaded into ARPE-19 cells 
and exposed to high intensity blue-light (Figure 3.6.). Thus, signifying that the 
bioreactive component of lipofuscin is indubitably associated with the granules and 
not the surrounding debris.
The major difference recorded between the two sample sets was the proteins 
identified in the two. Granules that were washed with SDS or proteinase K showed 
limited Coomassie blue reactivity when analysed using SDS-PAGE and few positive 
protein identifications when processed using conventional mass spectrometric 
methods. However, from the crude sample, including extragranular material, a total of 
186 proteins were identified, many of which had higher apparent mass than predicted 
indicating that they had undergone some sort of modification. Approximately 40% of 
the proteins identified in the crude sample have been previously described by others in 
reports on the protein content of retinal lipofuscin (Schutt et al., 2003b; Warburton et 
al., 2005). This is symptomatic that many of the proteins identified in these studies 
may have arisen from the extragranular debris. Of the proteins identified many 
originated from the POS, including rhodopsin and the RPE, such as RPE65.
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An important aspect of this study was the comparison of photoreactivity of retinal 
lipofuscin samples and their effect on RPE cells when irradiated with blue-light. 
Many studies analysing the photoreactivity of retinal lipofuscin and its effect upon 
RPE cells have used the discontinuous sucrose gradient method for obtaining a 
sample from RPE cells, and would, therefore, have obtained a sample that was also 
contaminated with inter-granular debris. We have demonstrated that the 
photoreactivity of retinal lipofuscin and its deleterious impact upon RPE cells when 
excited with blue-light is not affected by the removal of the co-isolated debris. 
Equally, this section of the study has demonstrated that if proteins are removed from 
the granular-surface, or from below the lost membrane, during the purification steps 
the proteins removed are not intrinsic to the damaging effect that photoexcited retinal 
lipofuscin has on RPE cells and appear to play no role in the bioreactivity of the 
lipofuscin molecules.
Oxidative stress has long been hypothesised to play a role in lipofuscinogenesis, with 
the suggestion that compounds become adducted or crosslinked to each other and are, 
therefore, no longer recognisable by lysosomal enzymes (Schutt et al., 2003b; 
Kaemmerer et al., 2007). Using Western slot blot techniques crude and purified 
lipofuscin granules showed positive immunoreactivity towards products of lipid 
peroxidation including CEP and iso[4 ]LGE2 . Another marker of oxidative stress, 
nitrotyrosine, was also observed in both samples. This is indicative that oxidative 
stress in the POS and probably the RPE plays a significant role in the formation of 
lipofuscin granules.
Nitrotyrosine adducts are formed in the presence of nitric oxide which is a free radical 
that reacts readily with other free radicals. This often results in the formation of 
species that are more reactive than their precursors. Particular research interest has 
focused on the reaction between nitric oxide and the superoxide anion to form 
peroxynitrite (Halliwell et al., 1999). Peroxynitrite has the potential to react with 
DNA and proteins producing modifications that can affect protein function (Halliwell, 
2001). Nitration of tyrosine in proteins has been shown to increase in vivo during 
oxidative stress, to be elevated in rats experiencing ocular inflammation, to be 
associated with a number of inflammatory related diseases and to cause an increase in
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the expression of VEGF in retinas when present in high levels (El-Remessy et al., 
2003; Koeck et a l, 2004; Adithi et al., 2005; Aslan et al., 2006).
Iso[4 ]LGE2 is a member of the family of isolevuglandins that are reactive y- 
ketoaldehydes generated by free radical oxidation of arachidonate containing lipids, of 
which there are many within POS (Bazan et al., 1990). Like nitrotyrosine, Iso[4]LGE2 
is a marker of oxidative stress and has also been demonstrated to have the ability to 
adduct to DNA and proteins (Iyer et al., 1989; Murthi et al., 1993). Adduction by 
iso[4]LGE2 has been shown to inhibit the function of proteins (Salomon, 2005). Even 
once adducted to proteins and DNA the levuglandins can continue to react with other 
proteins and DNA forming crosslinked molecules that cannot be degraded. Elevated 
levels of iso[4]LGE2 have been noted in patients affected by atherosclerosis (Salomon 
et al., 2000; Poliakov et al., 2004).
CEP-adducts are a family of 2-(co-carboxyalkyl)pyrrole adducts derived from the 
easily oxidised fatty acid docosahexaenoic acid (DHA), which is found in high 
quantities in POS (Bazan et al., 1990). CEP-modified proteins have been measured at 
high levels in the Bruchs membrane of patients suffering from AMD and been shown 
to induce angiogenesis in chick chorioallantoic membrane whilst they intensify 
choriodal neovascularisation in a mouse model (Ebrahem et al., 2006). This, taken 
together with its presence in drusen, a high risk factor in the progression of AMD, 
suggests that CEP-adducted molecules could play a role in the onset of AMD (Crabb 
et al., 2002; Combadiere et al., 2007). Indeed, a recent paper documented lesions 
forming in the RPE-layer of mice that had been exposed to CEP-adducted proteins 
(Hollyfield et al., 2008). The lesions were reminiscent of those seen with the onset of 
AMD and this could provide a link between oxidative stress in the retina and AMD.
Characterisation of granules in this study has demonstrated that retinal lipofuscin 
contains many molecules that have undergone extensive modification. Previous 
studies have also described such an occurance including proteins that have been 
adducted to malondialdehyde, 4-hydroxynonenal and advanced glycation end- 
products (Schutt et al., 2003a; Schutt et al., 2003b; Kaemmerer et al., 2007). Such 
thorough post-translational modifications of proteins within lipofuscin granules may 
prevent tryptic digestion or render them unidentifiable by LC MS/MS. Our results
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suggest that previous reports characterising the protein content of retinal lipofuscin 
may be largely based around the proteins associated with the extra-granular material 
that is co-isolated with granules (Schutt et al, 2002a; Warburton et al., 2005).
This study has succeeded in producing a sample of granules that are free from debris 
and has shown that these purified granules contain little if any protein. The study has 
clearly shown that the photoreactivity associated with lipofuscin is inherent to the 
granules and not the extragranular debris that is co-isolated. The unstable nature of the 
lipids and retinoids present in high quantities in the POS and their susceptibility to 
free radical attack, suggests that lipofuscin granules are composed mainly of 
conjugates of these molecules. Together these undegradable waste products form an 
agglomerate that has the capacity to generate free radicals and singlet oxygen, disrupt 
lysosomal enzyme function and inhibit the anti-oxidant enzymes of the RPE, each 
having a negative impact on RPE cell viability (Rozanowska et a l, 1995; 
Rozanowska et a l, 1998; Shamsi et al, 2001). These factors taken together with the 
ability of A2E to activate complement and CEP-adducts to cause RPE lesions and 
initiate CNV (Zhou et a l,  2006; Hollyfield et a l, 2008), form a strong link between 
oxidative stress, lipofuscin formation and the onset of AMD. The findings of this 
study can hopefully assist the further research that is needed to elucidate the 
connections involved in multifaceted diseases of the retina.
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Chapter 4
Development and Analysis of an In Vitro 
Model of Retinal Lipofuscin
74
Matthew Davies Chapter 4
4.1 Introduction
As described in Chapter 1 above, lipofuscin is an intra-lysosomal waste product 
composed primarily of oxidatively modified lipids and post-translationally modified 
proteins. These waste products gradually accumulate in post-mitotic cells with time. 
Indeed, in Chapter 3 we identified a number of post-translational adductions present 
in lipofuscin-granules derived from lipid peroxidation products. Retinal lipofuscin has 
characteristic fluorescence and absorbance spectra that differ from those seen in 
lipofuscins that are found in other post-mitotic cells (Boulton et al., 1990; Nilsson and 
Yin, 1997). Retinal lipofuscin also has demonstrable phototoxic properties and has 
been shown to produce a number of reactive oxygen species, including: singlet 
oxygen and superoxide (Boulton et al., 1993; Gaillard et al., 1995; Rozanowska et al., 
1995; Rozanowska et al., 1998).
It was of interest to this project to ascertain which components involved in retinal 
lipofuscin formation gave the granules their characteristic traits. To do so, we 
developed 6  in vitro models of retinal lipofuscin formation using enrichments of cell 
components we believed to play the most important role. Previous studies have 
identified POS as being the major substrate of retinal lipofuscin, bestowing it with a 
number of unique features including the presence of retinoid derivatives such as A2E, 
(Eldred, 1998; Boulton et al., 2004) however, the presence of retinoids in lipofuscin 
found in liver cells has also been recorded (Szweda, 1994). Some authors believe that 
the autophagy of old or damaged organelles, in particular mitochondria, within the 
RPE play a role that is as equally important as POS in the formation of retina; 
lipofuscin (Burke and Skumatz, 1998; Terman et al.. 2007).
As described previously, retinal lipofuscin has been associated with a number of 
retinal degenerative diseases (Beatty et al., 2000; Nowak. 2006a; Holz et al., 2007). 
Therefore, interest in retinal lipofuscin is driven by the strive for greater 
understanding of how it affects the function of RPE cells with age. A broade^ 
knowledge of the substrates and mode of genesis of retinal lipofuscin could be 
important as this has the potential to assist in the development of novel strategies in 
either preventing its formation, or, aiding its degradation. Preventing the formation of
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retinal lipofuscin or instigating the degradation of retinal lipofuscin that has 
accumulated in RPE cells has potential therapeutic implications. With this in mind, 
the in vitro lipofuscin formation models were designed and analysed in a manner that 
will enhance our understanding of the contribution made by both POS and 
mitochondria in the formation of retinal lipofuscin and how they influence its 
characteristics.
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4.2 Experimental design
4.2.1 Collection of components of the in vitro lipofuscin models
4.2.1.1 Isolation o f  POS from bovine eves.
POS were isolated from bovine eyes as described in the General Materials and 
Methods chapter, Section 2.3. One variance to the technique described in Section 2.3 
was that POS designated POS (dark) in the results section were isolated under dim red 
light to preserve the rhodopsin present in the outer segments.
4.2.1.2 Isolation o f  a lysosomal enzyme enriched fraction from bovine liver
Bovine liver was obtained from a local abattoir with tissue being transported on ice 
and all preparations undertaken immediately upon arrival. A lysosomal enzyme 
enriched fraction was obtained by sub-cellular fractionation involving the bovine liver 
being homogenised in Homogenising medium (0.25 M sucrose, 5 mM TRIS-HC1,
1 mM EDTA) using an electronic homogeniser (Kenwood, UK) to create smaller 
pieces of liver. The liver was further homogenised using a handheld homogeniser 
(Fisher Scientific, UK). The sample was subjected to four centrifugation steps all at 
4°C: (i) 700 g, 10 mins (Boeco U-32R, Hamburg, Germany), (ii) 11 300 g, 3 mins, 
(iii) 27 200 g, 7 mins. and (iv) 141 500 g , 60 mins (Sorvall Ultra-Pro 80, Sorvall. 
USA), retaining 1.5 ml samples and noting the volume of both the supernatant and 
pellet after each step. The lysosomal enriched fraction was identified by determining 
the specific activity of three lysosomal enzymes; acid phosphatase, N-acetyl p-D- 
glucosaminidase and Cathepsin D, in each fraction using methods adapted from that 
of Cabral et al (1988) (Section 4.2.1.2.2). The fraction identified as being enriched in 
lysosomes was disrupted using a dismembranator (Sartorius Stedin Biotech. France). 
Samples were transferred to a stainless steel shaking flask containing a ball-bearing 
and frozen in liquid nitrogen. The frozen shaker flask was then quickly inserted into 
the dismembranator and shaken at 3000 shakes per minute for 60 sec. The sample was 
transferred to a sample tube and maintained on ice. The process aimed to disrupt the
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lysosomal membranes and create a lysosomal enzyme cocktail that was sterilised by 
sequential filtration.
4.2.1.2.1 Protein determination of lysosomal fraction
Protein levels were determined using a BCA assay (Pierce Biotechnology, USA). The 
BCA protein assay is a routinely used laboratory technique used for the quantification 
of protein and was undertaken according to the manufacturers guidelines. The assay 
employs bicinchoninic acid (BCA) for the colourimetric quantification of protein and 
is based around the reduction of Cu2+ to Cu1+ by proteins under basic conditions.
A calibration curve was created using standards of known protein content ranging 
from 0 to 2000 pg/ml. The calibration curve was then used to calculate the protein 
content of the unknown sample. The volume of working reagent needed for each 
protein determination was calculated using the following formula: number of 
triplicates of the standard plus number of triplicates of the test sample plus three 
(pipetting error) times the volume of working reagent for each sample. The working 
reagent was prepared by mixing BCA reagent A and BCA reagent B in a ratio of 50:1. 
10 pi . of each standard in triplicate or test sample in triplicate were added to the 96- 
well plate (Orange scientific, UK). 200 pi of working reagent was added to each well 
and incubated at 37°C for 30 mins. The plate was cooled to room temperature before 
measuring the absorbance at 570 nm on a microplate reader (Multiskan Ascent. 
Labsystems, UK).
The standard curve was created by plotting the average measurement of each dilution 
of BSA standard into a regression of linear fit (Graphpad, Prism). Concentration of 
the total protein was determined by reference to the standard curve (Graphpad. 
Prism).
4.2.1.2.2 Lysosomal enzyme marker assays
Enzyme assays were carried out using a modification of the techniques described by 
(Cabral et a l, 1990). 25 pi of the sample being analysed for lysosomal enzyme 
activity was solubilised by exposure to 25 pi of 0.2% Triton-X 100 (1:1 dilution) for 5
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mins on a plate shaker (R-100 Rotatest Shacker, Luckham). After solubilization, 
buffer and substrates were added to the lysosomal isolates. Each sample was run in at 
least triplicate.
(i) Acid phosphatase assay
5 mM p-nitrophenol-phosphate was used as substrate, giving a final volume of 100 pi 
of 0.1 M acetate buffer (pH 4.5). The reaction was allowed to proceed for 30 mins at 
37°C before being stopped by the addition of 100 pi of 200 mM NaOH (pH 10.5, final 
concentration 100 mM).
(ii) N-acetyl p-D- glucosaminidase
5 mM p-nitrophenol -p-D  -glucosaminide in 0.1 M citrate buffer (pH 4.5) was used 
as substrate, in a final volume of 100 pi. The reactions were allowed to proceed for 45 
mins at 37°C and were stopped with the addition of 100 pi 0.8 M glycine NaOH (pH 
10.5; final concentration 0.4 M).
The reaction product for the acid phosphatase and N-acetyl P-glucosaminidase assay 
(p-nitrophenol) was measured spectrophotometrically at 405 nm (Multiskan Ascent, 
Labsystems, UK). The concentration of p-nitrophenol was expressed in nanomoles by 
reference to a calibration curve. The activity of these enzymes was then expressed as 
nM p-nitrophenol/ min / pg protein.
Data for the p-nitrophenol calibration curves were obtained by aliquoting 100 pi p- 
nitrophenol standards (Sigma, UK) of increasing concentration in 0.1 M acetate buffer 
(pH 4.5) into different wells of a 96-well plate. 100 pi of 200 mM NaOH was added 
to each well and the resultant absorbance was measured at 405 nm with a Multiskan 
Ascent multi-well plate reader. Wells used as blanks contained an identical 
concentration of acetate and NaOH but did not contain p-nitrophenol.
(Hi) Cathepsin D
50 pi of 2% (w/v) haemoglobin in 0.25 M formate buffer (pH 3.3) was used as 
substrate to give a final volume of 100 pi. The reaction was allowed to proceed for 60 
mins at 37°C before being stopped with the addition of 250 pi of 3% TCA. The
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eppendorf tubes containing sample were centrifuged at 220 g  for 10 mins (Micro 
Centaur, MSE). 25 pi of the supernatant was transferred to a 96-well plate and the 
protein quantified as described in Section 4.2.1.2.1, using tyrosine of known 
concentrations to create a calibration curve.
The coloured reaction product of the Cathepsin D assay was measured 
spectrophotometrically at 570 nm using a 96-well plate reader (Multiskan Ascent, 
Labsystems, UK). The absorbance values were converted to tyrosine equivalents 
using a calibration curve. The activity of Cathepsin D is expressed as ng of Tyrosine 
equivalents/ min/ pg protein. The calibration curve for tyrosine equivalents were 
created using 25 pi aliquots of tyrosine (Sigma, UK) in 0.25 M formate buffer (pH 
3.3) of varying concentrations that were introduced to different wells of a 96-well 
plate. Protein content was determined using the BCA assay as described in section
4.2.1.2.1 Wells used as blanks did not contain tyrosine.
Controls for each of the assays were established by running in tandem with the assay 
(a) wells that contained no sample only buffer, but with substrate present (b) wells 
containing no substrate only buffer, with sample present. The absorbance values of 
these wells were subtracted from the sample values when determining the activity of 
the enzymes of samples to account for light scattering, background absorbance and 
spontaneous hydrolysis of the substrate.
4.2.1.3 Isolation o f  mitochondria from bovine liver
Isolation of mitochondria took place using a technique adapted from that described 
by; Johnson, and Lardy, 1967 (Johnson and Lardy. 1967). To isolate mitochondria, 
firstly, 500 g of bovine liver was dissected into ~25 mm sections. The bovine liver 
sections were next added to 1.5 volumes of mitochondria buffer (See Table 4.1 below) 
before being homogenised in a mechanical blender (Kenwood. UK) in 15 sec bursts 
until smooth. At this point the pH of the solution was adjusted to 7.8 using 1 M Tns 
base. The liver tissue was further disrupted by homogenising with a hand-held pestle 
and mortar (Fisher Scientific, UK) on ice. Next, the homogenate was centrifuged at 
1000 g for 10 mins at 4°C (Boeco U-32R, Hamburg, Germany), discarding the pellet 
and retaining the supernatant. The supernatant was filtered through cheesecloth before
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undergoing a further centrifugation at 1000 g for 15 mins, 4°C. The pellet of this 
centrifugation was discarded with the supernatant undergoing a further spin; 1 2 0 0 0  g 
for 15 mins at 4°C (Sorvall Ultra-Pro 80, Sorvall, USA). The resultant pellet was 
retained and washed in 4 volumes of mitochondria buffer containing a protease 
inhibitor cocktail consisting of: 1 M phenylmethanesulphonyl fluoreide, 1 mg/ml 
leupeptin, 1 mg/ml pepstatin (all from Sigma-Aldrich, UK) at 12000 g  for 15 mins at 
4°C. The washing step was repeated three times in total before the mitochondrial 
sample was suspended in a small volume of mitochondria buffer with an aliquot being 
used to determine the presence of Hsp60 and protein content (Section 4.2.1.2.1) by 
Western blot analysis (Section 4.2.1.3.1). The mitochondria were then re-suspended in 
either PBS (pH 7) or citrate buffer (pH 4.5) to be used as components of the in vitro 
lipofuscin models.
Table 4.1 Mitochondrial buffer used for the isolation of mitochondria from bovine liver.
EDTA 0.2 mM
Sucrose 0.25 M
Tris. HC1 (pH 7.8) 10 mM
4.2.1.3.1 Western blot to determine if mitochondria were present in the enriched 
fraction
The mitochondria (1/10 dilution in PBS) were suspended in sample loading buffer, 
boiled at 100°C for 10 mins, separated by 8 % SDS-PAGE and blotted on a 0.2 pm 
nitrocellulose membrane (350 A) (Bio-Rad). The membrane was blocked for 1 hour 
with 5% milk in 0.1% TBST (0.1% Tween 20 in TBS). Next the membrane was 
probed for 1 hour at room temperature with primary mouse monoclonal HspoO 
antibody [LK-2] (Abeam) (1:1000 dilution), washed four times in 0.1% TBST for 10 
mins each. Washing was followed by a 1 hour incubation with goat anti-mouse horse­
radish peroxidase (HRP) secondary antibody (1:10 000 dilution; Jackson 
ImmunoResearch Laboratories). After four washes in 0.1% TBST the signal on the 
blot was detected with enhanced chemiluminescence with HRP as substrate. (Pierce. 
UK).
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4.2.2 In vitro lipofuscin model maintenance conditions
Isolated mitochondria were re-suspended in either citrate buffer (pH 4.5) or PBS (pH 
7) and mixed with the lysosomal enzyme cocktail at the same pH. POS isolated either 
under dim red-light or full light conditions were suspended in either citrate buffer or 
PBS (pH 4.5 and 7, respectively) and mixed with the lysosomal enzyme cocktail at 
the same pH. Each model was maintained at 37°C in a humidified atmosphere 
containing 5% C02 / 95% air for four months. An initial volume of 18 ml was used 
for each model then 1 ml (-1 x 107 POS/ml) of light or dark isolated POS or 1 ml 
(-500 pg/ml protein content) of mitochondrial enriched sample plus 500 pi (-800 
pg/ml protein content) of lysosomal enzyme cocktail was added every 14 days to give 
a final sample volume o f 30 ml. For controls that consisted o f single components of 
the model, the volume was corrected to that of the models by the addition of either 
PBS for the controls at pH 7 or citrate buffer for the controls at pH 4.5.
4.2.3 Analysis of rhodopsin levels in POS
Analyses of rhodopsin levels in dark and light isolated POS were carried out using the 
U-2800 UV-VIS Spectrophotometer (Hitachi) with UV Solutions software. The 
absorbance spectra was measured between 400-600 nm with a characteristic peak at 
500 nm present in samples containing rhodopsin which disappeared with exposure of 
the sample to light for 6  mins. Samples that contained little or no rhodopsin did not 
show the peak at 500 nm.
4.2.4 Isolation of ex vivo lipofuscin for comparison with the in vitro models of 
lipofuscin
Lipofuscin was isolated from human donor eyes as described in the General Materials 
and Methods Chapter. Section 2.1.
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4.2.5 Analysis of in vitro models and comparison with ex-vivo retinal lipofuscin
4.2.5.1 Absorption and fluorescence spectra o f in vitro models and their components
Absorbance spectra of samples were measured for wavelengths between 260-700 nm 
in a 1 cm path length quartz cuvette using a U-2800 UV-VIS Spectrophotometer 
(Hitachi) with UV Solutions software. For each set of absorbance readings a buffer- 
only reading was taken to ensure the cleanliness of the cuvette, this spectrum was also 
used as a buffer baseline and subtracted from sample readings by the software. 500 pi 
of sample was made up to 3 ml with the appropriate buffer.
Fluorescence spectra were measured using a F4500 Fluorescence Spectrophotometer 
(Hitachi) with FL Solutions Software. Emission spectra of samples were measured 
using 364 nm and 476 nm as the excitation wavelength. These values were chosen as 
they are wavelengths cited in previous studies detailing the emission spectra of retinal 
lipofuscin (Boulton et a l , 1990). The fluorescence spectra of buffers alone were 
measured and the background removed from samples using Microsoft Excel 
(Microsoft, USA). No fluorescence spectra were corrected for the loss in sensitivity of 
fluorescence detection at longer wavelengths.
4.2.5.2 SDS-PA GE analysis
SDS-PAGE is an analytical tool designed to examine proteins by denaturing them to 
their polypeptide constituents. SDS is an anionic detergent that denatures proteins and 
leaves them with an overall negative charge. The protein sample can then be 
fractionated using a polyacrylamide gel according to size, since all polypeptides will 
have an identical mass to charge ratio, with smaller proteins moving quickest through 
the gel. SDS-PAGE can be used to estimate the molecular mass of proteins as well as 
to analyse the purity of sample and determine if any post-translational modifications 
have affected the sample.
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Table 4.2. Solutions for casting a 10% resolving and 5% stacking gel for SDS-PAGE
Resolving gel (10%) 
( 1 0  ml)
Stacking gel (5%) 
(3 ml)
Distilled H20 4.0 ml 2 . 1  ml
30% acrylamide mix 3.3 ml 500 pi
1.5 M Tris/HCl pH 8 . 8 2.5 ml -
1.0 M Tris/HCl pH 6 . 8 - 380 pi
10% SDS 1 0 0  pi 30 pi
10% APS 1 0 0  pi 30 pi
TEMED 4.0 pi 3.0 pi
A 10% (w/v) resolving gel with a 5% (w/v) stack gel (See Table 4.2 above) was used 
to separate the peptides in the samples prepared for the targets of interest. Samples 
were mixed with an equal volume of 2x electrophoresis sample buffer (sc-24945, Bio 
Rad laboratories Ltd, Herts, UK) and incubated at 95°C for 5 minutes. Equal amounts 
of protein at a volume of 15-20 pl/well were loaded and the gel was run at 30 mA in 
lx Laemmli buffer (Bio Rad laboratories Ltd, Herts, UK) until the dye approached the 
bottom of the gel. The gel was analysed by Coomassie blue staining for the protein 
profile. To ascertain the molecular weights of protein species detected with 
Coomassie blue staining, 5 pi of a pre-stained molecular weight standard (Precision 
Plus Protein Standards, range 7.2 -  250 kDa; Bio Rad laboratories Ltd, Herts, UK) 
was applied to the gel.
4.2.5.2.1 Visualisation of protein profile by Coomassie brilliant blue staining
After electrophoresis, gels were immersed in an acidic alcoholic solution of the 
Coomassie brilliant blue staining solution (MeOH and acetic acid in a ratio of 4.5:1. 
and Coomassie brilliant blue R250, 2.5 mg/ml). This denatures the proteins, fixes 
them in the gel and allows the dye to bind to them. Subsequently, the gel was 
destained in 2:1 MeOH and acetic acid solution for visualisation of bands.
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4.2.5.3 CEP Western Analysis.
For Western analysis, the in vitro lipofuscin model preparations were extracted by 
boiling in SDS sample buffer containing 0.1 M DTT. The sample material (~20 pi) 
was applied to a PVDF membrane (Millipore, Bedford, MA) using a slot blot 
apparatus (Bethesda Research Laboratories HS-1878) and probed with mouse anti-2- 
(co-carboxyethyl)pyrrole (CEP) mAb (Ebrahem et al., 2006).
4.2.5.4 Analysis o f A2E in samples
The samples were pelleted by centrifugation (10,000 g , 4°C, 10 mins) and the pellets 
extracted with 2  ml chloroform/methanol (2 :1 ). 2  ml of water was added to the 
extracts, vigorously mixed and centrifuged for phase separation. The organic phase 
was collected, the watery phase re-extracted with 2 ml CHCl3/MeOH (2:1). The 
organic extracts were combined and applied to a SepPak-C 18-cartridge. The cartridge 
was then washed with 5 ml CHCL/MeOH (1:1) and eluted with MeOH + 0.1% TFA. 
The eluents were dried under a stream of nitrogen. The samples were re-dissolved in 
100 pi MeOH and injected onto a reversed phase Cl 8 -column (Nucleosil 5C18, 
Phenomenex, 150 mm x 4.6 mm) and eluted with a gradient o f methanol in water (85- 
96% + 0.1% TFA, lml/min). Elution was recorded fluorimetrically (excitation 
wavelength 430 nm, emission wavelength 632 nm).
4.2.5.5 Measurement o f  sinslet oxvzen production
4.2.5.5.1 Preparation of in vitro lipofuscin formation samples for laser flash photolysis 
work
Samples were prepared initially using a modification of Folch’s lipid extraction 
technique; (Folch et al., 1957) using 8  ml of chloroform/methanol (2:1) mixture that 
was added to 5 ml of each in vitro lipofuscin formation model. After vortexing, the 
solutions were centrifuged before the chloroform layer was removed. The chloroform 
layer was dried under vacuum and re-solubilised in benzene ready for further 
experiments.
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4.2.5.5.2 Measurement of singlet oxygen production by the in vitro lipofuscin 
formation models
Measurement of singlet oxygen emission was conducted using an adaptation of the 
method described previously (Rozanowska et al., 1998). This involved monitoring 
singlet oxygen emission at 1270 nm using a liquid nitrogen cooled germanium 
detector (Applied Detector Company, Fresco, CA, USA) coupled with an Agilent 
digitising scope (Infiniium 54830B DSO, Agilent, Santa Clara, USA) interfaced with 
a Rise computer (Acorn, Swadlincote, UK). Samples were photoexcited using a 5 ns 
laser pulse at 420 nm from a Q-switched Nd:YAG laser (Continuum Surelite II; Santa 
Clara, USA) equipped with an optical parametric oscillator (Panther OPO; 
Continiuum, Santa Clara, USA). The laser energy reaching the sample was regulated 
using neutral density filters, with the addition of each neutral density filter resulting in 
lower laser energy reaching the sample (see Figure 4.1).
100
4 0  -
Number of neutral density filters
F i g u r e  4 . 1 .  G r a p h  d i s p l a y i n g  t h e  r e d u c t i o n  i n  l a s e r  e n e r g y  w i t h  i n c r e a s i n g  n u m b e r  o f  n e u t r a l  
d e n s i t y  f i l t e r s .
Rose Bengal and all-trans-retinal were used as the standard singlet oxygen sensitisers. 
The quantum yield of singlet oxygen generation by all-trans-retinal (ATR) in benzene 
has been measured as 0.30 1 0.04 (Rozanowska et a l,  1998). The difference in 
optical density of each of the samples did not allow for matching at the excitation 
wavelength of 420 nm, so a calibration curve of ATR absorbance against singlet 
oxygen yield was created to normalise for the difference in sample concentration 
when calculating quantum yields. A sample of Rose Bengal of equal concentration
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(according to absorbance as measured at 420 nm) was used with each experiment as a 
standard to allow for normalisation of the variability of the geometry of the exposure 
between experiments. Initial emission intensity extrapolated from the experimental 
points was measured as a linear function of laser energy. The slopes of graphs 
generated with this data gave a value for singlet oxygen quantum yield generated by 
the in vitro lipofuscin model samples.
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4.3 Results
4.3.1 Preparative results
4.3.1.1 Identification o f the lysosomal enriched fraction using lysosomal enzyme 
assays.
Lysosomes were isolated from bovine liver pieces and four samples collected during 
the isolation procedure were analysed for enzyme activity for three lysosomal marker 
enzymes. Fractions were collected after successive centrifugation steps, Fraction 1 is 
the pellet collected after a 700 g spin, Fraction 2 collected after a 11,300 g  spin, 
Fraction 3 collected after a 27,200 g spin and Fraction 4 after a 141,500 g spin. 
Results obtained using the three lysosomal marker enzymes suggest that fraction 4 
was most enriched with lysosomes as this fraction showed the greatest activity with 
acid phosphatase, N-acetyl (3-glucosaminase and Cathepsin D (Figure 4.2 a-c). Thus, 
fraction 4 was used to yield the lysosomal enzyme cocktail for the in vitro lipofuscin 
formation model as it would best mimic the lysosomal conditions under which 
lipofuscin forms within the RPE.
a) Acid phosphatase activity 
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b) N-acetyl p-glucosaminase activity
Chapter 4
Fraction 1 Fraction 2 Fraction 3 Fraction 4
c) Cathepsin D activity
Fraction 1 Fraction 2 Fraction 3 Fraction 4
Figure 4.2 The activity of 3 lysosomal marker enzymes was measured during the isolation of 
lysosomes. Each of the 4 fractions were measured for the activity of a) Acid phosphatase, b) N-acetyl 
P-glucosaminase activity, c) Cathepsin D. * indicates result is statistically different from others when 
analysed using one-way ANOVA (p>0.005).
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4.3.1.2 Identification o f Heat Shock Protein (HSP) 60 as a marker o f mitochondria
presence.
-  C c
Figure 4.3 Confirmation of the presence of HSP60 in the mitochondrial enriched fraction using 
Western Blotting. The band seen above is present between the 50 and 75 kDa markers, at around the 
60 kDa mark, the molecular weight of the HSP 60 protein.
Hsp60 (Heat shock protein 60) was used as a marker for the presence of mitochondria 
in the fraction expected to be enriched in mitochondria using the Western blotting 
technique (Figure 4.3). Hsp60 is a mitochondrial chaperone protein that is typically 
held responsible for the transportation and refolding of proteins from the cytoplasm 
into the mitochondrial matrix and is used as a marker for mitochondria. The presence 
of a strong band on the Western blot gel is a good indication that mitochondria were 
present within the sample. Therefore, the sample was used as the mitochondria 
substrate for the in vitro lipofuscin formation models. It is quite likely that other 
cellular components were present within the pellet labelled as the mitochondria 
sample. However, as the aim of this project was to determine the role of autophagy in 
retinal lipofuscin formation and its contribution to lipofuscin’s physical attributes a 
completely pure mitochondrial sample was not needed. This is due to other sub- 
cellular components most likely also being involved in autophagy and the 
development of retinal lipofuscin.
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4.3.1.3 Characterisation o f rhodopsin levels in dark isolated POS compared to lisht
isolated POS.
 Dark isolated PO S
 dark isolated PO S 6
min light exposure
 Light isolated PO S
0.05
0.04
0.03
0.02  -
0.01
400 450 500
Wavelength (nm)
550 600
Figure 4.4. Optical density spectra of dark isolated POS (blue), dark isolated POS after 6 mins 
irradiation with light (pink) and light isolated POS (green).
The optical density spectra seen in Figure 4.4 show POS isolated under dim-red light 
(dark) have absorbance maxima at -500 nm characteristic of the presence of 
rhodopsin. After irradiating the sample with light for six minutes the optical density 
spectra changed and the rhodopsin characteristic peak was lost, indicating rhodopsin 
was photodegraded during light exposure. The optical density spectra of POS isolated 
under light conditions did not have the peak characteristic of rhodopsin indicating that 
rhodopsin was bleached during the isolation procedure. Therefore, these samples were 
used as the dark and light isolated samples to determine if the presence of rhodopsin 
affected the formation of retinal lipofuscin and the characteristics of anything that 
forms within the models.
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4.3.2 Physical characteristics of the in vitro lipofuscin models
POS isolated in the light when first isolated had a predominantly creamy-white colour 
with a hint of yellow. Incubation with lysosomes at pH 7 for four months resulted in 
the colour of the solution gradually developing a deeper yellow shade (Figure 4.5). 
POS isolated in the light maintained in buffer alone also developed a yellow shade; 
however, the colour was deeper when POS were incubated with lysosomes. POS 
isolated in the dark were pink in colour. This gradually changed to yellow as the POS 
were exposed to lysosomes and incremental light during their four months in the 
incubator. Dark isolated POS maintained in buffer alone followed a similar trend of 
changing from pink to yellow, but as with the POS isolated in light, the yellow colour 
was not as deep when the lysosomal enzyme cocktail was absent. The mitochondrial 
enriched fraction developed a browny-yellow colour over the 4 month period that was 
a lot denser than that seen in any of the POS samples. This was true of mitochondrial 
samples maintained with or without the presence of lysosomes.
The in vitro lipofuscin models that were maintained at pH 4.5 followed similar trends 
to those seen in the models maintained at pH 7 (Figure 4.6). Light and dark isolated 
POS developed a yellow colouring that was lipofuscin-like. This colouring was more 
prominent in the models containing lysosomes than the controls that contained POS 
alone. The sample containing mitochondria and lysosomes was more yellow than the 
control of mitochondria alone that had a dark yellow /brown appearance.
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A B C D E  F G H
Figure 4.5. Line up of the in vitro lipofuscin models and their constituent parts separately at pH 7 
after 4 months. From right to left; A = Mitochondria and lysosomes, B = POS (light) and lysosomes, 
C = POS (dark) and lysosomes, D = mitochondria alone, E = POS (dark) alone, F = Lysosomes alone, 
G =POS (light) alone, H = buffer solution alone.
A B C D E  F G  H
Figure 4.6. Line up of the in vitro lipofuscin models and their constituent parts separately at pH 
4.5. after 4 months From right to left; A = Mitochondria and lysosomes, B = POS (light) and 
lysosomes, C = POS (dark) and lysosomes, D = mitochondria alone, E = POS (dark) alone, F= 
Lysosomes alone, G = POS (light) alone, H = buffer solution alone.
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4.3.2.1 Spectra o f in vitro lipofuscin models and components and ex vivo lipofuscin
a) Optical density spectra of in vitro lipofuscin models and components, and, ex vivo 
lipofuscin pH 7 and pH 4.5
A B
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Figure. 4.7 Optical density spectra of the in vitro lipofuscin models as compared to lipofuscin 
isolated from human RPE at pH 7 (A) and pH 4.5 (B) (both series of spectra are normalised to point 
290 nm). Dark blue = lipofuscin, Pink = Mito and Lyso, Yellow = POS (dark) and Lyso, Turquoise = 
POS (light) and Lyso, Mauve = Mito, Brown = POS (light), Green = POS (dark), light blue= Lyso. The 
in vitro models show emission maxima at approx. 260 nm at both pH 7 and 4.5. Lipofuscin from 
human donors shows a broader emission pattern with a maxima at a longer wavelength.
Figure 4.7 shows the optical density spectra of the in vitro lipofuscin formation 
models and ex vivo lipofuscin at both pH 7 (A) and pH 4.5 (B). The in vitro lipofuscin 
formation models and their constituents show optical density spectra that have little 
optical density at longer wavelengths that develop into a distinct absorbance maxima 
at -260 nm. This phenomena is seen with the models and their constituents that are 
maintained at both pH 4.5 and pH 7. The absorbance profiles of the models contrast 
with those measured for ex vivo retinal lipofuscin at both pH 4.5 and 7. Ex vivo 
lipofuscin displays a broad-band optical density spectra with emission maxima at 
longer wavelengths than the in vitro lipofuscin formation models.
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b) Fluorescence spectra of in vitro lipofuscin models and components, and, ex vivo 
lipofuscin pH7 and pH 4.5
A pH 7 B pH 4.5
Lipofuscin 
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PO S  (litfit) Lyso 
PO S  (dark) Lyso 
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PO S  (light)
PO S (dark)
Lyso___________
Lipofuscin 
Mito Lyso
POS (light) and lyso 
POS (dark) and lyso 
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POS (light)
POS (dark)
Lyso
Wavelength (nm) Wavelength (nm)
Figure 4.8. Emission spectra of in vitro lipofuscin models and ex vivo human lipofuscin when 
excited with 364 nm light at pH 7 and 4.5 (normalised at point 400 nm). Dark blue = lipofuscin, 
Pink = Mito and Lyso, Yellow = POS (dark) and Lyso, Turquoise = POS (light) and Lyso, Mauve = 
Mito, Brown = POS (light), Green = POS (dark), light blue= Lyso. The in vitro lipofuscin models and 
retinal lipofuscin isolated from human donors show similar emission patterns with that of lipofuscin red 
shifted.
When excited with light of wavelength 364 nm the lipofuscin in vitro models produce 
spectra that have emission maxima at shorter wavelengths than those produced by ex 
vivo lipofuscin at both pH 7 and 4.5 (Figure 4.8 A and B). Each of the retinal 
lipofuscin models display emission maxima at -450 nm. Those maintained at pH 7 
also have a shoulder or secondary peak at -525 nm. This peak is also present in some 
of the samples maintained at pH 4.5. These samples include: POS (dark) and lyso, 
POS (dark) and mito and lyso. The emission maxima of ex vivo retinal lipofuscin is 
found at the longer wavelength of -525 nm at both pH 4.5 and 7.
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Figure 4.9. Emission spectra of in vitro lipofuscin models and ex vivo human lipofuscin when 
excited with 470 nm light at pH 7 and 4.5 (normalised at 500 nm). Dark blue = lipofuscin, Pink = 
Mito and Lyso, Yellow = POS (dark) and Lyso, Turquoise = POS (light) and Lyso, Mauve = Mito, 
Brown = POS (light), Green = POS (dark), light blue= Lyso Both the in vitro models and retinal 
lipofuscin isolated from human donors exhibit emission maxima in the blue region with lipofuscin red 
shifted approximately 20 nm.
Excitation of samples that have been maintained at pH 7 with light of wavelength 470 
nm results in spectra that have emission maxima between 500 and 550 nm for the in 
vitro lipofuscin models and their constituents (Figure 4.9 A). POS from dark and light 
isolated sources both have emission maxima at -510 nm with a secondary peak at 
-540 nm. The mito sample and lyso sample incubated separately have emission 
maxima at -  525 nm with broad peaks. The samples incubated with lyso including: 
POS (dark), POS (light) and mito, each had a peak at -  525 nm which was sharper 
than when the constituents were incubated alone. The ex vivo retinal lipofuscin has a 
slightly red-shifted emission maxima, occurring at approximately 530 nm, with the 
spectra being broader than that seen with the in vitro models or their constituents. The 
lipofuscin formation models maintained at pH 4.5 (Figure 4.9 B) show similar 
emission spectra to those maintained at pH 7. The emission spectra of ex vivo 
lipofuscin measured in buffer at pH 4.5 was broader than the spectra seen with the in 
vitro models and had an emission maxima at -540 nm.
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4.3.3 Components of the in vitro lipofuscin models
4.3.3.1 SDS-PAGE profile o f models
250
150
100
75
50
37
25
20
Figure 4.10. Protein profile of in vitro lipofuscin models and ex vivo lipofuscin by Coomassie blue 
staining of a 10% SDS-PAGE gel. Mitochondria and lysosomes pH 4.5 (1), POS (light) and 
lysosomes pH 7 (2), POS (light) and lysosomes pH 4.5 (3), POS (dark) and lysosomes pH 7 (4), 
Mitochondria and lysosomes pH 7 (5), POS (dark) and lysosomes pH 4.5 (6), ex vivo RPE lipofuscin
(7).
SDS-PAGE analysis of the in vitro lipofuscin models show a similar smear pattern to 
that seen with SDS-PAGE analysis of ex vivo lipofuscin (Figure 4.10). Very few if 
any distinct protein bands are present, with samples leaving a lane long smear. This is 
indicative of the models containing proteins that have undergone modification.
1 2 3 4 5 6 7
1 2 3 4 5 6 7
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4.3.3.2 Carboxvethvlpyrrole (CEP)-modifications o f models
Chapter 4
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Figure 4.11. Slot-blot western analysis of in vitro lipofuscin models and ex vivo lipofuscin for CEP 
oxidative modifications. Mitochondria and lysosomes pH 4.5 (1), POS (light) and lysosomes pH 7 (2), 
POS (light) and lysosomes pH 4.5 (3), POS (dark) and lysosomes pH 7 (4), Mitochondria and 
lysosomes pH 7 (5), POS (dark) and lysosomes pH 4.5 (6), ex vivo RPE lipofuscin (7).
Using the slot-blot technique we were able to demonstrate that some of the in vitro 
lipofuscin models contained species that had under gone CEP-adduction in a manner 
similar to that seen in ex vivo lipofuscin (Figure 4.11). CEP-adduction was only seen 
in models that contained POS, and was not present in the models mimicking 
lipofuscin formed as a result of autophagy, i.e. those that contain the mitochondrial 
enriched sample. It is thought that the staining seen in lane 1 is due to background 
staining. That in vitro lipofuscin models consisting of POS have products that have 
undergone modification by CEP-adducts is to be expected as CEP is a downstream 
product of the peroxidation of DHA, a fatty acid that is present in high levels within 
the POS.
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4.3.3.3 Measurement ofA2E content o f models.
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Table 4.1 A2E levels in the respective in vitro lipofuscin models and their constituent parts
Sample A2E levels in sample (ng/mg)
POS (light) and lysosomes pH 7 22.9
POS (light) and lysosomes pH 4.5 3.1
POS (dark) and lysosomes pH 7 43.2
POS (dark) and lysosomes pH 4.5 2.9
POS (light) pH 7 30.0
POS (light) pH 4.5 2.9
POS (dark) pH 7 60.0
Levels of A2E were measured in each of the models and the controls including: 
mitochondria pH 7, mitochondria pH 4.5, mitochondria and lysosomes pH 7, 
mitochondria and lysosomes pH 4.5 and POS (dark isolated) pH 4.5, however, A2E in 
these samples was either below the limits of detection or absent.
A2E has been proposed to be a major component of retinal lipofuscin by numerous 
authors (Sparrow et al., 1999; Schutt et al., 2001; Sparrow et al., 2003a). So to 
determine if our in vitro models of retinal lipofuscin were valid A2E levels were 
measured in each of the models, together with the model constituents as controls. A2E 
was recorded in each of the models containing POS and controls with POS with the 
exception of dark isolated POS maintained at pH 4.5. A2E levels were higher in 
models maintained at pH 7 than those maintained at pH 4.5. However, levels of A2E 
seen in each of the models were quite low. No amount of A2E was recorded in the 
models containing mitochondria and lysosomes either together or alone.
4.3.4 Photoreactivity of in vitro lipofuscin models
4.3.4.1 Comparison o f singlet oxygen production by photoexcited in vitro lipofuscin 
models. their constituents andATR.
The absorbance spectra of ATR samples of increasing concentration were measured 
(Figure 4.12 A). The absorbance value of these samples at 420 nm was used to 
generate a calibration curve of singlet oxygen yield versus standard absorbance 
(Figure 4.12 B) that covered the range of in vitro lipofuscin formation model 
concentrations.
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Figure 4.12. Absorbance spectra of ATR samples and calibration curve demonstrating the 
change in singlet oxygen yield when the concentration of ATR is changed. The absorbance spectra 
of the samples seen in A were used to generate B, which shows that an increase in ATR
Figure 4.13 A and B show the optical density spectra of the in vitro lipofuscin 
formation models and their constituents that were used to measure singlet oxygen 
production when excited with 420 nm light. As the optical density of the in vitro 
lipofuscin models were not concentration matched at 420 nm, the ATR standard 
calibration curve was used to normalise for the differences. Light scattering 
contributed to the optical density spectra of some of the in vitro lipofuscin models and 
as such generation of singlet oxygen by the models is measured as a lower limit of the 
quantum yield.
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Figure 4.13. Optical density spectra of the samples used for the measurement of singlet oxygen 
production by the models and the controls. The spectra seen in A represent the in vitro lipofuscin 
formation models involving POS and the POS controls. Those seen in B represent the models 
containing mitochondria together with mitochondria and lysosomal enzyme cocktail controls.
Figure 4.14 A and B show representative singlet oxygen traces generated by the in 
vitro lipofuscin models and their constituent controls. Such data was collected for 
each sample using gradually increasing laser energy. The data collected was 
normalised for variations in laser output and used to generate the linear regression of 
the initial intensity value plots seen in Figure 4.15.
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Figure 4.14. Singlet oxygen production by the lipofuscin formation models and the controls. The
singlet oxygen phosphorescence kinetics for the in vitro models containing POS and the POS controls 
are shown in A, those for mitochondria models and mitochondria and lysosomal enzyme cocktail 
controls are displayed in B.
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Figure 4.15. Linear regression of initial emission signal intensity over a range of laser energy. The
slope of the linear regression plots was used to calculate the quantum yield o f singlet oxygen generated 
by the lipophilic material extracted from each of the in vitro lipofuscin formation models. Plot A 
represents the linear regression of initial emission signal intensity over a range o f laser energies for 
models and controls containing POS, B contains data for the models involving mitochondria and the 
mitochondria and lysosomal controls.
The slope created when the initial emission intensity measurement is plotted against 
laser energy gives an indication of the singlet oxygen produced by each of the 
samples and can be used to calculate the quantum yield of singlet oxygen formation 
for each of the samples (Figure 4.15 A and B). The slopes of absorbance matched 
samples can be used to compare their photoreactivity, as can the quantum yield,
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however, the samples used in this study were not absorbance matched at 420 nm. To 
compare the relative photoreactivity the difference in concentration of each of the 
samples needs to be taken into consideration and the final outcome for each sample is 
termed the singlet oxygen yield. The singlet oxygen yield for each of the in vitro 
lipofuscin models is presented in Table 4.2 below. The sample with the greatest 
singlet oxygen yield was that which contained POS isolated in the light and incubated 
with the lysosomal enzyme cocktail at pH 4.5, similarly POS maintained at pH 4.5 
alone showed high relative singlet oxygen production. The in vitro lipofuscin 
formation model consisting of mitochondria incubated at pH 4.5 with the lysosomal 
enzyme cocktail displayed the second highest relative singlet oxygen production of all 
the samples tested with a singlet oxygen yield greater than the equivalent model 
maintained at pH 7. Equally, mitochondria maintained alone at pH 4.5 had a greater 
singlet oxygen yield value than those maintained at pH 7. The singlet oxygen yields of 
the mitochondria samples were similar to those obtained for POS isolated in the dark 
and incubated with the lysosomal enzyme cocktail at both pH 4.5 and 7, suggesting 
that lipofuscin products formed from autophagy may play a role in the phototoxicity 
of retinal lipofuscin. The samples containing the lysosomal enzyme cocktail alone had 
very low relative singlet oxygen yields.
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Table 4.2 Summary o f  the quantum yield of each o f the lipofuscin formation models and the controls 
for comparison with A TR and also the Yield o f singlet oxygen that has been normalised to account 
for differences in concentration o f samples.
Sample Lower limit of singlet 
oxygen quantum yield
Lower limit of 
singlet oxygen yield
ATR 0.3 1 0.04
Mito and Lyso pH 7 0.04 ±0.013 0 . 0 2 0
Mito and Lyso pH 4.5 0.05 1 0.014 0.033
POS (light) and Lyso pH 7 0.111 0.150 0.024
POS (light) and Lyso pH 4.5 0.11 1 0.015 0.036
POS (dark) and Lyso pH 7 0.061 0.010 0.018
POS (dark) and Lyso pH 4.5 0.03 1 0.020 0.015
Mito pH 7 0.021 0.009 0.015
Mito pH 4.5 0.03 1 0.009 0.019
POS (light) pH 7 0.05 1 0.040 0.008
POS (light) pH 4.5 0 .1 0 1 0 . 0 2 1 0.031
POS (dark) pH 7 o 1+ p o o 0 . 0 2 2
POS (dark) pH 4.5 0.11 1 0.007 0.030
Lyso pH 7 0.03 1 0.009 0.008
Lyso pH 4.5 0 .0 1 1 0 . 0 2 0 0.005
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4.4 Discussion
The aim of this study was to develop in vitro models of retinal lipofuscin formation 
that mimicked the processes of autophagy and phagocytosis to gauge how each of 
these mechanisms contributed to lipofuscin granule accumulation and how they 
affected the physical and chemical characteristics of the granules formed. To do this 
we identified the key components of retinal lipofuscin formation as being lysosomal 
enzymes, POS as substrates of phagocytosis and mitochondria to represent the 
contribution of autophagy in retinal lipofuscin formation.
The results of the lysosomal enzyme assays show that we have achieved an enriched 
lysosomal fraction from which to extract a lysosomal enzyme cocktail. This together 
with the Western blot results identifying the presence of the mitochondrial marker, 
HSP60, in the mitochondrial enriched fraction indicates that two of the components of 
the in vitro lipofuscin models have been obtained. Using spectrophotometry we have 
shown that two separate samples of POS have been isolated, one that contains intact 
rhodopsin (dark) and another in which the rhodopsin has been dissociated due to light 
exposure (light), thus, providing two separate models of the formation of retinal 
lipofuscin as a result of phagocytosis. These models could provide some insight into 
the role of intact rhodopsin in lipofuscin formation and any effect it may have on the 
physical characteristics of the granules.
Incubation of each of the retinal lipofuscin model components lead to the 
development of a yellow colour in the sample mixture over a four month period. This 
colour change is likely due to the peroxidation of lipid and protein constituents 
present within the models and controls (Yin, 1996; Nilsson and Yin, 1997). It is 
believed that oxidative modification of cellular components leads to the accumulation 
of lipofuscins, indeed, in this study adduction of cellular components to lipid 
peroxidation products were observed in some of the models.
The optical density and fluorescence spectra of the models show maxima at shorter 
wavelengths than those seen with retinal lipofuscin measured in this project and those 
published previously (Boulton et al., 1990). The spectra seen with the lipofuscin
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models resemble that of lipid peroxidation products that have been shown to emit in 
the far blue-region (Eldred and Katz, 1989,1991). The lipid peroxidation products 
may be responsible for the absorbance patterns of retinal lipofuscin at this 
wavelength, however, retinal lipofuscin contains a number of chromophores that may 
contribute to its absorbance spectra, some of which were not present in the in vitro 
lipofuscin models (Katz and Robison, 2002; Fishkin et a l , 2005).
The emission spectra of the lipofuscin models showed that they contained species that 
fluoresced at approximately 450 nm when excited with light of 364 nm. These results 
are similar to those recorded in other in vitro lipofuscin models based largely upon 
autophagy (Yin, 1992; Yin et al., 1995). It is possible that these fluorophores are 
Schiff bases that have arisen as the result of Maillard reactions between the models 
constituents. Some of the models including: Mito and Lyso, Mito, Lyso, POS (dark) 
and Lyso and POS (dark) when incubated at pH 7 exhibited a shoulder at -525 nm, 
this is also where the emission maxima of ex vivo retinal lipofuscin occurred. The 
shoulder at -525 nm was only seen in the Mito and Lyso model when incubated at pH
4.5. The presence of the shoulder indicates that there could be fluorescent species 
present within the models that are similar to those present in ex vivo lipofuscin.
Previously published in vitro models of lipofuscin formation have displayed 
fluorescence spectra that resembled those obtained in this study. However, some of 
these models were developed using cellular organelles that had been damaged by UV- 
radiation (Nilsson and Yin, 1997). This study avoided inducing oxidative damage 
using UV light despite it apparently being a quick: and easy method, as it has 
questionable physiological relevance to lipofuscin formation in the retina. The retina 
is well protected from UV-C light as the cornea does not transmit light of wavelengtn 
286 -  300 nm (Dillon et al., 2004). It is possible that longer wavelength UV-light 
would reach the retinas of children and aphakic individuals, however, lipofuscin 
continues to form in the eyes of older individuals whose crystalline lens no longer 
transmit light below -  400 nm and therefore the impact of UV in lipofuscin formation 
is likely to be minimal (Boettner and Wolter, 1962; Delori et al., 2001; Ernest, 2004).
The SDS-PAGE analysis of the protein profile of the lipofuscin models showed 
similar patterns to that seen with ex vivo lipofuscin. The smear of protein along the
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lane with very few if any distinct bands is indicative of the presence of numerous 
post-translational modifications. This phenomenon has previously been described in 
ex vivo lipofuscin (Warburton et al., 2005; Ng et al., 2008), and is seen again in this 
study. In vitro lipofuscin models and ex vivo lipofuscin also showed protein smearing 
with no distinct bands at the low molecular weight end of the gel, this would likely 
indicate that both samples contain partially digested or degraded proteins.
Of the numerous post-translational modifications that have been identified in retinal 
lipofuscin, one that has generated a lot of interest in the literature is CEP-adduction. 
CEP-adducts have been shown to be elevated in the blood plasma of AMD patients 
and to accumulate in drusen on Bruchs membrane (Crabb et al., 2002; Gu et al., 2003; 
Hollyfield et al., 2008) Equally, CEP has been shown to induce neovascularisation in 
vivo upon administration to a chick model (Ebrahem et al., 2006; Hollyfield et al., 
2008). The presence of CEP-adducts in the lipofuscin formation models adds 
credence to the theory of lipid peroxidation products playing an important role in the 
formation and accumulation of lipofuscin (Schutt et al., 2003a; Kopitz et al., 2004b). 
However, as seen in Figure 4.10 CEP-adducts were not present in all the models, 
being absent from those modelling lipofuscin formation as a result of autophagy. That 
CEP modifications were present in the models that contained POS is most probably 
due to the presence of large quantities of DHA, the unique precursor for CEP 
formation, which is present in high quantities within the POS (Bazan et a l, 1990).
No A2E was detectable in the models that contained only mitochondria or 
mitochondria and lysosomes. Previous studies have noted that A2E can accumulate in 
mitochondria, however, it was postulated that the A2E present was not formed within 
the mitochondria but had accumulated to a critical level within lysosomes and was 
released from there. The A2E then targeted the outer membranes of mitochondria and 
accumulated (Schutt et a l, 2007a).
It has been proposed that the precursors of A2E are formed within the POS before the 
final hydrolysis reaction that forms A2E occurs in the lysosomes (Liu et al., 2000; 
Ben-Shabat et al., 2002b). However, the presence of A2E in models containing only 
POS supports the findings of the Sparrow group, who have noted that A2E can form
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in photoreceptors before they are phagocytosed to the RPE (Sparrow and Boulton, 
2005). Measurement of A2E levels in the lipofuscin models also show a pattern of 
pH dependence, A2E levels were highest in the models maintained at pH 7, with the 
three lowest values each being at pH 4.5. This pattern of A2E formation may be 
linked to lysosomal enzyme activity, with activity decreasing at higher pH levels 
leading to less digestion of A2E precursors. Equally, phospholipase D is postulated as 
being one of the enzymes responsible for the hydrolysis reaction that converts the 
A2E precursor, A2PE, into A2E (Ben-Shabat et al., 2002b). This is a plasma 
membrane associated enzyme that works optimally at neutral pH and so formation of 
A2E in the models at pH 7 could possibly occur more optimally than at pH 4.5. There 
was no obvious pattern as to what effect intact rhodopsin had on the generation of 
A2E. Models and controls that contained dark isolated POS were measured as having 
the highest (POS (dark) pH 7, 60 ng A2E/ mg sample) and the lowest (POS (dark) and 
Lyso pH 4.5, 2.9 ng A2E/ mg sample) A2E levels.
The singlet oxygen yield of the lysosomal enzyme cocktail incubated alone at pH 4.5 
and 7 was lower than all others, with the exception of the light isolated POS sample at 
pH 7. However, when mitochondria and light isolated POS are incubated with the 
lysosomes the singlet oxygen yield of the model is greater than, or, equal to the sum 
of its parts. This may suggest that the mitochondria and light isolated POS undergo 
further modification when exposed to the lysosomal enzyme cocktail generating 
photoreactive species. The dark isolated POS did not follow this trend. Dark isolated 
POS had a lower singlet oxygen yield than those incubated alone.
A comparison of the quantum yield of singlet oxygen of A2E as calculated by Pawlak 
et al (0.0003) and the lower limits of singlet oxygen quantum yield obtained in this 
study for the in vitro lipofuscin formation models, suggests that each of the models 
generates more singlet oxygen when excited with blue-light than A2E (Pawlak et al.. 
2003). As the models were composed of what are thought to be the principle 
substrates of retinal lipofuscin, it can be postulated that the models contain 
photoreactive species that would also be present in retinal lipofuscin and that these 
species are more potent than A2E.
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Results obtained during this study imply that it is possible two species of RPE 
lipofuscin exist, one that originates from the incomplete degradation of old or 
damaged organelles and the other from the phagocytosis of POS. Equally, these two 
distinct origins could provide a source of material for the formation of a single type of 
lipofuscin granule that is a composite of both. Indeed, this may partially explain the 
heterogeneity of individual lipofuscin granules that has been noted (H aralampus- 
Grynaviski et al., 2003).
The study has succeeded in developing three in vitro models of retinal lipofuscin 
formation, each at pH 4.5 and 7, simulating the processes of autophagy and 
phagocytosis. Results obtained in this study suggest that both processes contribute to 
retinal lipofuscin formation. Analysis of the models indicates that there are a number 
of similarities between the in vitro and in vivo lipofuscin samples, however, there are 
also some distinct differences that are symptomatic of more complex mechanisms 
being involved in lipofuscin formation than simply exposing cell components thought 
to be the main substrates to lysosomal enzymes.
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Chapter 5
Can Yellow Tinted Filters Protect Against the 
Blue-Light Phototoxicity of Retinal 
Lipofuscin?
Matthew Davies Chapter 5
5.1 Introduction
The human eye is exposed to high energy non-ionizing radiation throughout 
life. However, irradiation below approximately 390 nm is prevented from reaching the 
retina by the cornea and lens allowing only the passage of light above this wavelength 
(Boettner and Wolter, 1962; van den Berg and Spekreijse, 1997). With age and 
increasing yellowing of the lens, likely due to the accumulation of tryptophan 
oxidation products and glycation of lens proteins, the quantity of short wavelength 
visible light in the blue region of the spectrum transmitted to the retina decreases 
(Weale, 1988; Dillon et a l, 2004). This affords protection to the retina from 
potentially harmful, high energy light in this region. However, this protective effect is 
negated by the age-related increase in the photoreactive pigment lipofuscin present in 
the RPE (Feeney-Bums et a l, 1984; Delori et a l , 2001).
As described previously, retinal lipofuscin has been shown to be photoreactive and 
damaging to RPE cells in vitro when excited with blue-light through multifaceted 
mechanisms including: damage to proteins, lipids and DNA (Boulton et a l, 1993; 
Rozanowska et a l , 1995; Rozanowska et a l , 1998; Davies et a l , 2001; Boulton et a l , 
2004; Godley et a l,  2005). Such experimental work has resulted in retinal lipofuscin 
being theoretically linked to RPE cell damage and, as a consequence, a number of 
diseases relating to macular dysfunction, in particular AMD (Margrain et a l, 2004; 
Nowak, 2006b).
Intra-ocular lenses (IOLs) are artificial lenses that are used to replace opacified 
natural crystalline lenses during cataract surgery. Early IOLs were colourless and 
allowed transmission of UV irradiation as well as visible light. During the 1980s 
lenses were developed that prevented transmission of UV-light but still allowed the 
passage of harmful blue-light (Mainster, 1986). Replacement of a naturally yellowed 
lens with a clear one after cataract surgery exposes the aged retina to high energy 
blue-light when it is at its most vulnerable. Indeed, it has been reported that patients 
who have under gone cataract surgery and been implanted with a clear IOL are at 
increased risk of developing disciform ARM as compared to age matched controls 
(van der Schaft et a l, 1994; Pollack et al, 1996). The association of blue light and 
lipofuscin with macular degeneration and the theoretical protective properties of
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yellow compared to clear or UV-blocking only lenses has led to the development of a 
new series of IOLs that have the ability to block blue-light, but have yet to be 
universally accepted (Meyers et al., 2004; Mainster, 2005,2006).
There are a number of arguments against the use of blue-blocking lenses. One is that 
reducing the amount of blue-light reaching the back of the eye could adversely affect 
the patients colour sensitivity and also theoretically lead to a loss in scotopic vision 
(Pons et al., 2007). However, the amount of blue light blocked by an IOL is less than 
that of a natural 70 year old lens (van de Kraats and van Norren, 2007). Indeed, 
several clinical trials have failed to find any significant difference in scotopic vision, 
visual acuity, contrast sensitivity or colour vision between patients with blue-blocking 
and clear IOLs (Marshall et al., 2005; Hayashi and Hayashi, 2006; Greenstein et al., 
2007; Landers et al., 2007; Muftuoglu et al., 2007). Another cause for concern is 
based around the suggestion that the use of blue-blocking lenses may interrupt the 
excitation of melanopsin, a molecule found in blue-light sensitive retinal ganglion 
cells, believed to modulate circadian rhythms and pupillary function (Berson et al., 
2002; Dacey et al., 2005; Kawasaki and Kardon, 2007; Zaidi et al., 2007). A solution 
to this theoretical problem is the use of sharp cut-off filters that would block shorter 
wavelength visible light (the blue-light hazard peaks between 430-440 nm) but allow 
transmission at 480 nm which is the peak spectral sensitivity of melanopsin (Algvere 
et al., 2006; van de Kraats and van Norren, 2007). These problems highlight the 
importance of design when considering the manufacture of blue-blocking lenses 
where a balance needs to be struck between photoprotection and photoreception.
Previous studies demonstrated that blue-light blocking. lenses had a protective 
capacity towards RPE cells exposed to high intensity light for short periods and 
inhibit the light induced production of VEGF by RPE cells (Sparrow et al., 2004; 
Yanagi et al., 2006). Both studies used a single model of IOL that was a gradual blue- 
light blocker.
The aims of this study were to investigate the photoprotection offered by different 
IOLs, or equivalent filters, on the phototoxicity of retinal lipofuscin and associated 
RPE cell death. The relationship between lipofuscin granule number per cell and cell 
viability after light exposure was also explored. The effectiveness of optical filters
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was quantified using the MTT assay and visualised with the Live-Dead cell assay 
using a fluorescence microscope. This study sought to determine if there was a 
difference between the photoprotection afforded by a sharp-cut off filter and a gradual 
blue-blocking filter.
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5.2 Materials and Methods
5.2.1 Measurement of transmittance of light through blue-light transmitting 
filters
Transmission of light (290-1000 nm) through filters was measured using a 
spectrophotometer (U2800, Hitachi Digilab). The data was transferred from the UV 
solutions 2.0 software to Excel for graphing.
5.2.2 Optimisation of choice of blue-light transmitting filter to be used in this 
study
In order to identify a blue light filter with the appropriate spectral range and sufficient 
irradiance the transmission of a number of “blue-light” filters was measured. Initially 
the transmission of sharp cut-off filters (provided by AMO Inc, Santa Ana, CA), that 
allowed the passage of light between 400-440 and 440-500 nm, was recorded. These 
proved interesting as light of very specific wavelengths could be used. However, 
whilst an irradiance of 2.8 mW/cm could be achieved with the 440-500 nm filter, 
light levels attainable with the 400-440 nm filter were lower than those used in the 
validation studies. Increases in irradiation intensity can be achieved by moving the 
light source closer to the cells, however, this results in the temperature of the cells 
increasing. Using the 400-440 nm light transmitting filter it was not possible to 
achieve the required light level and maintain the temperature at a level that would not 
affect cell viability. For this reason work with these filters did not proceed.
Next, the transmission profile of blue-light creating filters purchased from Lee filters 
(Hampshire, UK) were measured, using single and combinations of filters. Both the 
Zenith blue (# 195) (Fig. 5.1.A) and the Special Medium Blue (#363) (Fig. 5.1.C) 
filters transmitted light of wavelength and irradiance suitable for future investigations. 
The addition of a Mauve filter (# 126) (Fig. 5.IB & D) to reduce the amount of red 
light passing through the filter reduced the irradiance of light effectively creating the 
same problem that was encountered with the sharp cut-off filters. Therefore, the 
Special Medium Blue filter was chosen as this filter suited our needs and had been
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used in previous work on RPE phototoxicity studies found in the literature (Godley et 
a l , 2005).
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Figure 5.1. Transmission spectra of blue light transmitting filters for 400-500 nm. The
transmission of light through the filter was measured between 300 and 700 nm using a 
spectrophotometer (U2800 Hitachi digilab) as described in 5.2.1. Transmission spectra through zenith 
blue (A), zenith blue and mauve (B), special medium blue (C) and special medium blue and mauve (D) 
filters were measured.
5.2.3 Isolation of lipofuscin
Lipofuscin was isolated as described in the Materials and Methods, Section 2.1. 
Briefly, RPE cells were isolated from human donor eyes obtained from Bristol Eye 
Bank with Human Tissue License (average age of donor 6 8  years, donors within the 
age range 58-92 years old). RPE cells were disrupted and the lipofuscin isolated using 
a series of discontinuous sucrose density gradients. Once isolated lipofuscin was 
quantified by counting on a haemocytometer (Btirker, Germany) and stored at -80°C 
until required.
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5.2.4 Cell culture
Prior to experimentation ARPE-19 cells were stored and maintained as described in 
the Materials and Methods, Section 2.2. For illumination and flow-cytometry studies 
cells cultured in 24 well plates (Orange Scientific, Belgium) in Hams F-10 medium 
supplemented with 10% FCS were cultured in a humidified incubator at 37°C in an 
atmosphere containing 5% CO2 . Cells for Live/Dead staining studies were seeded into 
6 -well (Orange Scientific, Belgium) plates with a sterile 22 x 22 mm coverslip (VWR 
International, Leicestershire) placed at the base. Once confluent the cells were 
maintained in basal medium (2% FCS) for 1 week. Cells for studies analysing the use 
of optical filters in protecting RPE cells were exposed to lipofuscin (-300 granules 
per cell) for 24 hours. RPE cells used in the quantification of lipofuscin phototoxicity 
as a function of granule number and those used in flow-cytometry studies were 
exposed to either: 0, 10, 50, 100, 300, 500 or 700 granules per cell for 24 hours. After 
lipofuscin loading the cells were maintained in basal medium for a further week with 
medium changes every 2  days.
5.2.5 Experimental set-up for illumination
For illumination studies light was generated using a Sunlight simulator (SOL 120, 
Honle technology, Munich, Germany). Cells with and without lipofuscin were placed 
above the optical filter being tested. Light exposed control cells were irradiated 
directly by the light. Dark control cells were wrapped in black foil and placed atop the 
light source. Aluminium foil was positioned between the dark control cells and lamp 
to prevent over heating. The distance cells were kept from the lamp and the use of 
heat shields ensured that cells were exposed to light at the intensity required and also 
maintained at a constant temperature of 37°C (Fig. 5.2). Spectral range of light was 
controlled by using a Special Medium Blue filter for blue-light exposures and a clear 
glass sheet for white light (390-720 nm).
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Figure 5.2. Experimental set-up used for determining the potential of blue-light blocking lenses in 
reducing the blue-light hazard of retinal lipofuscin
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5.2.6 Illumination of RPE Cells
Prior to light exposure, the basal medium was replaced with SF10PF (Gibco, UK) 
medium, which lacks the photosensitisers phenol red, tryptophan, tyrosine, riboflavin 
and folic acid.
Light conditions used were;
(a) blue-light, 400-500 nm, 2.8 mW/cm2, 37 °C.
(b) white-light, 380-720 nm, 19.0 mW/cm2, 13.0 mW/cm2 or 2.8 mW/cm2, 37 °C.
5.2.7 Measurement of spectral irradiance of light emitted from the sunlight 
simulator
Spectral irradiances were measured using a spectroradiometer (Specbos 121, 
HORIBA Jobin Yves, UK) held over the light source in the position of the cell culture 
plate. Data was transferred from the JetLi software to Excel for graphing.
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5.2.8 Cell Viability assays
5.2.8.1 MTT assay
Cell viability of ARPE-19 cells after light exposure was quantified using the MTT 
assay as described in the Materials and Methods, Section 2.4.
5.2.8.2 Live/Dead staining
Changes in cell viability were visualised using the Live/Dead staining assay. Viable 
cells take up Cyto-dye, a cell-permeable green fluorescent dye. Dead or damaged cells 
take up propidium iodide, a non-permeable red fluorescent dye that can only enter the 
cell when there has been membrane damage that results in permeabilisation (Frey, 
1995).
Cells with and without lipofuscin were prepared as described above and either 
exposed to blue-light (400-500 nm) at an intensity of 2.8 mW/cm in the presence or 
absence of Filters 1 or 2 supplied by AMO (Santa Ana, CA, USA) or maintained in 
the dark for 48 hours.
After a 48 hour exposure to light or maintenance in the dark, cells were treated with 1 
ml of Live/Dead staining solution (Calbiochem, UK) for 15 mins at 37°C as 
recommended by the manufacturer. The coverslips were removed from the wells of 
24-well plates and inverted onto glass microscope slides with a small drop of PBS to 
prevent cells drying out during microscopy. The cells were viewed immediately using 
a fluorescence microscope (Leica CTR 6000, Leica, Milton Keynes) equipped with 
band-pass filters that detect FITC and rhodamine and a DFC359 FX camera (Leica, 
Milton Keynes). Images were analysed using Microsoft Picture Manager (Microsoft, 
USA).
5.2.9 Measurement of lipofuscin-like fluorescence of cells using flow cytometery
Cells were prepared for analysis by flow cytometry as described in Chapter 2 Section
2.5. However, one week before experimentation cells were exposed to a graduated 
series of lipofuscin granule concentrations that ranged from 0 -  700 granules/cell for
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24 hours. The range was as follows: 0, 10, 50, 100, 300 and 700 granules/cell. Cells 
were then maintained in basal medium containing 2% FCS and a full complement of 
antibiotics and fungizone for 7 days.
5.2.10 Statistical analysis
All tests of optical filters were carried out at least three times and in triplicate. 
Analysis of variance (ANOVA) was used to determine the significance of differences 
in cell viabilities of populations treated with different filters or loaded with differing 
numbers of lipofuscin granules using Minitab software (Minitab 14, Minitab Ltd, 
Coventry, UK). Students’ /-test was used to determine the significance of results 
gathered in the validation of methodology section, when only two values were 
compared (Excel, Microsoft), p < 0.05 was regarded as statistically significant.
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5.3 Results
5.3.1 Optimisation of Experimental Conditions
5.3.1.1 (Photo)toxic effect o f  lipofuscin on ARPE-19 cells
This experiment was undertaken to investigate whether retinal lipofuscin was 
phototoxic to RPE cells under standard experimental conditions used in the laboratory 
and to optimise an exposure time for the IOL trials. The results in Figure 5.3 show 
that lipofuscin was phototoxic towards ARPE-19 cells when exposed to blue light 
(400-500 nm, created using Special Medium Blue filter, 2.8mW/cm ). This resulted in 
a significant (p<0.05) loss of RPE cell viability (60% cell viability) over a 24 hour 
period when compared to cells maintained in the dark ( 1 0 0 % cell viability) or not 
exposed to lipofuscin (90% cell viability). To determine if cell viability was 
dependant on irradiance time, the length of exposure was increased from 24 to 48 
hours. Figure 5.4 shows that there was a greater loss in cell viability between RPE 
cells loaded with lipofuscin and those not after a 48 hour period (43 and 84%, 
respectively) compared with 24 hours. 48 hours was, therefore, chosen as the 
appropriate time duration for future experiments. This series of experiments also 
verified that the experimental set-up was suitable for analysing the effect of blue-light 
and optical filters on cell viability of light irradiated cells.
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Plus lipofuscin Minus lipofuscin
F i g u r e  5 . 3 .  C e l l  v i a b i l i t y  o f  A R P E - 1 9  c e l l s  a f t e r  a  2 4  h o u r  e x p o s u r e  t o  4 0 0 > 5 0 0  n m  l i g h t .
A comparison of the viability o f cells that have been exposed to -300 lipofuscin granules per cell and 
those that have not been exposed to lipofuscin after irradiation with blue-light (400-500 nm, 2.8 
mW/cm2) for 24 hours. Results are the average of three exposures, each performed in triplicate. Error 
bars indicate standard deviation. Values significantly different to those o f cells loaded with lipofuscin 
and irradiated with blue-light: *p< 0.05.
Minus lipofuscinPlus lipofuscin
F i g u r e  5 . 4 .  C e l l  v i a b i l i t y  o f  A R P E - 1 9  c e l l s  a f t e r  a  4 8  h o u r  e x p o s u r e  t o  4 0 0 - 5 0 0  n m  l i g h t
A comparison of the viability o f cells that have been exposed to -300 lipofuscin granules per cell and 
those that have not after irradiation with blue-light (400-500 nm, 2.8 mW/cm2) for 48 hours. Results 
are the average of three exposures each performed in triplicate. Error bars indicate standard deviation. 
Values significantly different to those of cells loaded with lipofuscin and irradiated with blue-light:
**p< 0.01.
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5.3.2 Determination of the phototoxicity of lipofuscin as a function of the number 
of granules taken up by RPE cells
The results seen in Figure 5.5 indicate there is a relationship between increasing 
number of lipofuscin granules per cell and decreasing cell viability within the 
population. The trend is reproduced with each of the light conditions; higher and 
lower intensity white light and blue-light. However, the loss in cell viability when 
using the lower intensity white light (2.8 mW/cm ) did not become significantly 
different from 0 lipofuscin granules until cells were exposed to 500 granules per cell 
(P< 0.01), with a further significant decrease when cells were exposed to 700 granules 
per cell (P<0.005)
When exposed to higher intensity white light (13 mW/cm2) or blue-light (2.8
'y
mW/cm ), the loss in cell viability compared to cells loaded with 0 lipofuscin granules 
becomes significantly different when cells have been exposed to 50 lipofuscin 
granules per cell (P< 0.005). The effect of increasing numbers of lipofuscin granules 
showed a dose-dependent loss of cell viability up to the accumulation of 300 granules 
per cell with blue-light and 100 granules with white-light. At this point there 
continues to be an increase in cell death with increasing granule number, however, the 
difference in cell viability measured by the MTT assay is not as great as at lower 
lipofuscin granule levels. This is possibly due to the limitations in sensitivity in the 
MTT assay at low cell numbers. By 700 lipofuscin granules per cell, viability was less 
than 10%. This work indicates that the effect of lipofuscin upon cells is both 
concentration and light intensity dependant (Fig. 5.5D).
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Figure 5.5. Quantification of lipofuscin phototoxicity as a function of granule number. Cells were 
exposed to an increasing number of lipofuscin granules and irradiated with A, blue light (400-500 nm, 
2.8 mW/cm2), B, lower intensity white light (380-720 nm, 2.8 mW/cm2) or C higher intensity white 
light (380-720 nm, 13 mW/cm2) for 48 hours. D is a comparison of figures 5 B and C. Control cells 
were maintained in the dark by wrapping in black foil. Data are the average of 3 exposures each carried 
out in triplicate. Error bars represent standard deviation.
To determine if uptake of lipofuscin granules by RPE cells increased with exposure to 
increasing number of granules cells were exposed to a range of lipofuscin granule 
concentrations from 0 to 700 per cell. The lipofuscin-like autofluorescence within the 
cells was then semi-quantitatively measured by flow cytometery. The results indicate 
that increasing the number of lipofuscin granules that RPE cells are exposed to causes 
an increase in the number of lipofuscin granules phagocytosed by the cells (Fig. 5.6).
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Figure 5.6. Graph charting the change in cellular autofluorescence with exposure to lipofuscin 
granules. The graph shows an increase in auto-fluorescence of cells that are exposed to an increasing 
number of lipofuscin granules. The results are the average of triplicate readings, each run three times. 
The error bars indicate the standard deviation.
5.3.3 Analysis of blue-blocking IOLs and a UV-blocking IOL in reducing the 
blue-light hazard of lipofuscin towards RPE cells
Trials of IOLs using cells cultured in 96-well plates and IOLs attached to a grid gave 
results that showed inconsistencies between wells under the same conditions and 
repeats of trials. It was suggested that the irregularities arose because of a lack of 
sensitivity of the MTT assay with cells cultured in 96-well plates and focusing issues 
of the IOLs. To overcome the problem of sensitivity and to increase the irradiance 
area new filters which exhibited the transmission characteristics of the yellow IOLs 
and a UV-blocking control were manufactured.
5.3.4 Testing of AMO filters
5.3.4.1 Transmission spectra o f optical filters received from AMO
The filters used in this study were labelled as: Control la  and lb, Filter la  and lb and 
Filter 2a and 2b so that trials would be carried out in a ‘blind’ manner. The 
transmission of light through each filter can be seen in Figure 5.7. The transmission 
spectra show that the control filters used in these trials are UV-blocking filters that 
prevent the passage of nearly 100% of light below 400 nm in wavelength, but transmit 
light of longer wavelength. Filter 1 is a blue-light blocking filter that allows the 
passage of minimal light below 400 nm but gradually allows the transmittance of light 
up to 500 nm, and all greater than this. Filter 2 is a sharp cut-off blue-light blocking
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filter that has 0% transmission below ~ 425 nm wavelength but almost 100% at ~ 450 
nm.
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Figure 5.7.Transmission spectra of optical filters (AMO, Inc., Santa Ana, CA)
5.3.4.2 Transmission o f  light from the sunlight simulator through the optical filters
Figures 5.8 and 5.9 show the spectral irradiance that cells are exposed to during 
white-light and blue-light exposures, respectively, and the effect each of the filters has 
on the spectrum of light reaching the cells. Figures 5.8 A and 5.9 A show the full 
spectrum as would be transmitted with no filter. Figures 5.8 B and 5.9 B are the full 
spectrum via the control filter. It can be seen that light below -400 nm is blocked by 
the control filter, but light of longer wavelengths is not obstructed. Figures 5.8 C and 
5.9 C show the light that would reach cells via filter 1. Filter 1 also blocks light below 
400 nm, plus causes a decrease in the intensity of blue-light up to approximately 480 
nm. Figures 5.8 D and 5.9 D represent light that would reach cells via filter 2. It can 
be seen that there is a sharp cut off point at approximately 430 nm. Light below that 
wavelength is blocked but light above is transmitted.
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Figure 5.8. Irradiance spectra measured at the level of cells from the sunlight simulator equipped 
with a combination of heat shield and white light-transmitting Filters with and without tested 
filters. A is with no filter, B through control filter, C is through filter 1 and D through filter 2. Arrows 
high-light the differences in spectra caused by the filters at the shorter wavelength end of the spectrum.
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Figure 5.9 Irradiance spectra measured at the level of cells from the sunlight simulator equipped 
with a combination of heat shield and blue light-transmitting filters with and without tested 
filters. A is with no filter, B through control filter, C is through filter 1 and D through filter 2. Arrows 
high-light the differences in spectra caused by the filters at the shorter wavelength end of the spectrum.
5.3.5 Assessment of filters in reducing the lipofuscin phototoxicity to RPE cells
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5.3.5.1 Blue-lisht studies
The data shows that lipofuscin has a phototoxic effect upon cells under all test 
conditions (Fig 5.10). However, the phototoxic effect is diminished by the use of the 
blue-blocking filters, Filters 1 and 2 (56 and 54% cell viability, respectively, p < 
0.001) and to a lesser extent the control filter (32% cell viability, p < 0.005) when 
compared to cells that have been exposed to blue-light directly. Cells exposed directly 
to blue-light in the absence of lipofuscin displayed a decrease in cell viability (73% 
cell viability) (measured according to the cells mitochondrial activity) when compared 
to dark maintained controls (100 % cell viability). Cells exposed directly to blue-light 
showed a statistically significant decrease in viability when compared to cells 
irradiated via the blue-light blocking filters, Filters 1 and 2 (89 and 98% cell viability, 
respectively, p < 0.005). There was no statistical difference between cells that were 
irradiated via either the control filter or no filter in the absence of lipofuscin. The data 
collected in this study also determined that there was no statistical difference in the 
viability of cells irradiated via either of the blue-light blocking filters. The cell 
viability of dark controls with and without lipofuscin indicates that loss of cell 
viability is probably due to phototoxicity and not another toxic feature of lipofuscin.
128
Matthew Davies Chapter 5
Plus NoLF Plus NoLF Plus NoLF Plus NoLF Plus No LF
LF LF LF LF LF
Dark Control No filter Control filter Filter 1 Filter 2
Figure 5.10. The effect of blue-light irradiation and lipofuscin loading on ARPE-19 cells. Cells 
were irradiated with blue-light (400-500 nm 2.8 mW/cm2) for 48 hours. Cells were either wrapped in 
black foil as a dark control, exposed directly to blue light or blue light through an optical filter. For 
each condition cells were present with or without lipofuscin (exposed to -300 granules per cell). 
Results are the average o f 3 exposures each carried out in triplicate. Error bars represent standard 
deviation. Statistically significant difference to cells loaded with lipofuscin and irradiated directly with 
blue-light: *p< 0.05. Statistically significant difference to cells not loaded with lipofuscin and 
irradiated directly with blue-light: **p< 0.05.
5.3.5.2 White light studies
As was found in the blue-light studies, studies using white light showed no statistical 
difference in cell viability of cells maintained in the dark regardless of whether they 
had been loaded with lipofuscin or not. This would indicate that any loss in cell 
viability seen during these tests can be attributed to a phototoxic effect.
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Figure 5.11. The effect of white-light irradiation and lipofuscin loading on ARPE-19 cells. Cells 
were irradiated with white-light (380-720 nm 2.8 mW/cm2) for 48 hours. Cells were either wrapped in 
black foil as a dark control, exposed directly to white light or white light through an optical filter. For 
each condition cells were present with or without lipofuscin (exposed to -300 granules per cell). 
Results are the average of 3 exposures carried out in triplicate. Error bars represent standard deviation.
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Under the test conditions described in the experimental design section (section 
5 .2 .5 /6 ) it was found that cells loaded with lipofuscin and irradiated with white light 
(390 -  720 nm) at an intensity of 2.8 mW/cm2 (Fig. 5.11) showed a consistent 
decrease in viability. Cells maintained in equivalent conditions but without lipofuscin 
showed no decrease in viability, however, this difference was found to be statistically 
insignificant. The study found that at this intensity there was no statistical difference 
between cells irradiated with the test filters, control filter or no filter.
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F i g u r e  5 . 1 2 .  T h e  e f f e c t  o f  w h i t e - l i g h t  i r r a d i a t i o n  a n d  l i p o f u s c i n  l o a d i n g  o n  A R P E - 1 9  c e l l s .  Cells 
were irradiated with white-light (390-720 nm 13 mW/cm2) for 48 hours. Cells were either wrapped in 
black foil as a dark control, exposed directly to white light or white light through an optical filter. For 
each condition cells were present with or without lipofuscin (exposed to -300  granules per cell). 
Results are the average of 3 exposures carried out in triplicate. Error bars represent standard deviation. 
Statistically significant difference to cells loaded with lipofuscin and irradiated directly with white- 
light: *p< 0.05. Statistically significant difference to cells not loaded with lipofuscin and irradiated 
directly with white-light: **p< 0.05.
Increasing the intensity of light to 13 mW/cm (providing 2.8 mW/cm in the range 
400-500 nm) resulted in a decrease in cell viability of cells under all conditions when 
compared to the dark maintained controls (Fig. 5.12). Cells exposed directly to high 
intensity white light recorded the lowest cell viability (65%), followed by cells above 
the control filter (72%). Cells placed above filters 1 and 2 showed identical cell 
viability, both recording averages of 82%. Cells loaded with lipofuscin showed the 
greatest decrease in viability. This effect was reduced by the presence of the yellow- 
tinted, blue-light blocking filters (Filter 1 and 2, 50 and 54% cell viability, 
respectively) compared with the effect of the control (33% cell viability) or no filter 
(14% cell viability) (P <0.005). However, there was no significant difference between 
the viabilities of cells protected by either of the blue-light blocking filters. The blue-
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blocking filters also conferred more protection from white light to cells not loaded 
with lipofuscin than either the control or no filter (P < 0.001).
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Figure 5.13. The effect of white-light irradiation and lipofuscin loading on ARPE-19 cells. Cells 
were irradiated with white-light (390-720 nm 19 mW/cm2) for 48 hours. Cells were either wrapped in 
black foil as a dark control, exposed directly to white light or white light through an optical filter. For 
each condition cells were present with or without lipofuscin (exposed to -300  granules per cell). 
Results are the average of 3 exposures carried out in triplicate. Error bars represent standard deviation. 
Statistically significant difference to cells loaded with lipofuscin and irradiated directly with white- 
light: *p< 0.05. Statistically significant difference to cells not loaded with lipofuscin and irradiated 
directly with white-light: **p< 0.05.
A further increase in white light intensity (19 mW/cm ) resulted in more drastic 
decreases in viability (Fig. 5.13). Lipofuscin loaded cells showed greater loss in 
viability than cells not loaded with lipofuscin and maintained under equivalent 
conditions. Cells loaded with lipofuscin and exposed to high intensity light via the 
control or no filter had viabilities of 9 and 15% of the dark control, respectively.
When Filters 1 and 2 were used the loss in cell viability was significantly decreased 
when compared to the clear or control filters (P< 0.05), displaying cell viabilities of 
36% and 39%, respectively. There was, however, no statistically significant difference 
between cells irradiated via either of the blue-light blocking filters.
Tests using cells that had not been loaded with lipofuscin showed that there was no 
significant protection afforded by the control filter when compared to no filter. 
However, both Filter 1 and 2 showed significant protection (P< 0.05) when compared 
to the control or no filter. No significant difference between the two blue-light 
blocking filters was seen.
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5.3.6 Live/Dead staining
Control cells, with or without lipofuscin, maintained in the dark showed an uptake of 
the cell-permeable green fluorescent dye but none of the cells stained with propidium 
iodide (Fig. 5.14 A, B). Red autofluorescent lipofuscin granules could be observed in 
the cells fed lipofuscin (Fig. 5.14 B). The staining patterns confirmed that the ARPE- 
19 cells remained viable throughout the 48 hour period. Cells exposed to light 
without lipofuscin also showed uptake of Cyto-dye with minimal co-staining for 
propidium iodide thus indicating their viability (Fig. 5.14 C). However, a large 
number of lipofuscin-fed cells exposed to blue-light became co-stained with Cyto-dye 
and propidium iodide which suggested cell damage (Fig. 5.14 D). In addition, it was 
apparent that some cells that had become detached from the coverslip surface. 
However, experiments using cells loaded with lipofuscin using the blue blocking 
filters, Filter 1 or Filter 2, in the presence of blue light exhibited minimal cell death 
(Figs. 5.14 F, H).
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Figure 5.14. The effect of blue-light exposure with/without lipofuscin loading on the viability of 
ARPE-19 cells visualised with Live/Dead staining. ARPE-19 cells with (B, D, F, H) or without (A, 
C, E, G) lipofuscin either maintained in the dark (A, B), exposed to blue light (C, D) or using the blue 
blocking filters (Filter 1 (E,F), Filter 2 (G,H) together with blue light exposure for 48 hours. Scale bar 
represents 75 pm.
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This study has demonstrated that the phototoxicity of lipofuscin towards RPE cells is 
dependent on the number of granules present, with increasing granule number per cell 
leading to a decrease in the viability of a cell population. This effect has been verified 
using blue and white-light. When tested with full visible spectrum light (390-720 nm) 
lipofuscin phototoxicity was shown to be light intensity dependent, where an increase 
in light intensity led to an increase in cell death when equal concentrations of 
lipofuscin granules were used. These findings correlate with the work of Boulton et al 
(1993) who noted that lipofuscin granules in suspension generated free radicals in a 
light intensity dependant manner.
This project has also led to the development of an experimental design that is capable 
of allowing fair comparison between optical filters and the appropriate controls. Trials 
involving lower intensity full visible spectrum light showed no significant difference 
in viability between the dark maintained controls and experimental cells. It is possible 
that light at this intensity and for the relatively short period of time was not sufficient 
to cause measurable damage to the cells and that any ROI generated by lipofuscin 
present could be dealt with by anti-oxidants and other protective mechanisms present 
within the cells (Snodderly, 1995; Cai et al., 2000; Jarrett and Boulton, 2005).
Using blue-light (400-500 nm) and higher intensity full spectrum light (390-720 nm), 
we were able to demonstrate that the control filter had a positive protective effect 
when compared to no filter. It is possible to explain this effect using the spectra of 
light reaching the cells via the filters as measured with a spectroradiometer. The 
spectra show that the control filter blocks light up to about 400 nm, preventing the 
passage of light between 390 and 400 nm that would still reach the cells that are 
irradiated directly. As this would be high energy light, preventing it reaching the cells 
above the control filter could have caused the decrease in loss of cell viability. 
Equally, there may be a number of chromophores present in the lipiofuscin granules 
or RPE cells that absorb light in this region and exhibit photosensitiser properties. 
Preventing the excitation of such chromophores by blocking light of short wavelength
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would reduce the number of photoactivated molecules present within the cell that 
could generate ROI. This again would provide a protective effect towards the cells.
We have also demonstrated that yellow tinted blue-light blocking optical filters 
(Filters 1 and 2) have a significant protective effect towards the RPE by reducing the 
blue-light hazard when compared with the presence of a UV-blocking (control) 
optical filter or no filter. Results obtained using the Live/dead staining technique 
support our observations with the MTT assay. These data correlate with previous 
studies that examined the protective effect of a single blue-light blocking lens towards 
A2E-laden RPE cells (Sparrow et al., 2004; Yanagi et al., 2006) The protective effect 
was seen in both cells loaded with lipofuscin and those not. RPE cells, even in the 
absence of lipofuscin, have been shown to generate free radicals and undergo 
mitochondrial DNA damage when exposed to blue-light (Dorey et al., 1990; Godley 
et al., 2005). Lipofuscin has been shown to have a multi-faceted phototoxic effect on 
cells that have been exposed to blue-light or high intensity white light (Davies et al.,
2001). Thus, the protective effect of both the blue-light blocking optical filters can 
probably be explained as a reduction in these processes. A greater relative protective 
effect was seen when cells had been loaded with lipofuscin. This is most likely due to 
the reduction in photoexcitation of the photosensitisers present in the granules 
(Rozanowska et al., 1998; Schutt et al., 2000; Sparrow et al., 2000; Sparrow et al.,
2002).
The fact that there was not a total reduction in cell death is probably attributable to not 
all blue-light being blocked by the lenses, therefore, some high energy light was still 
able to reach the RPE cells. As blue-light is critical for a number of ocular functions 
and also in maintenance of a regular circadian rhythm, the detrimental effects of 
completely blocking blue-light would probably outweigh the benefits (Brainard et al., 
2001; Berson et al., 2002; Hanifin and Brainard, 2007; Hankins et al., 2008). As such, 
a sharp cut-off blue-light blocking filter would possibly be of greatest benefit to a 
patient who would require such an optical filter. The rational behind this lies in the 
fact that as there was no statistical difference in protection afforded by either of the 
blue-light blocking filters, preference must be drawn from other properties of the 
filters. Filter 2 is less likely to affect circadian rhythm as it blocks less of the light 
involved in stimulating melanopsin, which peaks at 480 nm, whereas Filter 1
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continues to block light of 480 nm wavelength. If yellow tinted lenses were to have an 
effect on scotopic vision, which peaks at 506 nm, it is likely that Filter 1 would again 
have the greatest unfavourable effect.
If no adverse effects of the insertion of yellow lenses are proven and the positive 
effects such as reduced susceptibility to the blue-light hazard are real, with the 
development of sharp-cut off filters that would reduce any impact on circadian rhythm 
the widespread use of blue-light blocking filters in cataract surgery should have a 
beneficial impact for the patient.
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Chapter 6
The Use o f Nanomedicines in Degrading or 
Preventing the Formation o f Retinal
Lipofuscin.
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6.1 Introduction
Nanotechnology is a term that has begun to appear in the media and scientific journals 
with increasing regularity as people strive to design and create products that are 
smaller and more efficient. The ability to produce designs on such a minute scale has 
captivated both the scientific and medical communities and has led to the advent of 
nanomedicines. Like other nanotechnologies, nanomedicines are compounds that are 
defined by their scale (usually between 1 and 1 0 0 0  nm) and the term is most widely 
used when describing molecules that have potential therapeutic capabilities and are 
sized within this range. However, unlike other nanotechnologies which have small 
workings for the sake of convenience or style, the tiny scale of nanomedicines has a 
functional role. Nanomedicines often consist of a carrier molecule such as a polymer, 
dendrimer, micelle or liposome that is conjugated to, or, encapsulates an active 
component. Active components are most often a drug or an enzyme, yet in certain 
instances the carrier molecule itself can fulfil this role.
Carrier molecules are often designed to combine a helpful blend of lipophilicity and 
hydrophilicity to ensure quick and efficient delivery. The hydrophilicity allows the 
molecules to be transported through the aqueous phases of the circulatory system and 
the lipophilic nature of the molecule assists its passage across cell membranes. Carrier 
molecules exist to encase the active component of the medicine until the conjugated 
molecules reach their target area; thus, performing a dual function of assisting passage 
of the active component through the delivery pathway and preventing its degradation 
or non-specific activity until reaching the target cells. The use of carrier molecules in 
this way aids the localised accumulation of active molecules at the required site 
without the side effects of the drugs or enzymes effecting other cells or tissues that are 
not its targets, particularly in areas prone to toxicity such as the heart and bone 
marrow (Duncan et al., 2005) This results in higher drug levels at the target site 
without concomitant side effects that would be seen with a non-specific drug delivery 
system.
Unfortunately, the problem with many of the polymers that have been trialled 
previously, whether synthetic or natural, is that they are non-biodegradable (Garnett
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and Kallinteri, 2006). Synthetic polymers such as poly(ethyleneglycol) (PEG) and N- 
(2-hydroxypropyl)methacrylamide (HPMA) are non-biodegradable. Some natural 
polymers such as dextran, which in its natural state is biodegradable, became 
considerably less so when modified, for example, by the attachment of an active 
component (Etienne Schacht, 1985; Schacht et al., 1985). The reduction in 
biodegradability means that prolonged administration of the conjugate holds the 
possibility of high levels of polymer accumulation within the target cells.
One polymer that has proven therapeutic potential for drug delivery is dextrin 
(Hardwicke et al., 2008). Dextrins are low molecular-weight carbohydrates that are 
analogues of glucose and are used routinely as thickeners in food products due to the 
low cost and ease of their production, they are also used in peritoneal dialysis solution 
due to their non-toxic properties (Duncan et a l , 2008). Dextrin is degraded by 
amylase; meaning that it is a biodegradable product that is unlikely to accumulate 
within cells or tissues. The rate at which dextrin is degraded can be determined by the 
level of succinoylation, with increasing succinoylation leading to an increase in 
degradation time (Hreczuk-Hirst et al., 2001). Dextrins contain less than 5% a-1,4 
links and therefore do not demonstrate much branching. This allows their molecular 
weight to be kept below 40,000 daltons, which is an important size as this means the 
molecules can undergo renal elimination.
As stated previously, non-specific activity of the drug whist in circulation would be 
undesirable. Previous studies have shown that conjugating dextrin to a protein can 
considerably reduce its activity. Addition of dextrin to trypsin reduced its activity by 
up to 6 6 % when polymer bound, with activity being restored to approximately 1 0 0 % 
when the polymer was degraded (Duncan, 2007; Duncan et al., 2008).
An enzyme of potential therapeutic application in detoxification and removal of lipid 
peroxidation products is Glutathione s transferase (GST). GSTs exist as a family of 
isoenzymes that catalyse the conjugation of glutathione (GSH) to the electrophilic 
centres of other compounds. GSTs have two active sites, one of which is highly 
specific towards the binding of GSH, the other which binds substrates, is less specific 
and thus assists catalysis of the conjugation of GSH to a variety of substrates (Ketterer 
and Meyer, 1989; Ketterer, 1998; Salinas and Wong, 1999). Conjugation of molecules
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that are potentially harmful to the cell to GSH renders them less reactive and more 
water soluble, thus they are more easily eliminated from the cell. Substances that act 
as substrates to GST include environmental pollutants and other xenobiotics, but also 
importantly and pertinent to this study, metabolic waste products and the products of 
biological oxidative stress including; epoxides, aldehydes and hydroperoxides (Alin et 
al., 1985). As lipofuscin has been shown to be composed of a number of species that 
have been modified due to oxidative stress an increase in the GST composition of the 
RPE cell could theoretically assist the cell in degrading or removing potentially 
harmful substances and reduce the accumulation of lipofuscin. Equally, the action of 
GST and GSH may assist in the degradation of lipofuscin that has already 
accumulated within the cell, as well as reducing secondary accumulation that occurs 
when photo-excited lipofuscin reacts with the lipid membrane of the lysosomes in 
which it is housed.
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Figure 6.1. Schematic showing the theoretical stages of drug delivery. The protein is delivered 
masked by the polymer. The polymer is degraded by the activating enzyme releasing the active protein. 
The protein is then free to catalyse a reaction between the substrate and acceptor molecule. GST = 
Glutathione s transferase. GSH = Glutathione.
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A theoretical mode of action of the proposed nanomedicine is outlined in Figure 6.1. 
The polymer-protein is delivered to the target cell where the polymer is degraded. 
This leaves the unbound polymer free within the cell to undertake the task for which it 
was chosen (Duncan et a l , 2008). In this instance it is proposed that GST would 
conjugate to GSH and reactive molecules within the cell. GST would next catalyse the 
conjugation of GSH and the reactive molecule, thus rendering it less reactive and 
assisting it removal from the cell.
The aims of this study were to identify a drug delivery system that was non-toxic to 
RPE cells even after prolonged exposures and could be specifically targeted to the 
lysosomes of RPE cells when conjugated to a protein. The study also sought to 
identify a protein that has the potential to assist RPE cells in the degradation or 
removal of the substrates of lipofuscin or remove lipofuscin that had already 
accumulated within the cells. A polymer-protein conjugate comprising the candidate 
polymer and protein was then assessed using an in vitro model to determine its 
capability in degrading or removing lipofuscin that was already present within cells.
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6.2 Experimental Design
6.2.1 Synthesis and characterisation of dex-GST conjugate
6.2.1.1 Succinoylation o f  dextrin
Chemical modification of dextrin and the synthesis of dex-GST conjugate, together 
with the characterisation and measurement of dex-GST enzyme activity was 
undertaken at the Cardiff School of Chemistry, Cardiff University in the laboratory of 
Dr Alison Paul. Succinoylation of dextrin (51 000 g mol'1) was performed according 
to methods described previously (Hreczuk-Hirst et al., 2001). Briefly, Dextrin and 
Succinic anhydride were stirred in a 1:1 ratio in anhydrous N, N  -dimethyl formamide 
(DMF), under nitrogen. 4-Dimethylaminopropanol (DMAP) was dissolved in DMF 
and added under nitrogen. The reaction was heated to 60°C and stirred overnight. 
After 15 hours the reaction mixture was cooled to room temperature before 
precipitation of the polymer with the addition of diethyl ether. The crude product was 
obtained by filtration and washing. The modified polymer was purified by dialysis 
and freeze dried. Succinoylation was confirmed by Fourier transform infrared 
spectroscopy (FTIR) (absorbance band 1716cm'1 from ester group). The degree of 
modification was calculated by titration of carboxylic acid groups with sodium 
hydroxide using bromophenol blue indicator.
6.2.1.2 Conjugation o f  succinovlated dextrin and GST
Succinoylated dextrin and A-ethyl-A’-(3-dimethylaminopropyl)carbodiimide (EDC) 
in a 2:1 ratio were dissolved in PBS at pH 7.4 and stirred at room temperature for 10 
minutes. Two equivalents of /V-hydroxysulfosuccinimide (Na-NHS) were added as a 
solution in PBS. The GST protein was added after 30 minutes as a solution in PBS to 
create a 2:1 polymer:protein ratio. After stirring overnight the crude reaction mixture 
was purified by fast-protein liquid chromatography (FPLC) to remove free protein and 
unreacted EDC/Na-NHS, using a Superdex 75HR 10/30 column connected to an Akta 
FPLC set-up (P-920 pump, UPC-900 monitor) with UV detector. The pooled fractions 
were concentrated by centrifugation using a Centriprep (30 000 MW cut-off)
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membrane, and desalted by washing with water before freeze drying to obtain the 
conjugate.
6.2.1.3 Results o f  succinoylation and conjugation
Results of the succinoylated dextrin and dextrin-GST conjugate analysis are given in 
Table 6.1 and Figure 6.2. Succinoylation of dextrin was confirmed by an increase in 
the FTIR absorbance band at 1716 cm' 1 and quantified by titration giving consistently 
18 (±3) mol% succinoylation typically. Dextrin-GST conjugates were purified by size 
exclusion chromatography (Figure 6.2). A clear shift of the observed peak towards 
shorter retention times indicates a significant increase in size of the conjugate 
compared to the free protein, consistent with conjugation to the polymer. 
Fractionation at the slight shoulder of the peak (shown by the dotted lines in figure 
6.2) ensures removal of free protein as indicated by an analytical FPLC trace of 
purified conjugate shown over the same x-axis in the figure. Total protein content was 
obtained by BCA assay, with results shown in Table 1.
Table 6.1 Characterisation o f synthesised succinoylated dextrin, conjugates and fluorescent probe 
labelled materials.
Sample Mol%
Succinoylation
Oregon- 
green 
loading/ 
wt% (free)
Protein 
content/ wt%
Overall wt% 
yield (wt% 
wrt protein)
Succinoylated dextrin 18 n/a n/a 75
Succinoylated dextrin 16 n/a n/a 90
Succinoylated dextrin 13 n/a n/a 90
Succinoylated dextrin 18 n/a n/a 90
Dex-OG 18 0.85 n/a 92
Dex-GST 16 n/a 15.5 37(34)
Dex-GST 16 n/a 13 42
Dex-GST-OG 16 n/a 13 Not
determined
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Figure 6.2 Preparative FPLC trace showing volume collected (vertical dashed lines) for dex-GST 
conjugate (solid line). Also shown, FPLC trace for free GST protein (dashed line). Inset, analytical 
trace for purified conjugate.
6.2.1.4 Characterisation o f  the dex-GST conjugate
Conjugate characterisation was by assay of total protein using a BCA assay (see 
section 4.2.1.2.1, Chapter 4) with GST standards and SDS-PAGE. A separating gel 
was prepared using water, running gel buffer, SDS (10% w/v), 40% acrylamide/bis, 
APS (10% w/v) and TEMED. Stacking gel (0.125 M Trizma base, pH 6.8) was 
prepared from water, stacking buffer ((100 ml prepared in water using Trizma base 
(6g), adjusted to pH 6.8 with 1 M HC1), 2.5ml), SDS (10% w/v), 40% acrylamide/bis, 
ammonium persulphate (10% w/v) and TEMED (1%). Conjugate or protein samples 
(approx. 1 mg ml'1, 20pl) were prepared in PBS and mixed with an equal volume of 
denaturing solution consisting of water, Tris HC1 solution (0.05 M, pH6.8), Glycerol 
and SDS (10%w/v solution (aq.)), mercaptoethanol and bromophenol blue (1% w/v). 
Samples were heated for 5 mins at 100°C and loaded onto the gel (20 pi per well). 
The electrophoresis experiment was run for approx. 40 minutes at 140 V (constant 
voltage), 400 mA. Gels were developed with Coomassie blue solution and air dried.
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Figure 6.3 SDS-PAGE gels showing molecular weight standards, dex-GST conjugate and free 
GST.
SDS-PAGE analysis (Figure 6.3) shows a high running band (high MW) for the 
conjugate and a feint band for residual GST at 27 000 kDa. The free GST was not 
noted with the FPLC trace implicating that dimerised GST is released after 
denaturation with SDS. This suggests that in some species the polymer may only be 
bound to one half of the dimer.
6.2.1.5 Labelling o f succinoylated dextrin with a fluorescent probe
Succinoylated dextrin, EDC and Na-NHS were dissolved in a solution of PBS in the 
ratio; 1:2:2.2. After stirring, Oregon Green 488 cadaverine *5-isomer was added and 
the pH increased to 9 by addition of sodium hydroxide. The reaction was stirred in 
the dark for 2-4 hours, monitored by TLC in methanol, viewed under UV light. The 
crude reaction mixture was purified by dialysis in the dark and free Oregon green 
removed before freeze drying.
6.2.1.6 Measurement o f  enzyme activity o f  free GST and dex-GST conjugate
The enzyme activity of GST was determined with respect to 1-chloro-2,4- 
dinitrobenzene according to the method of Habig et al (1974). GST was dissolved in
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a buffer solution consisting of 100 mM K2 PO4 with 1.0 mM EDTA, adjusted to pH
6.5 with 1.0 M KOH. 100 mM reduced GSH was prepared in the same buffer 
solution. These solutions were stored on ice. The substrate solution, 1-chloro-2,4- 
dinitrobenzene (lOOmM) was prepared in EtOH. Protein, substrate and buffer 
solutions were mixed as required to provide 1 ml samples at 1 mM GSH and CDNB. 
Absorbance at 340 nm was recorded for 3 mins after addition of the enzyme. Samples 
with conjugate were prepared at equivalent protein content and the activity compared 
to a calibration plot constructed from the free protein solutions.
Free protein controls at equivalent protein activity were used in all conjugate activity 
evaluation experiments. Protein activity after conjugation was measured using an 
equivalent protein concentration to the free protein controls, based on the protein 
content of the conjugate from BCA assay. It was found that the protein retains activity 
on conjugation to the polymer. This suggests that the active site is not occluded by the 
polymer which may reflect the location of polymer conjugation to the polymer, the 
conformation of the polymer around the protein or the amount of polymer bound.
6.2.2 Analysis of dextrin as a potential carrier polymer
6.2.2.1 Safety o f  dextrin loaded into RPE cells
Cells were maintained in a humidified incubator at 37°C, in an atmosphere of 95% air 
and 5% CO2 (Galaxy S, Wolf Laboratories). Cultures were grown in 24-well plates 
(Orange Scientific) in Hams F-10 nutrient mix (Gibco, UK) containing 10% FCS 
(Bio-West, UK), antibiotics - streptomycin, kanamycin and penicillin (100, 100 and 
60 pg/mL, respectively, all from Sigma) and fungizone (1.25 pg/mL, ampotericin, 
Gibco) until confluent. When confluent, the amount of FCS in the medium was 
reduced to 2% and cells were stabilised in this for a further week. At this point cells 
were either maintained in basal medium or in basal medium supplemented with 
succinoylated dextrin ( 1  pg/ml succinoylated dextrin) with medium changes every 
two days. The viability of cells was measured after 7, 14 and 21 days using the MTT 
(Sigma, UK) assay, as described in the General Material and Methods Section 2.4.
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6.2.2.2 Uptake o f  dextrin tagged with Oregon-green into RPE cells
6.2.2.2.1 Flow cytometry
Analysis of uptake of OG into ARPE-19 cells as measured by flow cytometry was 
undertaken as described in the General Materials and Methods chapter, Section 2.5. 
However, some alterations in the experimental design were made and these are 
described below. Cells were seeded at a density of 1 x 106 per well into wells of a six- 
well plate (Orange Scientific). Cells were maintained in Hams F-10 nutrient mix 
(Gibco, UK) containing 10% FCS (Bio-West, UK), antibiotics - streptomycin, 
kanamycin and penicillin (100, 100 and 60 pg/mL, respectively, all from Sigma) and 
fungizone (1.25 pg/mL, ampotericin, Gibco) in a humidified incubator at 37°C 
(Galaxy S, Wolf Laboratories, UK) in an atmosphere of 5% CO2 for 24 hours.
Hams F-10 nutrient mix containing 10% FCS medium was removed from wells and 
replaced with Hams F-10 nutrient mix containing 2% FCS and dextrin-Oregon green 
(OG)(1.5 pg/ml with respect to OG), initially for the 180 mins time point. This was 
repeated for each of the time points, 120 mins, 90 mins, 60 mins, 30 mins and 0 mins 
in this study. The cells were maintained in the incubator and wrapped loosely in black 
foil (Lee filters, UK) to allow air circulation. When cells had been exposed to dextrin- 
OG for the required time, the medium was removed and immediately replaced with 
ice-cold PBS (PBS tablets, Sigma, UK). For 0 mins, Hams F-10 nutrient mix 
containing 10% FCS medium was removed and replaced with Hams F-10 nutrient 
mix containing 2% FCS and dextrin-OG, this was immediately removed and replaced 
with ice cold PBS.
Cells were washed three times by the gentle addition of PBS. After the third PBS 
wash cells were detached from the wells by exposure to a 0.25% (w/v) trypsin 
solution (Sigma, UK) containing 0.02% EDTA (w/V) made up in PBS and incubated 
for 2 mins (37°C, 95% air, 5% CO2). Trypsin was inactivated by the addition 1 ml of 
Hams-FlO medium containing 10% FCS. Cell suspensions were removed from their 
wells and centrifuged at 340 g , 4°C for 5 mins (U-32R, Boeco, UK) to create a pellet. 
The medium was gently aspirated from the centrifuge tube and replaced with 1 ml of 
PBS. The pellet of cells was then washed twice in PBS by centrifugation at 340 g, 4°C
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for 5 mins. After the final wash cells were re-suspended in 300 pi of PBS and 
transferred to a FACs tube (Falcon, UK). FACs tubes containing cell suspensions 
were taken on ice to the flow cytometer (FACSCaliber, BD Life Sciences, UK) for 
analysis. The levels of OG fluorescence were measured using the flow cytometry, 
with an increase in Oregon green specific fluorescence being interpreted as an 
increase in the up take of the dextrin-OG conjugate into ARPE-19 cells.
6.2.2.2.1.1 Flow Cytometry Data Analysis
Data collected from the FACSCaliber was analysed using WinMDI 2.8 Software 
(Purdue University, USA) and Excel software (Microsoft, USA) as described in the 
General Materials and Methods chapter, Section 2.5.1.
6.2.2.2.2 Confocal Microscopy Analysis
6.2.2.2.2.1 Cell preparation
Cells were prepared as for the flow cytometry work, with the exception that the 6-well 
plates had a glass cover slip placed at the bottom of the well. Hams F-10 medium 
containing 10% FCS and a full compliment of antibiotics and fungizone was replaced 
with medium containing 2% FCS and dextrin-OG (1.5 pg/ml with respect to OG) for 
0, 5, 10, 30, 60 and 180 mins. At the respective time point, cells were washed thrice 
with sterile PBS then fixed.
6.2.2.2.2.2 Fixation o f  cells
Cells were fixed in 2% paraformaldehyde (20 mins at 25°C) made in PBS, fresh on 
the day of use. Samples were mounted using Vectashield (Vector Labs, USA) 
mounting medium (30 pi) to prevent sample photobleaching during microscopic 
examination.
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6.2.2.2.2.3 Microscopy
Confocal microscopy was performed using a Leica SP5 system (Leica, UK). Data was 
collected using dedicated software supplied by the manufacturers and exported as 
tagged image files (TIF). At least three representative images were obtained from 
each sample. Standard procedures were used to minimise bleed from channel to 
channel and sample photobleaching. All images were collected using monochromatic 
CCD cameras.
6.2.2.3 Determination o f  the ratio o f  dex-OG to free OG
Free and dextrin bound OG were separated using a PD-10 column (Amersham 
Biosciences, UK). The column was equilibrated using 25 ml o f elution buffer with the 
through flow being discarded once collected. The sample was layered onto the column 
in 2.5 ml of buffer and the eluent discarded. A further 25 ml of buffer was added to 
the column with the eluent being collected in 0.5 ml fractions. The fluorescence of 
each fraction was measured at 494 nm using a Fluostar Optima plate reader (BMG 
Lab Technologies, Offenburg, Germany).
6.2.2.4 Localisation o f  dextrin tagged with Oreson-green in RPE cells
6.2.2.4.1 Preparation of cells
Cells were cultured as for the uptake of dextrin-OG studies using confocal 
microscopy. After 24 hours the medium was replaced with basal medium containing 
Texas-red bovine serum albumin (TxR-BSA, 10 mg/ml) or TxR-BSA and dextrin-OG 
or TxR-BSA and dextrin-GST-OG. Cells were exposed to this medium for four hours 
then washed three times with PBS, followed by 16 hours incubation in basal medium 
at 37°C, 95% air 5% CO2 .
6.2.2.4.2 Fixation
Cells were immuno-stained using EEA1 (an early endosomal marker) and anti- 
LAMP1 (a late endosome/ lysosomal marker) markers. Cells were fixed in cold
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methanol (pre-chilled at -20°C) and incubated for 5 mins at -20°C. Cells were then 
fixed using 2% paraformaldehyde (20 mins at 25°C) made in PBS, fresh on the day of 
use.
6.2.2.4.3 Immuno-labelling
Cells to be immuno-labelled were first incubated in 2% (v/v) goat serum (in PBS) for 
60 mins at 25°C. Primary antibody incubations were then conducted over 60 mins at 
25°C in the dark. The following antibody dilutions were used; anti-EEAl (1:300) and 
anti-LAMP-1 (1:10). Secondary incubations were performed using either anti-mouse 
or rabbit specific antibodies labelled with Alexa Fluor 488, Cy5 or FITC. An 
incubation period of 60 mins at 25°C after dilution (1:200 using 1% (v/v) goat serum 
in PBS) was conducted in the dark. All samples were mounted using Vectashield 
mounting medium (30 pi) to prevent sample photobleaching during microscopic 
examination.
6.2.2.4.4 Microscopy
Microscopy was carried out as described in section 6.2.2.2.2.
6.2.3 Analysis of GST as the active component in the nanomedicine
6.2.3.1 Analysis o f  free GST in preventing the accumulation o f  livofuscin-like 
fluorescent inclusions in RPE cells loaded with POS?
6.2.3.1.1 Isolation of POS
POS were isolated as described in the General Materials and Methods chapter, Section 
2.3.
6.2.3.1.2 Cell Culture.
Cells were cultured in 24-well plates as described previously (General Materials and 
Methods, Section 2.2) Once confluent, cells were maintained in basal medium for a 
further 7 days. After 7 days cells were maintained in 1 ml of basal medium containing 
1 x 107 POS and ‘free’ GST protein (not conjugated to dextrin, equivalent to 1, 4 or
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10 units GST activity, plus GSH 0.5 mM and N-acetyl cysteine (NAC) 0.5 mM). 
Medium was replaced every two days for 21 days. Control cells were each maintained 
in either basal medium alone, basal medium supplemented with free GST protein 
(equivalent to 1, 4 or 10 units GST activity, 0.014, 0.056 and 0.14 mg GST 
respectively), plus GSH (0.5 mM) and NAC (0.5 mM)), or 1 x 107 POS for 21 days. 
After 21 days the lipofuscin-like fluorescence of cells maintained under each of the 
conditions was measured using flow cytometry.
6 .2.3.1.3 Measurement of lipofuscin-like fluorescence in ARPE-19 cells using flow 
cytometry
For analysis using flow cytometry cells were treated as described in the General 
Materials and Methods chapter (Section 2.5).
6 .2.3.1.4 Data analysis
Data collected from the FACSCaliber was analysed using WinMDI 2.8 Software 
(Perdue University, USA) and represented graphically using Excel software 
(Microsoft, USA)
6.23.2 Can free GST degrade or remove livofuscin that has accumulated in ARPE-19 
cells?
6.2.3.2.1 Isolation of lipofuscin
Lipofuscin was isolated as described in the Materials and Methods chapter, Section 
2 . 1.
6.2.3.2.2 Cell Culture
For analysis of the ability of free GST to degrade retinal lipofuscin in cells, cells were 
cultured as described in General Materials and Methods, Section 2.2. After 7 days in 
basal medium cells were exposed to ~ 300 lipofuscin granules per cell for 24 hours. 
After 24 hours medium was changed to basal medium not containing lipofuscin. Cells 
were then allowed to stabilise for a further 7 days in basal medium. After this period, 
medium was changed to basal medium supplemented with ‘free’ GST protein
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(equivalent to 4 units GST activity). Cells were maintained in the GST supplemented 
medium for 7 days, with changes of medium every two days. Control cells included; 
cells that had not been loaded with lipofuscin but maintained in basal medium alone, 
basal medium supplemented with free GST protein (equivalent to 4 units GST 
activity) or cells that had been loaded with lipofuscin (exposed to ~ 300 granules per 
cell) and maintained in basal medium alone. After treatment the lipofuscin-like 
autofluorescence of cells was measured using flow cytometry.
6 .2.3.2.3 Flow cytometry
For analysis using flow cytometry cells were treated as described in the General 
Materials and Methods chapter (Section 2.5) with the lipofuscin-like autofluorescence 
of cells being measured using the flow cytometer (FACSCaliber, BD Life Sciences, 
UK).
6.2.3.2.4 Data analysis
Data collected from the FACSCaliber was analysed using WinMDI 2.8 Software 
(Perdue University, USA) and represented graphically using Excel software 
(Microsoft, USA).
6.2.4 Can the dextrin-GST nanomedicine degrade or remove lipofuscin that has 
accumulated in ARPE-19 cells?
6.2.4.1 Isolation o f  lipofuscin
Lipofuscin was isolated as described in the General Materials and Methods chapter, 
Section 2.1.
6.2.4.2 Cell Culture
For analysis of the ability of dextrin-GST conjugate to degrade retinal lipofuscin in 
cells, cells were prepared as described in section 6 .2.3.2.2. After the second 7 day 
period, medium was changed to basal medium supplemented with dextrin-GST 
conjugate (equivalent to 4 units GST activity). Cells were maintained in the GST
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supplemented medium for 7 days, with changes of medium every two days. Control 
cells included; cells that had not been loaded with lipofuscin but maintained in basal 
medium alone, basal medium supplemented with dextrin-GST conjugate (equivalent 
to 4 units GST activity) or cells that had been loaded with lipofuscin (exposed to ~ 
300 granules per cell) and maintained in basal medium alone. After treatment the 
lipofuscin-like autofluorescence of cells was measured using flow cytometry and cells 
were analysed using TEM analysis.
6.2.4.3 Flow cytometry
For analysis using flow cytometry cells were treated as described in the General 
Material and Methods, Chapter 2, Section 2.5
6.2.4.4 TEM analysis o f  cells
TEM analysis of the cells was conducted as described in the General Materials and 
Methods chapter, Section 2.6. Images collected to determine if  dex-GST could assist 
in the degradation or removal of retinal lipofuscin were analysed using Image J 
software (NIH, USA) and Excel (Microsoft, USA). This allowed for calculation of the 
average size of retinal lipofuscin granules in the cell populations and the percentage 
cell area occupied by the granules.
6.2.5 Statistical analysis
The statistical significance of the difference between the means of results obtained in 
determining the safety of dextrin and the ability of GST in preventing the 
accumulation of lipofuscin were determined using one-way ANOVA and separately 
Tukey Post-Hoc test (SPSS 12.0 for Windows, SPSS Inc, USA). The significance of 
results obtained in lipofuscin degradation studies, lipofuscin granule size and cellular 
occupation were determined using Students t-test (Excel, Microsoft USA).
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6.3 Results
6.3.1 Cell viability of cultures maintained in medium supplemented with 
succinoylated dextrin
The initial series of experiments conducted in this study sought to determine the 
safety of the chosen carrier molecule towards ARPE-19 cells. The carrier polymer of 
choice in this study was dextrin, a D-glucose polymer that is used in a variety of roles 
including: food products and dialysis fluid. Consequently it has been shown to be 
non-toxic to most cells and tissues within the body. However, as the dextrin based 
nanomedicine under investigation in this study is targeted directly to the RPE, levels 
of dextrin may exceed those experienced under normal circumstances. Therefore, it 
was pertinent that the initial stage of this trial determined whether dextrin displayed 
any toxicity towards RPE cells over prolonged exposures. The mitochondrial activity 
(used as a measure of cell viability) of cells maintained in medium with or without 
succinoylated dextrin was compared every 7 days over a 21 day time course (Figure 
6.4). No statistically significant difference in mitochondrial activity was observed 
between the two populations of cells indicating that dextrin modified by 
succinoylation does not display toxicity towards RPE cells even after prolonged 
exposure.
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Figure 6.4 Comparison of mitochondrial activity of cells maintained in basal medium or basal 
medium supplemented with succinoylated dextrin. Cells were maintained in basal medium (BM) 
with/without succinoylated dextrin (SD) for up to 21 days with the cell viability being measured every 
7 days using the MTT assay. Control cells were considered to be those maintained in basal medium 
without SD. Data are the mean of three experiments each conducted in triplicate. Error bars represent 
SEM.
6.3.2 Uptake of succinoylated dextrin into RPE cells as measured by flow 
cytometry and confocal microscopy
120 
Tim e (mins)
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Figure. 6.5. Uptake of dextrin-OG by ARPE-19 cells as measured by flow cytometry. The uptake 
of dextrin-OG into RPE cells over a 4 hour period was determined using flow-cytometry by measuring 
the increase in fluorescence of the cells. Controls included cells that were not exposed to OG, the 
autofluorescence of these cells was normalised to 0.
For drug delivery to be successful the polymer conjugated to the active component 
must be able to traverse the cell membrane and be internalised by the cell. To
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determine if dextrin was able to perform this function the polymer was conjugated to 
the fluorescent tag Oregon-green (OG) and solubilised in the culture medium. Cells 
were exposed to dextrin-OG for increasing lengths of time, then OG fluorescence of 
cells measured by flow cytometry (Figure 6.5). Increasing length of exposure resulted 
in a concomitant increase in OG related fluorescence indicating that dextrin-OG was 
internalised by RPE cells. The graph shows an initial burst in the increase in cellular 
fluorescence representing polymer-OG endocytosis by the RPE. The rate of polymer- 
OG uptake then gradually slows, however, polymer continues to be internalised by the 
RPE.
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Figure. 6.6. Visualisation of the uptake of dextrin-OG into RPE cells. Confocal images showing 
internalisation of dextrin-OG into RPE cells at increasing levels with an increase in the length of 
exposure. Scale bar represents 10 pm.
The images of Figure 6 . 6  confirm the results obtained using flow cytometry. Images 
show an increase in cellular OG fluorescence with increasing time of dex-OG 
exposure enabling the visualisation of dex-OG uptake. The fluorescent granules are 
present in distinct punctuate moieties indicating that the polymer conjugate has been 
internalised into the RPE cells and is not cell membrane bound.
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6.3.3 Determination of the quantity of free and dextrin bound OG used in 
experiments
The proportion of unconjugated OG present in the dextrin-OG mixture was measured 
before, and after 4 hours o f exposure to RPE cells (Figure 6.7). Initial levels of free 
OG were 0.11% but rose to just under 4% after 4 hours of incubation. Such low levels 
of free OG mean that results seen are representative of the uptake of dextrin-OG and 
not biased by the action of free-OG. The increase in free-OG present in the basal 
medium after 4 hours of exposure to RPE cells could represent OG formerly bound to 
polymer that has been internalised, degraded and exocytosed by RPE cells.
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Figure. 6.7. Evaluation of the proportion of free and dextrin-bound OG present in the dextrin- 
OG mixture, before (A) and after (B) incubation with RPE cells. Free and conjugated OG was 
separated according to size using a PD-10 column. The fluorescence o f fractions eluting from the 
column were then assessed using a fluorescence plate reader. Single arrow identifies bound dex-GST, 
double arrow represents free OG.
Table. 6.2 Levels o f free and conjugated Oregon green (OG) before and after incubation with 
ARPE-19 cells
Before incubation After 4 hr incubation
Total fluorescence (AU) 33647
( 1 0 0 %)
Total fluorescence (AU) 2579(100%)
Fluorescence attributable 
to conjugated OG (AU)
33611
(99.89%)
Fluorescence attributable 
to conjugated OG (AU)
1809
(96.07%)
Fluorescence attributable
to ‘free’ OG
36
(0 .1 1 %)
Fluorescence attributable 
to ‘free’ OG
770
(4%)
The percentage of free OG present with dextrin-OG that RPE cells were exposed to 
was calculated by separating free OG from dextrin bound using a PD-10 column. The
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free and bound OG was separated according to size and the fluorescence of each 
fraction eluting from the column measured using a fluorescence plate reader (Figure 
6.7 A and B). The amount of free OG present increased after exposure to RPE cells. 
Total fluorescence levels dropped in the sample that had been exposed to cells as the 
dex-OG had been diluted by the cell culture medium.
6.3.4. Endocytic fate of dextrin-OG in RPE cells
To determine the endocytic fate of the dex-OG polymer an immunocytochemistry 
technique for identifying cellular organelles, optimised by members of the group 
(Richardson et al., 2008) was used to establish the intracellular localisation of the 
polymer within RPE cells.
After 4 hours incubation with TxR-BSA followed by 16 hours incubation in basal 
medium the cellular organelles: early endosomes (EEA-1) or late
endosome/lysosomes (LAMP-1) were immuno-labelled. Upon analysis of the cells 
using a confocal microscope able to detect fluorescent markers it could be seen that 
the TxR-BSA and EEA-1 were distinct structures (Figure 6 . 8  a-c). Secondly, cells 
were immuno-labelled with LAMP-1 antibody. Images showed labelling of cellular 
components that were visible as doughnut-like structures (Figure 6.9). Merged images 
highlight the TxR-BSA molecules occupying the ‘ring’ of the lysosomal doughnut, 
indicating that at this time the BSA was localised within the late endosomal or 
lysosomal compartments of the cell.
Therefore, if another molecule was to co-localise with the BSA-TxR under the same 
conditions, it could be assumed that both molecules were present within the late 
endosomal/ lysosomal compartments of the cell. Merged images in Figure 6.10 show 
BSA-TxR and dex-OG co-localising within RPE cells, indicating that the dex-OG is 
present within the cells lysosomal machinery at this time. Conjugation of GST to 
dextrin in the presence of OG did not affect the movement of dextrin through the cells 
endocytic pathway. Cells co-loaded with dex-GST-OG and BSA-TxR showed that the 
two fluorophores accumulated in the same cellular compartments (Figure 6.11), 
previously shown to be the cells late endosomes/ lysosomes.
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Figure. 6.8. Tracking the intra-cellular distribution of BSA-TxR in ARPE-19 cells. ARPE- 19 cells 
were incubated with BSA-TxR for 4 hours and then chased for 16 hours. Images were taken 20 hours 
after initial exposure to the fluorophore. The early endocytic compartments were immuno-stained with 
EEA1. The merged images show at this point the early endosomes (green) and BSA (red) are distinct 
moieties. Three representative images were recorded on a Leica SP5 system confocal microscope, 
images were collected using a monochromatic CCD camera. Scale bar represents 5pm.
159
Matthew Davies Chapter 6
Merge BSA-TxR a-LAMPl
* * % • 2
* rv
.
Figure. 6.9. Localisation of BSA-TxR (red) into lysosomal-associated membrane protein (LAMP- 
1, green) positive structures. Cells were loaded with TxR labelled BSA with a 4 hour pulse and 16 
hour chase. Images were taken 20 hours after initial exposure to the fluorophore. Cells were then fixed 
and immuno-labelled with anti-LAMP-1 antibody. LAMP-1 positive structures appeared doughnut-like 
with the TxR-BSA located within the ‘ring’ on the merged cells. This indicates that the BSA-TxR has 
been taken up into lysosomes within the cell. Other experimental conditions as in Figure 6.6. Scale bar 
represents 5 pm
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Figure. 6.10. Tracking the intra-cellular distribution of dextrin-Oregon green and BSA-TxR in 
ARPE-19 cells. Cells were incubated with dextrin-OG and BSA-TxR for 4 hours and then chased for 
16 hours. Images were taken 20 hour after initial exposure to the fluorophore. In the merge image the 
yellow areas indicate co-localisation between the dextrin-Oregon green molecules (green) and the 
BSA-TxR (red). Previous work demonstrated that BSA-TxR is located within LAMP-1 positive 
structures (lysosomal organelles) at this time, so co-localisation with dextrin-OG infers that both 
molecules are lysosomally located. Other experimental conditions as in Figure 6.6. Scale bar represents 
5 pm
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Figure. 6.11. Tracking the intra-cellular distribution of dextrin-Oregon green-GST and BSA- 
TxR in ARPE-19 cells. Dex-OG-GST localises with BSA-TxR indicating that GST does not disrupt 
the movement of dextrin within the cell. Other experimental conditions as in Figure 6.6. Scale bar 
represents 5 pm
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6.3.5 Prevention of the accumulation of lipofuscin-like inclusions in RPE cells
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Figure. 6.12 Monitoring of changes in lipofuscin-like fluorescence of cells using flow cytometry 
over a 21 day period. Culture medium containing the POS, GSH, NAC and GST at three 
concentrations; 1, 4 and 10 units activity was replaced every two days. Control cells included 1) those 
maintained in basal medium alone (BM), 2) BM with GST/GSH and NAC and 3) BM with POS. The 
lipofuscin-like fluorescence o f cells maintained in basal medium containing POS was taken as 100% 
for this study. Trials were carried out three times, each in triplicate.
Exposing RPE cells to POS in their medium has been shown to lead to the 
development of inclusion bodies that have lipofuscin-like fluorescence properties 
(Boulton et al., 1989; Wihlmark et al., 1996a). The ability of GST in preventing this 
accumulation was analysed by measuring the lipofuscin-like fluorescence of cells 
exposed to POS using flow cytometry. Figure 6.12 shows that cells loaded with POS 
developed lipofuscin-like fluorescence to levels approximately 8  times higher than 
cells maintained in basal medium alone. The weekly increase in cellular fluorescence 
slowed in the presence of GST, GSH and NAC, with a statistically significant 
difference in the lipofuscin-like fluorescence of cells fed POS in basal medium (825 + 
47.9 % cellular fluorescence) compared to those fed POS in the presence of 10 units 
GST activity (578 + 16.4 % cellular fluorescence) and 4 units GST activity (624 + 
23.0 % cellular fluorescence) after 21 days (p< 0.05). No difference in cellular 
fluorescence between cells maintained in basal medium and cells maintained in basal 
medium supplemented with GST/GSH and NAC was observed. To generate Figure 
6 .1 2 , the geometric mean of a cells’ lipofuscin-like fluorescence was calculated using
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histograms created using WinMDI software (Figure 6.13) from data collected by the 
flow cytometer. Cellular fluorescence of cells maintained in basal medium was taken 
as 1 0 0 % and the cellular fluorescence of cells under the other conditions normalised 
to this.
Figure 6.13 Histograms generated using data collected from flow cytometery. The mean 
fluorescence of the cells is calculated using the histograms and was used to create Figure 6.11. (BM- 
Red, BM + GST/GSH/NAC -  Black, BM + POS -  Green, BM + POS + GST (10 units)/GSH/NAC -  
Turquoise, BM + POS + GST (4 units)/GSH/NAC -  Purple, BM + POS + GST (1 unit)/GSH/NAC -  
Blue).
Figure 6.13 shows a histogram representing the fluorescence distribution of cells after 
21 days. FL1-H represents the lipofuscin-like fluorescence of cells on a log scale. The 
results show that cells not exposed to POS have a much lower fluorescence than those 
that were exposed to POS. Cells that have been exposed to POS without the presence 
of GST/GSH and NAC represented by the green plot have its maxima furthest to the 
right signifying these cells have the highest levels of cellular fluorescence. The rate at 
which the fluorescence of cells exposed to POS and GST/GSH/NAC increased was 
inversely proportional to the concentration of GST present in the culture medium, 
with fluorescence of cells being 10 units< 4 units< 1 unit (percentage fluorescence of 
578, 624 and 676, respectively). After analysis of the results of this trial it was 
decided that future studies would be conducted using 4 units GST activity. The 
decision was based on results obtained thus far in the study including: medium 
containing 4 units GST resulted in significantly lower lipofuscin-like fluorescence in 
cells fed POS compared to those fed POS alone (p< 0.05). Another contributing factor 
was the expense of the GST and its limited availability at this time. Thus, using the
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optimised level of GST activity ensured that the most work could be carried out 
within the constraints of this projects time and budget.
6.3.6. Assessment of the use of GST in degrading lipofuscin in RPE cells when in 
its free state or when conjugated to dextrin polymer
Work with GST not conjugated to dextrin demonstrated the enzyme had the potential 
to prevent lipofuscin accumulation within RPE cells by either degrading or facilitating 
the removal of the primary substrates, POS. The next phase of this study was to 
determine if GST could degrade lipofuscin already present within cells. To establish if 
GST alone, without the dextrin polymer was capable of this, cells were loaded with 
lipofuscin and maintained in medium that was supplemented with free GST, 
equivalent to 4 units GST activity for seven days. Flow cytometry was used to 
measure the lipofuscin-like fluorescence of these cells, which could be compared to 
control cells loaded with lipofuscin and maintained in basal medium alone. Figure 
6.14 shows that cells loaded with lipofuscin had fluorescence levels approximately 12 
times greater than cells not loaded with lipofuscin. Cells loaded with lipofuscin and 
maintained in either basal medium alone or basal medium supplemented with free 
GST showed no statistically significant difference in cellular fluorescence. This 
indicates that supplementing cells with free GST alone does not decrease the level of 
lipofuscin in cells or degrade the granules in anyway that would lead to a reduction in 
lipofuscin-like fluorescence levels.
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Figure 6.14. Lipofuscin-like fluorescence o f cells with/without lipofuscin maintained with/without 
free GST. Cellular lipofuscin-like fluorescence was measured in cells using flow cytometry. Cells that 
were not loaded with lipofuscin were maintained in either basal medium (BM) alone or in BM 
supplemented with free GST. Cells loaded with lipofuscin (~ 300 granules per cell) were maintained in 
BM alone or BM supplemented with free GST. Cellular fluorescence o f cells loaded with lipofuscin 
and maintained in BM was assumed as 100% and other results normalised to this. Data represents the 
results of three experiments each carried out in triplicate. Error bars represent + SD.
Next, cells loaded with lipofuscin were maintained in medium that had been 
supplemented with the dextrin-GST conjugate at levels equivalent to 4 units GST 
activity. Again, cells loaded with lipofuscin displayed greater levels of fluorescence 
than those not exposed to lipofuscin. The level of lipofuscin-like autofluorescence 
was significantly lower in cells loaded with lipofuscin and maintained in basal 
medium supplemented with GST-dextrin conjugate (lipofuscin-like fluorescence 
60.59%) than cells loaded with lipofuscin and maintained in basal medium alone 
(lipofuscin-like fluorescence 100%) (p= <0.05). This indicates that the conjugate, in 
which GST is protected and localised to the lysosome, has the capacity to degrade or 
alter lipofuscin granules in a way so as to lower their fluorescence.
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Figure 6.15. Lipofuscin-like fluorescence o f cells with/without lipofuscin maintained with/without 
dex-GST. Cellular lipofuscin-like fluorescence was measured in cells using flow cytometry. Cells that 
were not loaded with lipofuscin were maintained in either basal medium (BM) alone or BM 
supplemented with the dextrin-GST conjugate (dex-GST). Cells loaded with lipofuscin (~ 300 granules 
per cell) were maintained in BM alone or BM supplemented with dex-GST. Cellular fluorescence of 
cells loaded with lipofuscin and maintained in BM was assumed as 100% and other results normalised 
according to this. Data represents the results o f three experiments each carried out in triplicate. Error 
bars represent ± SD. * represents a statistically significant difference p< 0.005.
The reduction in lipofuscin-like fluorescence measured in cells treated with dex-GST 
could be the result o f lipofuscin granules being degraded or removed from cells. 
However, it could be a consequence of the granules having been manipulated so as to 
reduce their fluorescence, perhaps by removal or alteration of the fluorophores 
present. To gain a greater understanding of the effect that dex-GST is having on 
lipofuscin granules, TEM images of cells with or without lipofuscin and then 
maintained either in basal medium with or without supplementation with dex-GST 
were analysed. Cells not exposed to lipofuscin showed characteristic organelles of 
functional cells including mitochondria, endoplasmic reticulum and a nucleus (Figure 
6.16), as did those exposed to lipofuscin (Figure 6.17). In cells that were exposed to 
lipofuscin, the granules were obvious as electron dense bodies (Figure 6.17), the 
morphology, size and abundance of which could be compared between the test 
conditions (Table 6.3). Using image J software to calculate the percentage of the cell 
area occupied by lipofuscin it was found that on average less of the cells cytoplasmic 
space was taken up by lipofuscin in cells maintained in medium supplemented with 
dex-GST (6.02%) than cells maintained in basal medium alone (10.90%) (p=<0.05).
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Analysis of the micrographs also revealed that lipofuscin granules were significantly 
smaller in cultures maintained in the dex-GST medium (0.53 pm2) than basal medium 
(0.72 pm2) (p=<0.05).
Table 6.3 Comparison o f cytoplasmic area o f cell occupied by lipofuscin and size of lipofuscin 
granules in RPE cells loaded with lipofuscin and maintained in medium with/without dex-GST.
Cells exposed to lipofuscin 
and maintained in BM
Cell exposed to lipofuscin 
and maintained in BM 
supplemented with dex- 
GST
Average area of cell 
occupied by lipofuscin (%) 10.90 %(± 4.70) 6.02 % (±5.40)
Average size of lipofuscin 
granules (pm ) 0.72 (±0.48) 0.53 (p 0.52)
Lipofuscin granules seen in TEM images of cells maintained in medium with or 
without dex-GST appear to have similar morphology and are consistent with images 
found in the literature (Boulton et al., 1990). Some granules in cells treated with dex- 
GST conjugate appear to have undergone modification leaving a prominent 
endoskeleton surrounded by a less electron dense granule. These granules were 
present in a number of the images collected of cells maintained in medium containing 
dex-GST but in none of the images taken of cells loaded with lipofuscin and 
maintained in basal medium alone.
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Figure 6.16. Representative TEM micrographs of cultured ARPE-19 cells maintained in (A, B) 
basal medium alone, (C, D) basal medium supplemented with dex-GST. N denotes the nucleus of 
each of the cells. All images were taken at the same magnification (8K magnification), the scale bar 
represents 1pm.
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Figure 6.16. Representative TEM micrographs of cultured ARPE-19 cells maintained in (A, B) 
basal medium alone, (C, D) basal medium supplemented with dex-GST. N denotes the nucleus of 
each of the cells. All images were taken at the same magnification (8K magnification), the scale bar 
represents 1pm.
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Figure 6.17. Representative TEM micrographs of cultured ARPE-19 cells loaded with lipofuscin 
and maintained in basal medium (A, B) and loaded with lipofuscin and maintained in basal 
medium supplemented with dex-GST (C, D). The electron dense bodies, highlighted with single 
arrows, seen in the images are lipofuscin granules. N denotes the nucleus o f each of the cells. All 
images were taken at the same magnification (8K magnification), the scale bar represents 1 pm.
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6.4 Discussion
This study aimed to identify a drug delivery polymer and suitable enzyme that could 
be conjugated to form a nanomedicine that assists RPE cells in either preventing 
lipofuscin formation by the removal of lipofuscin substrates or in the degradation and 
removal of lipofuscin that is already present. As discussed previously, retinal 
lipofuscin accumulates in RPE cells with age and is composed primarily of 
oxidatively modified components of POS and other intra-cellular organelles (Feeney - 
Bums and Eldred, 1983; Boulton et al., 1989; Brunk et al., 1992; Brunk et al., 1995). 
Lipofuscin has been demonstrated to be phototoxic to RPE cells in vitro and to 
generate free radicals when illuminated with blue-light with the potential to cause 
RPE dysfunction (Boulton et a l,  1993; Rozanowska et al., 1997; Rozanowska et al., 
1998; Davies et a l,  2001). Loss of RPE function is a key feature in a number of 
macular diseases where increased levels of lipofuscin have accumulated. Thus, 
lipofuscin has been associated with a number of degenerative macula conditions 
including; AMD, Best’s and Stargardt’s diseases (Katz, 2002; Karan et a l,  2005; 
Gerth et a l , 2007; Kim et a l , 2007).
Initially, the safety of dextrin, the polymer chosen as a potential delivery vehicle, was 
measured by assaying the viability of RPE cells maintained in medium that was 
supplemented with it. The viability was compared to control cells in basal medium 
with no statistically significant difference in viability between the two. This indicates 
that dextrin, even in its succinoylated form, is non-toxic to RPE cells. This was the 
predicted outcome given that dextrin has been approved for a variety of clinical uses 
(Verco et a l, 2000). However, this study is the first to target dextrin specifically to the 
RPE and these results are important in showing that the polymer is compatible with 
our cell type. Therefore, proceeding with further studies using dextrin as our carrier 
molecule of choice was justified.
Having ensured that the polymer was non-toxic to RPE cells, next we demonstrated, 
using both flow cytometry and confocal microscopy, that dextrin-tagged with Oregon- 
green was internalised by RPE cells. Endocytosis of dextrin molecules into RPE cells 
is likely to be predominantly via phagocytosis with pinocytosis also involved (Geiser
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et a l,  2005). Most discussion of movement of nanomedicines across cell membranes 
has focused on receptor mediated mechanisms (van Deurs et al., 1989). Dextrin is an 
analogue o f mannose, thus it is probable that the mannose receptors that have been 
identified on the apical membrane of the RPE are largely responsible for the 
internalisation of the dextrin conjugates (Tamowski et al., 1988; Shepherd et al., 
1991).
Once intracellular, for nanomedicines to be clinically relevant it is essential to 
understand their endocytic fate by identifying the organelles they associate with 
(Duncan, 2007). In this instance the target organelles were the numerous lysosomes 
that are present within the RPE, where lipofuscin gradually accumulates. To 
determine the intracellular fate of dex-OG and later dex-GST-OG within the RPE cell, 
a novel immunocytochemical technique was developed to visualise the endocytic 
outcome of the polymer and polymer-protein conjugate. Previous studies have used 
sub-cellular fractionation to determine the localisation of polymeric drugs. This is a 
technique that has many draw-backs including the need for excellent levels of user 
skill, standardisation for each cell type used and the high risk for contamination 
between fractions, particularly when the organelles o f interest are of similar density 
(Brunet et al., 2003). The immunocytochemistry technique developed through this 
study allows for the accurate labelling of specific intracellular compartments in a way 
that is transferable to many cell types (Richardson et al., 2008). The technique works 
by tagging essential components in the endocytic pathway (Figure 6.17) to see which 
are co-localised with the polymeric drug of choice. Using a combination o f TxR-BSA, 
dex-OG and immuno-labelled organelles we showed for the first time in ARPE-19 
cells the endocytosis and intracellular localisation of a polymeric carrier. The 
nanomedicine was found to be exclusively within late endocytic structures. Thus, we 
had succeeded in choosing a polymer that would localise to the area of our cells that 
was required.
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Figure 6.17. Simplified diagram  of the endocytic pathway. The principle components together with 
markers used for definition are annotated. Times indicate approximate values taken by materials to 
reach the compartments. Adapted from Richardson et al (Richardson et al., 2008).
Whilst characterising dextrin and its endocytic behaviour within RPE cells, the 
enzyme, GST, was being assessed with regard to its suitability as the active 
component in preventing lipofuscin accumulation. GST (at three concentrations, 1, 4 
and 10 units activity), together with GSH and NAC, the precursor for GSH formation 
within the body, were supplemented in basal medium of RPE cells exposed to POS 
(Tirouvanziam et al., 2006). The lipofuscin-like fluorescence of these cells was then 
compared to cells exposed to POS in basal medium alone. It was noted that the 
combination of GST, GSH and NAC resulted in a reduction in the rate at which the 
lipofuscin-like fluorescence of cells increased. The difference in lipofuscin-like 
fluorescence measured in cells exposed to POS alone and those exposed to POS, 
GSH, NAC and 1 unit GST could be the result of a combined response of GSH, NAC 
and GST to the POS challenge. Indeed, previous studies have shown that lysosomal
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accumulation of lipofuscin-like products was reduced in RPE cells exposed to POS 
when the cells were also supplemented with NAC, whilst other studies have 
demonstrated that NAC can protect RPE cells against oxidative insult (Sternberg et 
a l,  1993; Schutt et a l ,  2007b). Equally, GSH has been shown to detoxify reactive 
aldehydes generated from lipid peroxidation and to alter the redox potential of cells, 
determining the function o f the ubiquitin proteasome pathway (Sternberg et a l, 1993; 
Jahngen-Hodge et a l , 1997). Changes in the ratio of reduced and oxidised glutathione 
that results in an increase in oxidised glutathione have been shown to down regulate 
proteasome activity in RPE cells resulting in increased levels of protein carbonyls 
(Shang and Taylor, 1995; Shang and Taylor, 2004). Both co-factors could be 
influential in reducing the level of accumulation of lipofuscin-like products within the 
RPE. However, the difference in lipofuscin-like fluorescence recorded between the 
cells cultured in medium supplemented with different levels o f GST activity could 
only be the result of GST action as GSH and NAC were maintained at constant levels 
in each of the cultures. The results obtained in this study corroborate with work in the 
literature that have established that GSTs are key in protecting the RPE against 
oxidative stress, particularly against reactive aldehyde accumulation (Singhal et a l, 
1999; Maeda et a l,  2005).
The statistically significant difference in lipofuscin-like fluorescence measured 
between cells exposed to POS with or without GST indicated that GST was indeed a 
potential candidate for the active component of a nanomedicine. Unfortunately, due to 
difficulties in the production of GST-dextrin conjugate, studies looking into whether 
the nanomedicine was capable of preventing the formation of lipofuscin-like material 
were not conducted. To determine whether GST was able to remove or degrade retinal 
lipofuscin, cells were pre-loaded with lipofuscin and maintained in medium 
supplemented with free GST. After 7 days of supplementing cells with free GST the 
lipofuscin-like fluorescence of these cells was compared to cells maintained in basal 
medium alone with no significant difference noted. These results contrasted with 
those seen with cells pre-loaded with lipofuscin and maintained in basal medium 
supplemented with dex-GST. Dex-GST treated RPE cells showed significantly lower 
lipofuscin-like fluorescence than those maintained in basal medium, with cells 
containing smaller lipofuscin granules that occupied less of the cytoplasmic area. This
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is symptomatic that the polymer-protein conjugate was in some way degrading or 
removing lipofuscin granules, or components of the granules.
It is possible that free GST had little or no effect in reducing lipofuscin-like 
fluorescence in cells as it was itself metabolised before exerting any influence. GST 
conjugated to dextrin however, may have had sufficient protection from the polymer 
so as to be able to act upon the lipofuscin granules before being degraded. This 
mechanism of action for polymers has been previously described in the literature and 
given the acronym PUMPT, standing for polymer masked-unmasked protein therapy 
(Duncan et al., 2008). By enveloping the protein, the polymer protects it from 
degradation until it is digested itself. It is predicted that by the time of degradation the 
polymer-protein conjugate has reached its intended destination and that the freed 
active component can have its desired effect. We have shown that the dex-GST 
conjugate is localised to the cells lysosomes where lipofuscin accumulates. It is, 
therefore, likely that the dextrin surrounding and protecting GST is degraded by one 
of numerous enzymes capable of degrading a-1,4-linkages in polysaccharides present 
in human lysosomes (Joumet et a l, 2000; Joumet et al., 2002). Liberated GST would 
then have an opportunity to act on the lipofuscin present in the lysosomes, before 
being broken down.
Towards developing a nanomedicine that could be used to prevent lipofuscin 
accumulation within the RPE, we have succeeded in demonstrating dextrin is a 
polymer that is: non-toxic to RPE cells, is internalised by the cells and can be shown 
to associate with late endocytic structures using a novel technique for visualising the 
endocytic fate of polymeric drugs within cells. Thus, dextrin has been identified as an 
ideal candidate for the carrier molecule for this drug.
We have also conjugated the potential drug delivery polymer to an enzyme with the 
capacity to degrade the primary substrates of lipofuscin formation in its free state and 
degrade lipofuscin already present within RPE cells when supplemented as a 
conjugate. Together, the results obtained with the polymer and enzyme indicate that 
when conjugated they have the potential to be developed as a therapeutic agent 
against the onset of AMD if a causal link between lipofuscin and the disease can be 
proven. The advantage of a strategy such as this over drugs currently available in the
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battle against AMD is that the nanomedicine could be used to prevent the onset of the 
disease and be used against the dry form of the disease, whereas current treatments 
attempt to prevent further progression once the late stage of the wet form of the 
disease has been reached.
As discussed in Chapter 1, lipofuscin accumulates in many post-mitotic cells with 
age. Lipofuscin accumulation has been associated with loss o f function in these cells 
and subsequently the onset of age-related diseases. The results collected to date using 
the early-stage nanomedicine indicate that it has the potential as a therapeutic agent in 
a variety of lipofuscin-related afflictions of the aged.
The development of this nanomedicine would benefit from further research using the 
in vitro RPE model before moving onto an in vivo model. One necessary study would 
be to complete the analysis of preventing the formation of lipofuscin-like products in 
RPE cells when fed POS in conjunction with the dex-GST conjugate. Further to this, 
phototoxicity measurements need to be carried out on cells that have either been pre- 
loaded with lipofuscin or exposed to POS and administered the dex-GST conjugate. 
Viability levels would then be compared to cells laden with lipofuscin or fed POS and 
maintained in basal medium. As many of the deleterious effects o f lipofuscin have 
been attributed to its phototoxic properties, the effect the conjugate has on this would 
be most important.
Results obtained during this study indicated that exposing lipofuscin-loaded cells to 
the dex-GST conjugate led to a decrease in the lipofuscin-like fluorescence of the 
cells compared to lipofuscin-loaded cells maintained in basal medium. However, the 
exact mechanism of how the conjugate works is not fully understood. Analysis of 
lipofuscin granule size suggests that granules in cells fed dex-GST were significantly 
smaller than those maintained in basal medium. This change could possibly account 
for the decrease in the lipofuscin-like fluorescence of cells; nevertheless, another 
possible mechanism that would reduce lipofuscin-like fluorescence would be the 
conjugate specifically targeting lipofuscin fluorophores. It would be interesting to 
chromatographically analyse cells that had been loaded with lipofuscin and treated 
with dex-GST or basal medium to see if any constituents of the lipofuscin granules 
had been specifically degraded or removed.
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Upon completion of the in vitro work using the dex-GST conjugate, studies could 
proceed on in vivo work, with a mouse model of AMD being an ideal system. In vivo 
work would most probably mirror the studies conducted with the in vitro model. 
Initially, the drug would need to be targeted to the lysosomes of the RPE and the 
safety of the drug assessed. If the drug is safe within a living system and could be 
targeted to the required area, analysis of any changes in lipofuscin accumulation could 
start. Of interest would be the quantification of lipofuscin granules present, spectral 
changes of the retina and measurement of disease progression within the model.
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Discussion and Conclusions
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7.1 General discussion
The formation of retinal lipofuscin has been shown to involve POS that have been 
phagocytosed into the RPE (Feeney -Bums and Eldred, 1983; Boulton et a l, 1989; 
Wihlmark et a l, 1996a,b). Equally, others have shown that old or damaged 
organelles, in particular mitochondria, that under go autophagy also play a role 
(Moore et a l, 2006; Terman et a l ,  2006; Kurz et a l ,  2007; Kurz et a l, 2008). 
However, some authors believe that one or other is the dominant process (Katz and 
Robison, 2002).
In vitro models of retinal lipofuscin based around the substrates that derive from 
phagocytosis and autophagy developed during this project (C hapter 4) indicate that 
both processes contribute to retinal lipofuscin formation. Lipofuscin-like products that 
were formed from both models displayed similar optical density and fluorescent 
spectra. They also present some characteristics that were reminiscent of ex vivo retinal 
lipofuscin including: protein smears when analysed using SDS-PAGE and the ability 
to photogenerate singlet oxygen. However, analysis also highlighted differences 
between the autophagy and phagocytosis models. The lipofuscin models that were 
formed using POS contained A2E and molecules adducted to CEP. These were absent 
from the autophagy model, indicating that retinal lipofuscin does indeed obtain unique 
components from the phagocytosed material that may not be present in lipofuscins 
found in other post-mitotic cells. We have demonstrated that retinal lipofuscin 
accumulates as a result of malfunctions in the processes of phagocytosis and 
autophagy, however, the products formed consequently are slightly different. It is, 
therefore, possible that there are two distinct forms of retinal lipofuscin that 
accumulate, or, that retinal lipofuscin is an amalgamation of material accrued from 
both sources.
RPE lysosomes contain over forty hydrolytic enzymes that are there to rid the cell of 
waste and degrade spent tips of photoreceptors (Kennedy et a l ,  1993; Boulton et a l, 
1994). Nonetheless, the degradation is an inefficient process as demonstrated by the 
accumulation of retinal lipofuscin. It is proposed that organelles of the RPE and the 
POS are subject to oxidative stress and thus, undergo oxidative modification leading
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to products that are no longer recognised by the lysosomal enzymes (Schutt et al., 
2003a; Kopitz et al., 2004a; Kaemmerer et al., 2007). Indeed, in Chapter 3 we 
demonstrated that lipofuscin granules, although almost devoid of protein, did indeed 
have a number of components present that had been adducted to: nitro-tyrosine, 
iso[4 ]LGE2 or CEP, each o f which are markers of oxidative stress (Ng et al., 2008). 
These findings add credence to the theory that oxidative stress precedes retinal 
lipofuscin accumulation (Katz, 1985; Wihlmark et al., 1996a,b; Holz et al., 2004; 
Hoppe et al., 2004).
The progressive accumulation of retinal lipofuscin with time means that by the age of 
80 years it can occupy up to 20% of an RPE cells’ cytoplasmic volume (Feeney-Bums 
et al., 1984). Amassing such waste can have adverse consequences on the cells 
function. Some effects may simply arise through congestion within the cell, but also 
as demonstrated in C hapter 5, increasing the concentration o f lipofuscin in a cell 
increases the phototoxic effect it exerts.
The phototoxic properties of retinal lipofuscin have been demonstrated to be 
wavelength dependant, with the production of reactive oxygen species being greater 
when lipofuscin is irradiated with light of shorter rather than longer wavelength 
(Rozanowska et al., 1998; Davies et al., 2001). In this study we have demonstrated 
that irradiance levels as well as the wavelength of light influence the impact that 
retinal lipofuscin has on RPE cell viability. These findings emphasise the importance 
of light irradiance levels when considering the design of in vitro experiments.
In vitro experimentation demonstrating the toxic effect of retinal lipofuscin towards 
RPE cells has led to its theoretical association with AMD (Davies et al., 2001; Katz, 
2002; Kopitz et al., 2004a; Nowak, 2006b). It has also been noted that there is an 
increased incidence of AMD in patients who have under gone cataract surgery than in 
age matched controls (van der Schaft et al., 1994; Pollack et al., 1996). The cause of 
this has been speculated to be photic injury during surgery or inflammatory changes 
as a result of surgery. Another possible explanation is that during cataract surgery the 
naturally yellowed lens is often replaced with a UV-blocking only lens. This subjects 
the retina to increased levels of high-energy blue-light that can photoexcite lipofuscin, 
placing it under oxidative stress at a time when it is most vulnerable. Consequently,
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artificial lenses that mimic the blue-light blocking properties o f aged lenses are being 
developed (Ernest, 2004). C hapter 5 describes a comparison of two blue-light 
blocking optical filters, one that gradually blocks blue-light between 400-500 nm and 
another sharp-cut off lens that blocks light below ~425 nm, with an optical filter with 
transmission properties similar to conventional UV-blocking IOLs. The data suggest 
that both the yellow-tinted filters provide significantly more protection against 
lipofuscin phototoxicity than the UV-blocking filter when irradiated with blue or 
white light. Thus, as blue-light blocking lenses have been shown to have no adverse 
effects on visual acuity, contrast sensitivity, colour vision or scotopic vision they 
could prove to be beneficial to the retinas o f cataract patients (Marshall et al., 2005; 
Hayashi and Hayashi, 2006; Greenstein et a l ,  2007; Landers et a l ,  2007; Muftuoglu 
et a l , 2007).
To date, therapeutic strategies aimed at combating AMD have targeted the wet form 
of the disease and have largely avoided treatment of the early stages o f the disease. 
The wet form is the more aggressive and the cause of a larger number of cases of 
blindness than the dry form. However, around 80% of AMD sufferers have the dry 
form, for which there are currently no proven treatments. Retinal lipofuscin has been 
identified as a potential target in the treatment of early AMD due to its phototoxic 
properties that exert oxidative stress upon RPE cells (Nowak, 2006a,b; Birch and 
Liang, 2007).
C hapter 6 describes the development of a nanomedicine that has the potential for 
degrading retinal lipofuscin or preventing its formation within the RPE. It was 
demonstrated that the carrier molecule, dextrin, could be targeted to RPE lysosomes 
and that the active component of the drug, GST, could assist in the degradation or 
removal of POS in in vitro RPE cells. When conjugated, the nanomedicine had the 
ability to reduce the level of retinal lipofuscin that had been loaded into in vitro RPE 
cells. Results obtained during these studies prove there is potential for further 
development of a nanomedicine for the treatment of early AMD. The ability to target 
the drug to the RPE and to be activated within the lysosomes leads to the possibility 
of replenishing levels of lysosomal enzymes. O f particular interest would be 
increasing levels of the Cathepsin family of enzymes. These have been identified as 
important in the degradation of POS, which, as demonstrated in a previous chapter
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(Chapter 3), are key substrates in the formation of retinal lipofuscin (Deguchi et al ,  
1994; Rakoczy et al., 1999; Rakoczy et al., 2002; Sugano et al., 2006). Equally, anti­
oxidants, either enzymatic or not, could be specifically targeted to RPE lysosomes, 
possibly in combination with other treatments to maintain the health of the RPE.
7.2 Conclusions
The work contained within this thesis sought to gain important insight into the 
genesis, phototoxicity and means of degrading retinal lipofuscin. The aims of the 
project were broad in nature; however, they were all interconnected by the theme of 
retinal lipofuscin as detailed in Figure 7 .1.
In summary the conclusions of this study are:
• Retinal lipofuscin contains a minimal amount of protein, but is comprised of a 
number of molecules adducted to lipid peroxidation products.
• Substrates for retinal lipofuscin are derived from material shuttled to RPE
lysosomes during both phagocytosis and autophagy. The material that
accumulates is that which cannot be degraded by the lysosomes.
• POS are the main source of A2E and CEP-adducts for retinal lipofuscin
• Yellow-tinted optical filters provide significantly more protection to in vitro
lipofuscin-loaded RPE cells than UV-blocking optical filters when irradiated
with high intensity blue or full spectrum visible light.
• The phototoxic effect of retinal lipofuscin towards RPE cells is retinal
lipofuscin concentration and light intensity dependant.
• The nanomedicine carrier molecule, dextrin, can be specifically targeted to the 
lysosomal compartment of RPE cells.
• GST has been identified as an enzyme able to assist RPE cells in vitro to 
degrade phagocytosed POS.
• When conjugated, dex-GST can decrease the lipofuscin-like fluorescence of
retinal lipofuscin loaded RPE cells and cause a reduction in granule size when 
treated in vitro.
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Figure 7.1 Flow diagram linking the broad interests of this project. Genesis of retinal lipofuscin via 
incomplete autophagy or phagocytosis may lead to possible deleterious consequences of lipofuscin 
accumulation and its photoreactivity. Additionally, key targets for preventing lipofuscin formation and 
diminishing its phototoxic effects are highlighted, together with the strategies investigated during the 
studies to facilitate that.
7.3 Future work
Results obtained in Chapter 4 using the in vitro lipofuscin formation models indicate 
that they are capable of producing singlet oxygen when excited with short wavelength 
visible light (420 nm). Ex vivo lipofuscin has been demonstrated to also produce other 
ROI including the super oxide anion (Boulton et al., 1993). Analysis of the ability of 
our retinal lipofuscin models to generate such ROI may prove interesting. Also of 
interest would be to analyse whether other lipid peroxidation products such as 
nitrotyrosine and iso[4 ]LGE2 that form adducts in ex vivo retinal lipofuscin were 
present in the in vitro lipofuscin models. This would help to validate the similarity
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between the in v itro  models and ex vivo lipofuscin and also to elucidate whether such 
lipid peroxidation products originated from the phagocytosis source, as did CEP, from 
autophagy, or, both.
Studies conducted in Chapter 3 identified a number o f components of retinal 
lipofuscin granules that have been associated with initiating the onset of AMD. 
Further investigation into the molecular mechanisms by which these compounds act 
could be undertaken. Greater knowledge of lipofuscin bioreactivity pathways could 
assist in developing preventative measures against the onset o f AMD.
In Chapter 5, it w as shown that yellow-tinted lenses were able to reduce the loss in 
cell viability o f lipofuscin loaded cells relative to cells irradiated directly. Recent 
studies by Zhou e t  a l (2006) using an in vitro model demonstrated that irradiation o f 
A2E laden RPE ce lls  resulted in an increase in the level o f complement factor present 
in serum overlying the cell-layer (Zhou et al., 2006). It would be of interest to 
determine w hether stimulation of complement by irradiated, lipofuscin-laden cells 
could be reduced b y  the use of a yellow-tinted blue-light blocking filter.
The work conducted in Chapter 6  was part o f a preliminary study that yielded some 
very interesting results. As such, further research could stem from these introductory 
experiments form ing future projects. Work that could develop from the preliminary 
findings is discussed in Chapter 6 , Section 6.4.
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Appendices
Appendix 1
A. 1.1 Phototoxicity of retinal lipofuscin
ANOVA result obtained from the results of the analysis of the determination of the 
phototoxicity of crude and washed retinal lipofuscin:
p = <0.000001.
The result is only significant if  the p-value is less than 0.05
Post Hoc test using Tukey analysis
Dark Control 
crude LF
Dark control 
washed LF
Light exposed 
no LF
Light exposed 
crude LF
Light 
exposed 
washed LF
Dark Control no LF 0.844575 0.934132 0.750515 <0.000001 <0.000001
Dark Control crude 
LF 0.427568 0.999968 <0.000001 <0.000001
Dark control 
washed LF 0.345919 <0.000001 <0.000001
Light exposed no 
LF <0.000001 <0.000001
Light exposed 
crude LF 0.978901
The result is only significant if the p-value is less than 0.05. Those not significant have been 
highlighted in grey.
Table A .l Statistical analysis o f a comparison o f the phototoxicity o f  crude and washed retinal 
lipofuscin. p-values displayed in this table relate to data displayed in Figure 3.5.
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A. 1.2 Identification of proteins present in crude retinal lipofuscin preparations
Swiss Prot 
Accession Protein8 Calc. Mass5
PI 1488 Guanine nucleotide-binding protein G(t), alpha-1 subunit
(KD)
40
P68871 Hemoglobin subunit beta 16
P68371 Tubulin beta-2C chain 50
P04406 Glyceraldehyde-3 -phosphate dehydrogenase 36
P I2277 Creatine kinase B-type 43
P12271 Cellular retinaldehyde-binding protein 36
P68363 Tubulin alpha-IB chain 50
P08100 Rhodopsin 39 35
P60709 Actin, cytoplasmic 1 42
P14618 Pyruvate kinase isozymes M1/M2 58
Q71U36 Tubulin alpha-1A chain 50
P62873 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta 1 37
Q16518 Retinal pigment epithelium-specific 65 kDa protein 61
P06733 Alpha-enolase 47
P25705 ATP synthase subunit alpha, mitochondrial 60
P I0745 Interphotoreceptor retinoid-binding protein 135
Q9BQE3 Tubulin alpha-1C chain 50
Q9BVA1 Tubulin beta-2B chain 50
P00505 Aspartate aminotransferase, mitochondrial 47
P07195 L-lactate dehydrogenase B chain 37
P07437 Tubulin beta chain 50
P05091 Aldehyde dehydrogenase, mitochondrial 56
P01009 Alpha-1 -antitrypsin 47
Q16555 Dihydropyrimidinase-related protein 2 62
P09211 Glutathione S-transferase P 23
PI 1142 Heat shock cognate 71 kDa protein 71
P07900 Heat shock protein HSP 90-alpha 85
P69905 Hemoglobin subunit alpha 15
P01871 Ig mu chain C region 50
P00338 L-lactate dehydrogenase A chain 37
P10523 S-arrestin 45
P22695 Ubiquinol-cytochrome-c reductase complex core protein 2 48
Q92781 1 1  -cis retinol dehydrogenase 35
P63104 14-3-3 protein zeta/delta 28
P09543 2 ',3 '-cyclic-nucleotide 3'-phosphodiesterase 48
P I0809 60 kDa heat shock protein, mitochondrial 61
P24752 Acetyl-CoA acetyltransferase, mitochondrial 45
Q99798 Aconitate hydratase, mitochondrial 85
P63261 Actin, cytoplasmic 2 42
043707 Alpha-actinin-4 105
Q96NY7 Chloride intracellular channel 6 73
Table A.2 Identification o f proteins isolated from crude retinal lipofuscin preparations after SDS- 
PAGE.
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Swiss Prot
Accession Protein8 Calc.Massb
(KD)
Q00610 Clathrin heavy chain 1 191
P09622 Dihydrolipoyl dehydrogenase, mitochondrial 54
P49411 Elongation factor Tu, mitochondrial 50
P09104 Gamma-enolase 47
P06396 Gelsolin 8 6
P06744 Glucose-6 -phosphate isomerase 63
P00367 Glutamate dehydrogenase 1 , mitochondrial 61
P09471 Guanine nucleotide-binding protein G(o) subunit alpha 1 40
P08107 Heat shock 70 kDa protein 1 70
P19367 Hexokinase-1 1 0 2
P01876 Ig alpha-1 chain C region 38
P01857 Ig gam m a-1 chain C region 36
P01834 Ig kappa chain C region 1 2
P40926 Malate dehydrogenase, mitochondrial 36
P28331 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial 79
P23942 Peripherin-2 39
P30086 Phosphatidylethanolamine-binding protein 1 2 1
P00558 Phosphoglycerate kinase 1 45
P35243 Recoverin 23
Q02846 Retinal guanylyl cyclase 1 1 2 0
Q8TC12 Retinol dehydrogenase 11 35
P I6499 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha 1 0 0
P35913 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta 98
Q5TZA2 Rootletin 228
P02768 Serum albumin 69
Q9BT40 Skeletal muscle and kidney-enriched inositol phosphatase 51
P05023 Sodium/potassium-transporting ATPase subunit alpha-1 113
Q01082 Spectrin beta chain, brain 1 274
P38646 Stress-70 protein, mitochondrial 74
P29401 Transketolase 6 8
P40939 Trifunctional enzyme subunit alpha, mitochondrial 83
P60174 Triosephosphate isomerase 27
P38606 Vacuolar ATP synthase catalytic subunit A 6 8
P21281 Vacuolar ATP synthase subunit B, brain isoform 56
P49748 Very long-chain specific acyl-CoA dehydrogenase, mitochondrial 70
a. Proteins were identified by LC MS/MS following SDS-PAGE fractionation o f crude lipofuscin 
preparation 1
b. Calculated mass based on sequence
Table A. 2 Identification ofproteins isolated from crude retinal lipofuscin preparations after SDS- 
PAGE (continued).
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A ccession* Protein* Calc M a s s c (kD )
Peptide
M atches
t  u tulin beta 49.6 vC
P03023 NaM  - transporting ATPas* * '2 8 43
'-o a ic o R h odopsn 38 9 4 r
7-044 5G Clyr*r*oesiyGe-3-p?70*pha:* dehydrogenase 30 23
Ouar^fNt s e l e c t  de-bnc»ng proten 43 35
c a e o E J Tufcuhn * pha 49 9 29
Actrr 41.7 27
P66 S7’: herspgpoMn sufcc.ni* p#?a '5 27
Pyruvate *inase is o r /r s e s  1214*2 57.9 23
7-07332 C atneosin D piecurso* 44.5 21
"CC20' fVyettn protean p d  jyciein 3C.1 19
pc2im S ifa s i  albumin precursor 0 9 3 13
P?227t C*iu--*r 'sdnatoenyde-fcincing pretem 30 5 14
7-00543 2 \ S-tyclic-nuciercice 3 -phospndd esterase 47.5 12PI7277 C re a te *  -unase 2 -type 42 G 12
H ilton* H4 114 13
P782G3 Refcnar-spacilk: A 7 P .» n # ( ij  cassette  ransoarter 205.8 1 1
706733 iMpha-efvaiasa 47.1 IG
P25705 ATP ly s d u iw  SUteUitfc atpna 59.7 10
f<.euraf cell a d h e s o n  -nolecuie 93.3 10
C 10518 Peir?*? pigment *ctthefcurri-so*cr5c 80 KDa *38 2 10 .
«2t79S V cltage-deqendent anion-se*ectr«-e channel o’otein 1 3C5 10
C0083® E1on®»d©ft facie? l-aipna 2 SC 4 9
OOONvVO K etone H 28 13.9 5
p o seae IVSyelm oasic o ’otei- 33.1 9
780723 Btmn a o d  soluble prc*e*n 1 22.7 8
00081C Clatn t  n heavy zr.»n 1 151 5 8
C033S5 P o d  Oidar s e i n e r s  m em bra?* p-c?ein “ 37.2 8
710523 S-arrestsn 45. ? 5
723634 P lasm a m em brane ca’ciyrn-transo&rlidg A TPase 4 ?37 8 7
002781 1 ?-ci* retinol oefcydrogenese 35 G
Q 18000 Oihycrocy^^iid n*»«*r*stec prcte n 02 3 G
totsgo H eat snec«  protein HSP 84. G 0
735513 R od iQ.VIP-soecir'c 3-.5-cyc c pbcsphcoiesieiss* 98 3 0
P i ? 108 S d u te  rarne? f e n  v 2 54 G
707?95 L-lactate dehyore-dsr.sse 38.0 5
7005 58 Thcspboylycerate «ins*e - 44 G 5
755243 Reccverin 23.1 5
0028*50 Reims* guanyyi cyco»« 1 p re c is e ? 12C 5
747084 R P E -re tn a ; G proiesn«c-&;jp;ed receptor 31.2 5
p e a 133 An-exm 75.5 4
702*288 Ub*qu4in 8 0 4
015830 Ves*c?e-*is©©r*5a© m em brane protein 3 11.3 4
708237 0-prcepPcffuctci<intase 85.1 3
7C231' Ajprta cp-statttn 20.1 3
PCC505 A sparute  ar* n jfca-rsferas* 47 4 3
743-329 B eta r /s ta 23 4 3
743003 Escdt; t n : acid transporter 1 5 9  S 3
7CS972 Frucsos fci*P «ph*?e aidoias* C 39 4 3
PC6737 Glycogen phosphcrylaae 97.1 3
7*1*42 H eal sboc* c e r a t e  7 '  4 0 s  protein 78 3 3
014188 Lysosom e -rterrfcrane prete n 2 54 3 3
735625 i^etallcproceinase ’-■note- 3 precursor 24 ' 3
720041 7ef«*iredcxm-8 25 3
G5HCL4 R as -re a re d  prote -  Aafc* 13 22 2 3
pm  74 TriOsephosoPaie *c*n« « w 20.7 3
OOS752 •5C KDa pepbdyl-prci, o s -  rans isontefase 48 7 2
708195 t - 2  cetl-surfece a n ta a '- -eavy en s n 57.3 'Ti
013518 Ac d ceram idase p -e r-  *or 44. G 2
PC-cm Alp -a- * -g-a*.fyps ft a t e .  «cr 40.7 2“
725973 cOU*P gatec c a a c -  c*,»"nel afcHa 1 79.1 2
pcmc* 3 Cytcc’  c - ie  c  osc dase subunit 2 25-5 2
709104 CaTtsna-enclase 47.2 2
7C6-74-4 Gl^cose-O-pbospbate iso rserase 03.1 2
7?7C0G H eal ■*'rc-t 7:< /,D i p-ctem 0 71 2
012931 H eat 2 'o r -r  oroier- 75 O a 80- * 2
O0P8F7 Lewc;ne-nch f«p»»t>conft*n;r9  proteifi 8B 92 3 2
014894 12 .-t*T allin  -o rrp o g 33,& 2
C972S2 Neure« n-2-alpha precursor 1849 2
000325 Pticsphate  carrier prote - 40 i 2
7070-32 P ic a c f ra tp ' pclypepfcc# precursor 58.1 2
OSNOY7 P rc p a a *  phcsphosty re  *a*.e mutas* 4 28.8 2
0434SC P rcn in rn - ' precursor 97 • 2
037C12 R e trc l  cebycrpgenase 1' 35 4 2
013813 SpectRn alpTa cner., brain 284 4 2
725*191 Trans<«:clase 07.-8 2
72128? Vacuolar A7“  syn tnsse ssA^nd B 53.5
a. Swiss-Protein database accession numbers.
b. Proteins were identified by LC MS/MS following off-line SCX and RP-HPLC fractionation of 
a tryptic digest o f crude lipofuscin
c. Based on protein sequence
Table. A. 3 Proteins identified from  crude lipofuscin after SCX chromatography.
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Appendix 2.
Statistical analysis o f work conducted in Chapter 4.
A.2.1 Identification of a lysosomal enriched fraction using lysosomal enzyme 
assays
A.2.1.1 Acid phosphatase
ANOVA results obtained from the analysis of a comparison of the Acid phosphatase 
activity in each cell fraction during the isolation of an enriched lysosomal fraction:
p = 0 . 0 0 0 0 1
The result is only significant if  the p-value is less than 0.05
Post Hoc test using Tukey analysis
Fraction 2 Fraction 3 Fraction 4
Fraction 1 0.002032167 0.001544862 0.000353720
Fraction 2 0.000637654 0.000000669
Fraction 3 0.000000179
The result is only significant if  the p-value is less than 0.05. Those not significant have been 
highlighted in grey.
Table A.2.1 Statistical analysis o f  a comparison o f the Acid phosphatase activity in each 
sedimentation fraction during the isolation o f an enriched lysosomal fraction, p- values displayed in 
this table relate to data displayed in Figure 4.2 a
A.2.1.2 N-acetlvl (3-D glucuronidase
ANOVA results obtained from the analysis of a comparison o f the N-acetlyl (3-D 
glucuronidase activity in each cell fraction during the isolation of an enriched 
lysosomal fraction: 
p = 0.00061
The result is only significant if  the p-value is less than 0.05
Post Hoc test using Tukey ana ysis
Fraction 2 Fraction 3 Fraction 4
Fraction 1 0.011877757 0.002523523 0.000036887
Fraction 2 0.000712261 0.000216566
Fraction 3 0.000712261 0.000397864
The result is only significant if  the p-value is less than 0.05. Those not significant have been 
highlighted in grey.
Table A.2.2 Statistical analysis o f a comparison o f the N-acetlyl p-D glucuronidase activity in each 
sedimentation fraction during the isolation o f an enriched lysosomal fraction, p-values displayed in 
this table relate to data displayed in Figure 4.2 b.
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A2.1.3 Cathepsin D
ANOVA results obtained from the analysis of a comparison of the Cathepsin D 
activity in each cell fraction during the isolation of an enriched lysosomal fraction: 
p= 0.00003
The result is only significant if  the p-value is less than 0.05
Post Hoc test using Tukey analysis
Fraction 2 Fraction 3 Fraction 4
Fraction 1 0.002032167 0.001544862 0.00035372
Fraction 2 0.00063765 0.00000067
Fraction 3 0.000637654 0.00000018
The result is only significant if  the p-value is less than 0.05. Those not significant have been 
highlighted in grey.
Table A.2.3 Statistical analysis o f  a comparison o f the Cathepsin D activity
in each sedimentation fraction during the isolation o f an enriched lysosomal fraction, p-values 
displayed in this table relate to data displayed in Figure 4.2 c.
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Appendix 3
Student’s t-tests conducted in Excel (Microsoft, USA) were used to determine the 
significance o f results containing only two test conditions. One way ANOVA was 
used with Tukey’s post-hoc test in SPSS (USA) to compare cell viability when 
multiple conditions were used to identify any significant changes.
A.3.1 Optimisation of experimental conditions
t-test analysis o f the means o f cells, either exposed to retinal lipofuscin or not, were 
conducted using Excel (Microsoft, USA) to determine if  there was a significant 
difference between the conditions.
Mean Variance p value
Cell with retinal lipofuscin 67.5 156.9 0.003
Cells minus retinal lipofuscin 95.3 146.5 0.003
Table A.3.1 1-test results used to determine whether the cell viability o f cells irradiated with blue- 
light (400-500 nm, 2.8 mW/cm2) fo r  24 hours, plus or minus retinal lipofuscin, was significantly 
different. The p-values in this table refer to the data found in Figure 5.3.
Mean Variance p value
Cell with retinal lipofuscin 43.9 108.6 0.00003
Cells minus retinal lipofuscin 84.0 30.9 0.00003
Table A.3.2 t-test results used to determine whether the cell viability o f cells irradiated with blue- 
light (400-500 nm, 2.8 mW/cm2)  fo r  48 hours, plus or minus retinal lipofuscin, was significantly 
different. The p-values in this table refer to the data found in Figure 5.4.
A.3.2 Determination of the phototoxicity of lipofuscin as a function of the 
number of granules taken up by RPE cells
A.3.2.1 Blue-light studies
ANOVA result obtained from the analysis o f the quantification o f retinal lipofuscin 
phototoxicity as a function o f granule number when irradiated with blue-light (400- 
500 nm, 2.8 mW/cm2):
p = 0 . 0 0 0 0 0
The result is only significant if  the p value is less than 0.05.
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Post Hoc test using Tukey analysis
10 granules 50 granules
100
granules
300
granules
500
granules
700
granules
0 granules 0. 3708 0.000013 <0.000001 <0.000001 <0.000001 <0.000001
10 granules 0.039112 0.000023 <0.000001 <0.000001 <0.000001
50 granules 0.007779 <0.000001 <0.000001 <0.000001
100 granules <0.000001 <0.000001 <0.000001
300 granules 0.251902 0.006063
500 granules 0.383741
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.3 Statistical analysis o f  the quantification o f retinal lipofuscin phototoxicity as a function 
of granule number when irradiated with blue-light (400-500 nm, 2.8 mW/cm2). The p-values 
contained within this table relate to the data displayed in Figure 5.5 (A).
A.3.2.2 White-light studies
ANOVA result obtained from the analysis of the quantification of retinal lipofuscin 
phototoxicity as a function o f granule number when irradiated with white-light (2 . 8  
mW/cm2):
p = 0 . 0 1
The result is only significant if  the p value is less than 0.05.
Post Hoc test using Tukey analysis
10 granules 50 granules
100
granules
300
granules
500
granules
700
granules
0 granules 0.9316878 0.9312835 0.9029033 0.0746920 0.0089449 0.0014719
10 granules 1.0000000 0.9999999 0.3860154 0.0601822 0.0096998
50 granules 0.9999999 0.3867314 0.0603350 0.0097253
100 granules 0.4331785 0.0707025 0.0114645
300 granules 0.8916429 0.3599983
500 granules 0.9434738
The result is only significant if  the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.4 Statistical analysis o f  the quantification o f retinal lipofuscin phototoxicity as a function 
of granule number when irradiated with white-light (2.8 mW/cm ). The p-values contained within this 
table relate to the data displayed in Figure 5.5 (B).
ANOVA result obtained from the analysis of the quantification of retinal lipofuscin 
phototoxicity as a function o f granule number when irradiated with white-light (13 
mW/cm2):
p = <0 . 0 0 0 0 1
The result is only significant if  the p value is less than 0.05.
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Post Hoc test using Tukey analysis
10 granules 50 granules
100
granules
300
granules
500
granules
700
granules
0 granules 0.10372 <0.000001 <0.000001 <0.000001 <0.000001 <0.000001
10 granules <0.000001 <0.000001 <0.000001 <0.000001 <0.000001
50 granules <0.000001 <0.000001 <0.000001 <0.000001
100 granules 0.006 <0.000001 <0.000001
300 granules 0.035 <0.000001
500 granules 0.191000
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.5 Statistical analysis o f  the quantification o f retinal lipofuscin phototoxicity as a function 
of granule number when irradiated with white-light (13 mW/cm ). The p-values contained within this 
table relate to the data displayed in Figure 5.5 (C).
A.3.3 Assessment of optical filters in reducing the lipofuscin phototoxicity to 
RPE cells
A.3.3.1 Blue-light studies
ANOVA result obtained from the analysis of the effect of blue-light (400-500 nm, 2.8 
mW/cm2) irradiation and lipofuscin-loading on the cell viability of ARPE-19 cells:
p = <0 . 0 0 0 0 1
The result is only significant if  the p value is less than 0.05.
Post Hoc test using Tukey analysis
No filter plus LF
Control filter 
plus LF Filter 1 plus LF
Filter 2 plus 
LF
Dark control plus 
LF <0.0001 <0.0001 <0.0001 <0.0001
No filter plus LF 0.0038 <0.0001 <0.0001
Control filter plus 
LF <0.0001 0.0001
Filter 1 plus LF 0.9869
The result is only significant if  the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.6 Statistical analysis o f the effect o f blue-light (400-500 nm, 2.8 mW/cm) 
irradiation and lipofuscin-loading on the cell viability o f ARPE-19 cells. The p-values 
contained within this table relate to the data displayed in Figure 5.10
ANOVA result obtained from the analysis of the effect o f blue-light (400-500 nm, 2.8 
mW/cm2) irradiation on the cell viability of ARPE-19 cells:
p = <0 . 0 0 0 0 1
The result is only significant if  the p value is less than 0.05.
221
Matthew Davies Appendices
Post Hoc test using Tukey analysis
No filter Control filter Filter 1 Filter 2
Dark <0.0001 <0.0001 0.0037 0.8146
No filter 0.9312 0.0002 <0.0001
Control filter 0.0005 <0.0001
Filter 1 0.0185
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.7 Statistical analysis o f  the effect o f blue-light (400-500 nm, 2.8 mW/cm2) irradiation on 
the cell viability o f ARPE-19 cells. The p-values contained within this table relate to the data displayed 
in Figure 5.10.
A.3.3.2 White-light studies
ANOVA result obtained from the analysis of the effect o f white-light (2.8 mW/cm2) 
irradiation and lipofuscin-loading on the cell viability of ARPE-19 cells:
p = <0 . 0 0 1
The result is only significant if  the p value is less than 0.05.
Post Hoc test using Tukey analysis
No filter plus LF
Control filter 
plus LF Filter 1 plus LF
Filter 2 plus 
LF
Dark control plus 
LF 0.1396 0.2321 0.3974 0.9321
No filter plus LF 0.9961 0.9350 0.4023
Control filter plus 
LF 0.9930 0.5895
Filter 1 plus LF 0.8132
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey> ,Table A.3.8 Statistical analysis o f the effect o f white-light (2.8 mW/cm )  irradiation and lipofuscin- 
loading on the cell viability o f ARPE-19 cells. The p-values contained within this table relate to the 
data displayed in Figure 5.11.
ANOVA result obtained from the analysis of the effect o f  white-light (2.8 mW/cm2) 
irradiation on the cell viability o f ARPE-19 cells:
p = <0 . 0 0 1
The result is only significant if  the p value is less than 0.05.
Post Hoc test using Tukey analysis
No filter Control filter Filter 1 Filter 2
Dark control 0.7431 0.8252 0.6110 0.9981
No filter 0.9998 0.9992 0.5802
Control filter 0.9938 0.6720
Filter 1 0.4518
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.9 Statistical analysis o f the effect o f white-light (2.8 m W /cm ) irradiation on the cell 
viability o f ARPE-19 cells. The p-values contained within this table relate to the data displayed in 
Figure 5.11.
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ANOVA result obtained from the analysis of the effect of white-light (13 mW/cm2) 
irradiation and lipofuscin-loading on the cell viability of ARPE-19 cells:
p = <0 . 0 0 1
The result is only significant if  the p value is less than 0.05.
Post-Hoc test using Tukey analysis
No filter plus LF
Control filter 
plus LF Filter 1 plus LF
Filter 2 plus 
LF
Dark control plus 
LF <0.0001 <0.0001 <0.0001 <0.0001
No filter plus LF 0.0020 <0.0001 <0.0001
Control filter plus 
LF 0.0033 0.0007
Filter 1 plus LF 0.7704
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.10 Statistical analysis o f the effect o f white-light (13 mW/cm2) irradiation and lipofuscin- 
loading on the cell viability o f  ARPE-19 cells. The p-values contained within this table relate to the 
data displayed in Figure 5.12.
ANOVA result obtained from the analysis of the effect o f white-light (13 mW/cm ) 
irradiation on the cell viability o f ARPE-19 cells:
p = <0 . 0 0 1
The result is only significant if  the p value is less than 0.05.
Post-Hoc test using Tukey analysis
No filter Control filter Filter 1 Filter 2
Dark control <0.0001 <0.0001 <0.0001 <0.0001
No filter 0.0243 0.0001 0.0001
Control filter 0.0064 0.0085
Filter 1 0.9996
The result is only significant if  the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.11 Statistical analysis o f the effect o f white-light (13 mW/cm)  irradiation on the cell 
viability o f ARPE-19 cells. The p-values contained within this table relate to the data displayed in 
Figure 5.12.
ANOVA result obtained from the analysis of the effect o f white-light (19 mW/cm2) 
irradiation and lipofuscin-loading on the cell viability of ARPE-19 cells:
p = <0 . 0 0 1
The result is only significant if  the p value is less than 0.05.
223
Matthew Davies Appendices
Post-Hoc test using Tukey analysis
No filter plus LF
Control filter 
plus LF Filter 1 plus LF
Filter 2 plus 
LF
Dark control plus 
LF <0.0001 <0.0001 <0.0001 <0.0001
No filter plus LF 0.8869 0.0115 0.0064
Control filter plus 
LF 0.0431 0.0252
Filter 1 plus LF 0.9938
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.12 Statistical analysis o f  the effect o f white-light (19 mW/cm2) irradiation and lipofuscin- 
loading on the cell viability o f  ARPE-19 cells. The p-values contained within this table relate to the 
data displayed in Figure 5.12.
ANOVA result obtained from the analysis of the effect of white-light (19 mW/cm2) 
irradiation on the cell viability o f ARPE-19 cells:
p = <0 . 0 0 1
The result is only significant if  the p value is less than 0.05.
Post-Hoc test using Tukey analysis
No filter Control filter Filter 1 Filter 2
Dark control <0.0001 <0.0001 <0.0001 <0.0001
No filter 0.9741 0.0065 0.0029
Control filter 0.0156 0.0068
Filter 1 0.9784
The result is only significant if the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.3.13 Statistical analysis o f the effect o f white-light (19 mW/cm )  irradiation on the cell 
viability o f ARPE-19 cells. The p-values contained within this table relate to the data displayed in 
Figure 5.12.
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Appendix 4
Student’s t-tests conducted in Excel (Microsoft, USA) were used to determine the 
significance o f results containing only two test conditions. One way ANOVA was 
used with Tukey’s post-hoc test in SPSS (USA) to identify any significant differences 
in results when multiple conditions were used.
A.4.1 Succinoylated dextrin safety
t-test analyses were conducted using Excel software (Microsoft, USA) to compare the 
viability of cells maintained in basal medium or basal medium supplemented with 
succinoylated dextrin over a 2 1  day period.
The p-value given in table A.4.1 refers to the difference in mean cell viability between 
the control cells maintained in basal medium and those in basal medium 
supplemented with succinoylated dextrin at the corresponding time-points.
p-value
BMSD Day 0 0.676
BMSD Day 7 0.591
BMSD Day 14 0.410
BMSD Day 21 0.160
The result is only significant if  the p value is less than 0.05. Those not significant are highlighted in 
grey.
Table A.4.1 Shows a comparison o f  the means o f cells maintained in basal medium or basal medium 
supplemented with succinoylated dextrin (BMSD) after 0, 7 ,14 and 21 days.
A.4.2 Prevention of the accumulation of lipofuscin-like fluorescence in RPE cells
ANOVAs were used to determine whether the difference in the lipofuscin-like 
fluorescence of cells loaded with POS in the presence or absence of GST were 
significant.
A.4.2.1 7 day trial
ANOVA results obtained from the analysis o f lipofuscin-like fluorescence of ARPE- 
19 cells after 7 days under each o f the conditions; 
p = 0.0003.
The result is only significant if  the p value is less than 0.05.
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Post Hoc test using Tukey analysis
BM + SD BM + POS
BM + POS + 
10 units GST
BM + POS + 4 
units GST
BM + POS + 1 
unit GST
BM 0.9999999 0.0039157 0.010292345 0.006069 0.005387
BM + SD 0.004249 0.011194 0.006594 0.005850
BM + POS 0.990179 0.999759 0.999949
BM + POS + 10 
units GST 0.99944463 0.998508551
BM + POS + 4 
units GST 0.999999631
The result is only significant if the p value is less than 0.05. Results not significant are highlighted grey 
Table A.4.2 Statistical analysis o f  the lipofuscin-like fluorescence o f ARPE-19 cells after 7 days with 
or without POS and or GST. The p-values contained within this table relate to data displayed in Figure
6.12
A.4.2.2 14 day trial
ANOVA result obtained from analysis of the lipofuscin-like fluorescence of ARPE-19 
cells after 14 days under each of the conditions;
p = 0 . 0 0 0 1 0 2
The result is only significant if  the p value is less than 0.05.
Post Hoc test using Tukey analysis
BM + SD BM + POS
BM + POS + 
10 units GST
BM + POS + 4 
units GST
BM + POS + 1 
unit GST
BM 0.999993 0.0008882 0.004857382 0.003559367 0.001880
BM + SD 0.001085 0.006022 0.004403 0.002312
BM + POS 0.882398 0.943456 0.995873
BM + POS+ 10 
units GST 0.999954302 0.989793712
BM + POS + 4 
units GST 0.998332466
The result is only significant if  the p value is less than 0.05. Results not significant are highlighted grey 
Table A.4.3 Statistical analysis o f  the lipofuscin-like fluorescence o f ARPE-19 cells after 14 days 
with or without POS and or GST. The p-values contained within this table relate to data displayed in 
Figure 6.12
A.4.2.3 21 day trial
ANOVA result obtained from analysis o f the lipofuscin-like fluorescence of ARPE-19 
cells after 2 1  days under each of the conditions;
p = 0 . 0 0 0 0 0 0 1 0
The result is only significant if  the p value is less than 0.05.
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Post Hoc test using Tukey analysis
BM + 
SD BM + POS
BM + POS + 
10 units GST
BM + POS + 4 
units GST
BM + POS + 1 
unit GST
BM 0.999956 0.000001 0.000044 0.000017 0.000006
BM + SD 0.000001 0.000056 0.000021 0.000008
BM + POS 0.013233 0.048889 0.196012
BM + PO S+ 10 
units GST 0.966797 0.591144
BM + POS + 4 
units GST 0.948258
The result is only significant if  the p value is less than 0.05. Results not significant are highlighted grey 
Table A.4.4 Statistical analysis o f  the lipofuscin-like fluorescence o f ARPE-19 cells after 21 days 
with or without POS and or GST. The p-values contained within this table relate to data displayed in 
Figure 6.12
A.4.3 Assessment of the use of GST in degrading lipofuscin in RPE cells when in 
its free state or when conjugated to the dextrin polymer
A.4.3.1 Lipofuscin-like fluorescence of cells measured in cells with or without 
lipofuscin and/or free GST.
ANOVA result obtained from analysis of the lipofuscin-like fluorescence of ARPE-19 
cells under each o f the conditions;
p = <0 . 0 0 0 1
The result is only significant if  the p value is less than 0.05.
Post Hoc test using Tukey analysis _________________
BM + 
GST BM + LF BM + LF + GST
BM 0.999984 0.000003 0.000003
BM + GST 0.000002 0.000002
BM + LF 1.000000
The result is only significant if  the p value is less than 0.05. Results not significant are highlighted grey 
Table A.4.5 Statistical analysis o f the lipofuscin-like fluorescence o f ARPE-19 cells with or without 
lipofuscin and or GST. The p-values contained within this table relate to data displayed in Figure 6.14
A.4.3.2 Lipofuscin-like fluorescence of cells measured in cells with or without 
lipofuscin and/or dex-GST.
ANOVA result obtained from analysis of the lipofuscin-like fluorescence of ARPE-19 
cells under each o f the conditions;
p = <0 . 0 0 0 0 0 1
The result is only significant if  the p value is less than 0.05.
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Post Hoc test using Tukey analysis
BM + 
GST BM + LF
BM + LF + 
dex-GST
BM 0.950195 <0.000001 <0.000001
BM + 
dex-GST <0.000001 <0.000001
BM + LF <0.000001
The result is only significant if  the p value is less than 0.05. Results not significant are highlighted grey 
Table A.4.6 Statistical analysis o f the lipofuscin-like fluorescence o f ARPE-19 cells with or without 
lipofuscin and or dex-GST. The p-values contained within this table relate to data displayed in Figure
6.15
Mean Variance p value
BM and lipofuscin 0.72 0.023 0.001149
BM, lipofuscin and dex-GST 0.527 0.027 0.001149
The result is only significant if  the p value is less than 0.05
Table A.4.7 t-test results used to determine whether the mean size o f lipofuscin granules in cells 
maintained with or without dex-GST was significantly different. The p-values contained within this 
table relate to data displayed in Table 6.3
Mean Variance p value
BM and lipofuscin 10.852 21.714 0.017
BM, lipofuscin and GST 6.021 29.016 0.017
The result is only significant if the p value is less than 0.05
Table A.4.8 t-test results used to determine whether the mean area o f cell cytoplasm occupied by 
lipofuscin granules in cells maintained with or without dex-GST was significantly different. The p- 
values contained within this table relate to data displayed in Table 6.3
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Appendix 5 
Solutions
10 x PBS (1000 ml)
80.Og NaCl (Sodium Chloride):
2.0g KC1 (Potassium Chloride):
14.4g Na2 PC>4 (di-Sodium Hydrogen Orthophosphate anhydrous)
2.4g KH2 PO4 (Potassium dihydrogen orthophosphate)
Disolves in 800 ml dH2 0 , adjusts pH to 7.4 (using HC1), add up to 1000 ml of dH20, 
mix well for use. To make 1 x PBS: dilute 1 Ox PBS 1:10 in dH2 0 , mix well for use.
Trypsin —EDTA solution
0.25% (m/v) trypsin 
0.05% (m/v) EDTA
Disolve in 1 x PBS, mix thoroughly, filtered using 0.2 pm filter, store at -20°C in 
aliquots.
Sucrose solutions (2 M)
171 g Sucrose
250 ml ddH2 0 .
Subsequent sucrose solutions were generated by diluting the stock solution with 
ddH20
Tris-acetate (40 mM, 1000 ml)
242 g Tris (Trizma) base
57.1 ml Glacial acetic acid
Make up to 1 L with ddH2 0 . The stock Tris-acetate was diluted with ddH2 0  according 
to the concentration needed.
SDS sample buffer (5x)
5 ml Glycerol
1 g SDS
2.56 ml 0 .1M D T T
2.13 ml 0.5 M Tris-HCl pH 6 . 8
Sample buffer was stored in 1 ml aliquots at -20°C until needed. Sample buffer was 
diluted to lx  using ddH2 0  when needed.
DTT solution
A stock 1 M solution o f DTT was created by dissolving 1.5425 g of DTT in 10 ml of 
ddH2<3 . The stock solution was diluted according to the required concentration for 
experiments.
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Gel solutions
Resolving gel (10%) 
(10 ml)
Stacking gel (5%) 
(3 ml)
Distilled H 20 4.0 ml 2.1 ml
30% acrylamide mix 3.3 ml 500 pi
1.5 M Tris/HCl pH 8.8 2.5 ml -
1.0 M Tris/HCl pH 6.8 - 380 pi
10% SDS 100 pi 30 pi
10% APS 100 pi 30 pi
TEMED 4 pi 3 pi
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